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Injurious falls in community-living older adults are associated with standing up suggesting that 
cerebral hypoperfusion following a postural transition might be a contributing factor. A large 
population study has recently indicated that one fifth of older adults do not fully recover BP after 
standing from a supine posture. The purposes of this thesis were to provide a comprehensive 
assessment between posture-related cerebral hypoperfusion and impaired postural stability, altered 
gait and falls in older adults. 
This thesis measured arterial blood pressure regulation and cerebral tissue oxygenation (tSO2) 
during orthostatic stressors including 3 different transitions to standing in older adults (n=77, ages 69-
100 years, average = 86.6±6.6 years) and 2 different transitions to walking in a sub-group of these 
older adults (n=27, ages 71-101 years, average = 86.8±5.3 years). Primary results included the finding 
that, like the altered blood pressure responses, 19.5% of older adults had low tSO2 on standing, and 
they had poorer postural stability. It was also found that a brief 10-s sitting-pause time improved tSO2 
and postural stability when performing a supine-sit-stand. Prospective tracking of older adults for 6-
months revealed a trend to an increased likelihood of a future fall in those who had the greatest drop 
in tSO2 on standing. Older adults with low tSO2 (≤60%) during walking had compromised gait dynamics 
(increased step-step variability).  Although gait speed was not directly related to reduced tSO2, the 
increased mean gait cycle time and stance time associated with changes in OxHb of the older adults 
with low tSO2 were significantly associated with reduced gait speed.  Increased vascular stiffness was 
associated with lower CBF and altered cerebrovascular hemodynamics while walking as well as lower 
gait speed. Collectively, the findings from these two investigations support a relationship between 
cerebral hypoperfusion induced by transitions from supine to upright posture and compromised 
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CHAPTER 1. REVIEW OF LITURATURE 
Preamble 
The proportion adults, aged 65 years and older, is increasing worldwide. The aging 
demographic is attributed to a decline in fertility rates and increased longevity of the older adult 
population. Globally, the proportion of older adults relative to the total population will double over 
the next 50 years, with proportions expected to be as high as 37% in more developed countries 
(United Nations 2002). In Canada, one in every four people will be aged 65 years or older by the year 
2051 (Statistics Canada 2011a).   
It is estimated that a third of older adults fall each year (Tromp et al. 2001).  Falls in older 
adults can have devastating impacts, accounting for 85% of all injury-related hospitalizations, 40% of 
nursing home admissions and approximately 20% of deaths due to injury (Statistics Canada 2011b). 
Falls also impact balance confidence and increase an individual’s fear of falling.  A fear of falling 
typically leads to limited involvement in activities which reduces strength and flexibility, placing the 
individual at an increased risk of falling and a lower quality of life (Cumming R.G. et al. 2000).   
Canada is a developed country and is in an advanced stage of demographic transition, 
implying that interventions designed to identify and reduce fall risk may have major health benefits 
for thousands of Canadians. Although the causes of falls are multifactorial, the literature suggests a 
clear relationship between impaired blood pressure regulation, or reduced cerebral blood flow 
regulation and fall risk  (Kario K. et al. 2001; Heitterachi E. et al. 2002; Quach L. et al. 2011; Sorond F.A. 
et al. 2011; Finucane C. et al. 2017; Gutkin M. & Stewart J.M. 2016; Mehagnoul-Schipper D.J. et al. 
2000b).  Orthostatic hypotension (OH) is defined as a sustained reduction of systolic blood pressure 




greater than 10 mmHg within three minutes of standing (Freeman et al. 2011). Initial OH is defined as 
a transient fall in SBP equal to or greater than 40 mmHg or DBP equal to or great than 20 mmHg 
within 15 seconds of standing (Freeman et al. 2011). Incidence rates of OH increase with age (Masaki 
K.H. et al. 1998; Gupta V. & Lipsitz L.A. 2007; Tilvis R.S. et al. 1996) and are shown to be a predictor of 
falls in older adults (Ooi et al. 2000; Gangavati A. et al. 2011).   
Posture changes are known to be an orthostatic stressor, as they cause a redistribution of 
blood volume, which evokes a reduction in mean arterial pressure.  Following a posture change, mean 
arterial pressure has been shown to account for half the reductions observed in cerebral blood flow 
(CBF) (Kim Y.S. et al. 2011).  If cerebral perfusion is not maintained, light-headedness and dizziness 
may ensue, thus leading to a potential fall.  Orthostaic hypotension and poor recovery of blood 
pressure (BP) are independent risk factors for future falls, unexplained falls and injurious falls  
(Finucane C. et al. 2017).  Yet the relationships between cerebral blood flow and oxygenation, with 
postural control or fall history has not been investigated.  
 
Cerebral Blood Flow 
The human brain accounts for merely two percent of total body weight yet requires 12-15 
percent of resting cardiac output and 15-20 percent of the resting metabolic rate (Rowell L.B. 
1993))p.242). Evidently, the brain is a highly metabolic organ which requires a constant and stable 
delivery of blood flow to ensure an adequate supply of oxygen (O2) and glucose, and the clearance of 
carbon dioxide (CO2). When cerebral blood flow is unstable or inadequate, functional activity is 
reduced.  A 50% reduction in cerebral perfusion below resting supine values marks the critical lower 
limit of cerebral perfusion where syncope develops (Njemanze P.C. 1992). Cerebral oxygenation is 




when syncope develops, following 5-7 seconds of neck occlusion (Rossen L.R. et al. 1943), both 
perfusion and oxygenation impact neuronal activity.  The tight relationship between insufficient 
perfusion/oxygenation to syncope demonstrates the low metabolic reserve of cerebral tissue (van Dijk 
& Wieling 2013), and the gravity of a disrupted or insufficient amount of cerebral blood flow.  
 
Regulation of Cerebral Blood Flow 
The brain demonstrates low metabolic reserve which is tightly coupled to neuronal activity, 
suggesting hypoperfusion can cause functional decline (Njemanze P.C. 1992; Rossen L.R. et al. 1943) 
and eventually tissue damage if flow is not re-established.  Since the brain is encapsulated by a rigid 
structure high levels of intracranial pressure can also cause severe cortical damage.  Thus, tight 
regulation of cerebral blood flow is essential to avoid excessive hypo- and hyper-perfusion.   Global 
cerebral blood flow is in part regulated by neurological regulation (sympathetic and parasympathetic 
components); however, it is the microcirculation (arterioles and capillaries) which regulates 
cerebrovascular resistance and greatly impacts cerebral blood flow (Equation 1-1). The myogenic 
response, neurological coupling and metabolic response, and chemical regulation (gas tension) are the 
local regulators of the microcirculation. 
 
Cerebral Blood Flow = Mean Arterial Pressure – Intracranial Pressure 
     Resistance 
Equation 1-1. Ohm’s Law for Regulation of Cerebral Blood Flow 
 
Neurological regulation  
Sympathetic fibers of extra-cerebral blood vessels originate from the superior cervical 




originate at the trigeminal ganglion (Hamel E. 2006).  Both sympathetic and parasympathetic activities 
have been shown to regulate cerebral blood flow.  A study by Mitchell et al. (2009) recorded the 
release rate of noradrenaline into the plasma, which is referred to as the ‘noradrenaline spillover’ 
(Mitchell D.A. et al. 2009; Seifert T. 2011).  Noradrenaline is an indicator of cerebrovascular 
sympathetic nerve activity since it is the primary neurotransmitter of the sympathetic nerves (Mitchell 
D.A. et al. 2009). When postganglionic sympathetic nerve activity is reduced (via clonidine and 
trimethaphan) jugular noradrenaline spillover is significantly reduced, suggesting sympathetic nerves 
have a regulatory function for cerebral blood flow outside of the brain blood barrier (Mitchell D.A. et 
al. 2009). Animal models have also demonstrate sympathetic nerve activity to protect the cerebral 
circulation against increases in blood pressure while sleeping (Loos N. et al. 2005). 
 The parasympathetic nervous system acts on the pial and arteriolar vessels through the 
release of potent vasodilators, namely acetylcholine, vasoactive intestinal peptide, substance-P and 
calcitonin gene-related peptide (Branston N.M. 1995; Farkas E. & Luiten P.G.M. 2001). As mentioned 
above, the parasympathetic activity is derived from the sphenopalatine ganglion, where removal of 
the sphenopalatine ganglion in rats results in a reduction of cerebral blood flow while still maintaining 
blood pressure (Boysen et al. 2009).  This demonstrates the vasodilatory capacity of parasympathetic 
activity on cerebral blood flow. Although parasympathetic activation can stimulate vasodilation, it 
does not appear to be a primary flow regulator in normal conditions, rather, its effects are 
predominately observed in pathological conditions (ischemia and migraines) (Hamel E. 2006).   
Arterioles and capillaries are not directly innervated by sympathetic and parasympathetic nerve fibers 
(Hamel E. 2006).  The cerebral parenchyma loses the peripheral nerve supply and the neural input is 
then received by neurons located within the brain (termed intrinsic innervation). Hence, sympathetic 




surface of the brain and the capacity of sympathetic and parasympathetic activity is to regulate 
cerebral blood flow is limited because vascular resistance is predominantly mediated by the 
microcirculation (Hamel E. 2006).   
 
Myogenic Response  
The myogenic response, also known as the ‘Bayliss effect’, is the smooth muscle reflex to a 
change in intravascular pressure (Bayliss N. 1902). The myogenic behaviour acts to protect 
downstream arterioles and capillaries form high levels of damaging perfusion by means of 
vasoconstriction in response to an increase in arterial pressure, and to ensure adequate tissue 
perfusion is maintained by means of vasodilation when arterial pressure decreases.  
 Increases in transmural pressure cause depolarization of the muscle cell membrane and 
opening of the voltage-gated calcium channels (Jaggar J.H. 2001).  With the release of calcium, 
vasoconstriction develops via increases in myosin light-chain phosphorylation (Jaggar J.H. 2001).  In 
humans, the calcium mediated response of active tone is present from 20 mmHg to 90 mmHg in 
cerebral resistance arteries (Wallis S.J. et al. 1996).  However, when calcium is abolished and 
intraluminal pressure is still raised, effective vascular constriction is no longer evident (Wallis S.J. et al. 
1996).  This suggests, the myogenic response is abolished by the deduction of extracellular calcium, 
making it a calcium dependent mechanism. Furthermore, the myogenic response is independent of 
the endothelium (Wallis S.J. et al. 1996). This is demonstrated by the removal of the endothelium (by 
passing an air bolus through the vessel) and exposing the vessel to a substance shown to elicit 
endothelial-dependent relaxation (Wallis S.J. et al. 1996). These findings are consistent with rat 
studies (McCarron J.G. et al. 1989; Smeda J.S. et al. 1989) but controversial in feline studies (Harder 




size, or the methods used to remove the endothelium (Wallis S.J. et al. 1996).  Despite the evidence 
from animal endothelial-dependent studies, the myogenic response in cerebral arteries is evident in 
humans (Wallis S.J. et al. 1996) (review by  (Koller A. & Toth P. 2012)). 
 
Neurovascular Coupling and Metabolic Regulation 
Neurovascular coupling, often termed as functional hyperemia, describes the increase in 
blood flow to cerebral tissue in neutrally active regions (Atwell D. et al. 2010).   Recent evidence 
supports a feed forward mechanism (neuronal activity → increase CBF → energy supplied) where 
neurotransmitter-mediated signaling, mainly the synaptic release of glutamate, controls cerebral 
blood flow through the activation of astrocytes (review by  (Atwell D. et al. 2010)).  Astrocytes 
physically link to neurons and cerebral vascular beds providing a structural connection.  This position 
allows astrocytes to identify changes in synaptic activity and couple them with energy metabolism.  
Functionally, it is thought that low to moderate synaptic activity gives rise to signaling molecules 
known to stimulate vasodilation (glutamate, potassium and adenosine triphosphate (ATP)) (Paulson 
O.B. et al. 2010). When glutamate is released it acts through a receptor on the neuron which raises 
intracellular calcium concentration, causing nitric oxide synthase to release nitric oxide, which cause 
dilation in the smooth muscle arterioles (Atwell D. et al. 2010).  Through various pathways of the 
astrocyte, the glutamate-signaling molecules mediate calcium release from the endoplasmic reticulum 
and also exchange intracellular sodium for extracellular calcium, which causes vasodilation (Paulson 
O.B. et al. 2010; Atwell D. et al. 2010). The astrocytes also produce arachadonic acid, 
epoxyeicosatrienoic acid (EET), potassium, and postaglandins which dilate the arterioles (Atwell D. et 
al. 2010).   ATP is utilized by the signaling pathways which increases cerebral metabolic rate for 




adenosine which also causes vasodilation. Local oxygen concentration impacts the functionality of 
these molecules to increase or decrease blood flow (Atwell D. et al. 2010). The oxygen availability 
impacts the synthesis of the messenger molecules involved with neurovascular coupling (nitric oxide, 
and arachadonic acid), and it impacts the lactate and adenosine levels which modulate vasodilation of 
the arterioles (Atwell D. et al. 2010).  There is a high energy cost for the astrocytes to process neural 
signaling to mediate blood flow. Thus, the high glucose consumption of the astrocytes is matched by 
increased cerebral blood flow in order to meet the needs of the cerebral tissue (review by  (Paulson 
O.B. et al. 2010)).   
The feed forward neurotransmitter-mediated signaling pathway mentioned above is 
supported by Gourine et al. (2005) who show increases in partial pressure of arterial carbon dioxide 
(PaCO2) triggers the release of ATP from chemo-sensitive regions on the medulla oblongata pia matter 
in anaesthetized rats (Gourine A.V. et al. 2005).  Although the exact mechanism responsible for ATP 
release in response to PaCO2 or hydrogen ion concentration ([H+]) is unclear, it is evident that this ATP 
release precedes the venality responses of PaCO2 (Gourine A.V. et al. 2005), supporting a feed forward 
response. 
 
Chemical Regulation (Gas Tension)  
The cerebral vasculature is highly sensitive to changes in PaCO2 (Lennox WG & Gibbs EL 1932).  
Increases in PaCO2, known as hypercapnia, result in cerebral vasodilation, which increases cerebral 
blood flow in an attempt to re-stabilize pH levels (Lennox WG & Gibbs EL 1932). Hypercapnic 
conditions are known to increase cerebral brain blood flow by 3-5% per mmHg rise in end-tidal carbon 
dioxide (PETCO2) (Pandit J.J. et al. 2003; Clivati A. et al. 1992; Hida W. et al. 1996; Ainslie P.N. & Duffin 




Conversely, low levels of PaCO2 , known as hypocapnia, result in vasoconstriction which reduces 
cerebral blood flow (Kety S.S. & Schmidt C.F. 1941; Wasserman A.J. & Patterson J.L.Jr. 1961).  Although 
the mechanisms of altering cerebral blood flow are still under debate, researchers do know that 
changes in [H+] are the drive to induce vessel dilation. It is perceived that hypercapnic conditions 
lower pH levels (acidosis) which actives potassium (K+) channels, specifically ATP-sensitive K+ and 
voltage-gated K+ channels, which lie in the vascular smooth muscle.  This generates an increase in K+ 
efflux and hyperpolarization of the endothelial cells. A hyperpolarized current travels along the 
endothelium where voltage gated calcium channels are then closed, which reduces intracellular 
calcium and activates vascular relaxation (review by  (Ainslie P.N. & Duffin J. 2009)).   
A second theory to alterations in cerebral blood flow from changes in PaCO2  is the mediated 
release of nitric oxide (NO) from the endothelium and neurovascular coupling (neurovascular coupling 
described above) (Ainslie P.N. & Duffin J. 2009; Atwell D. et al. 2010). NO is an easily diffused molecule 
that has a half-life of approximately six seconds, causing rapid and easily attenuated responses 
(Sanders D.B. et al. 2000; Hobbs A.J. & Ignarro L.J. 1996).  NO impairs calcium sensitivity and mediates 
smooth muscle relaxation (Sanders D.B. et al. 2000). Schmetterer et al. (1997) demonstrates 
hypercapnic increases in cerebral vasodilation in healthy young adults, and states this response is 
blunted by L-NMMA infusion, suggesting NO participates in hypercapnia-induced vasodilation 
(Schmetterer L. et al. 1997).  Furthermore, Lavi et al (2006) measured brachial flow-mediated dilation 
(an NO derived endothelial marker of function/dysfunction) and respiratory induced changes of 
cerebral blood flow velocity during normocapnia, hyperventilation and hypercapnia (Lavi S. et al. 
2006).  They performed identical tests on individuals known to have endothelial dysfunction 
(hypertension and Diabetes mellitus) and healthy controls.  A hyperemic response to increased PaCO2 




had preserved pressure-dependent autoregulation (changes in cerebrovascular resistance with varying 
blood pressure challenges).  This supports the hypothesis of NO involvement to cerebral blood flow 
regulation (Kleiger R.E. et al. 1987). In contrast, Ide et al (2007) suggests NO is not required for 
vasodilation in response to hypercapnia, based on the observation that L-NMMA did not alter cerebral 
blood flow velocity (Ide K. et al. 2007; Toda N. et al. 2009). Evidently the pathway of PaCO2, and NO 
requires further investigation.  
Changes in partial pressure of arterial oxygen (PaO2) levels are also known to alter cerebral 
blood flow (Kety S.S & Schmidt C.F. 1948; harris A.D. et al. 2013).  In an isocapnic hypoxic human 
condition (6.9% to 7.5% oxygen and CO2 was added to inspired gas), cerebral blood flow increased 
from 45 to 77 ml/100g per minute (Cohen P.J. et al. 1967).  Like increases in PaCO2, decreases in PaO2 
mediate vasodilation via K+ channel activation, increased intracellular calcium concentration and NO 
release (review on hypoxia by  (Brugniaux J.V. et al. 200)). This mechanism may be of importance in 
hypoxic conditions (altitude or pulmonary disease) however in day-to-day activity low hypoxic 
conditions are not normally present.   
 
Assessment of Cerebral Blood Flow 
Cerebral blood flow can be measured by a variety of techniques, however, due to the non-
invasive nature and portability of the transcranial Doppler ultrasound (TCD) and near infrared 








Transcranial Doppler Ultrasound 
As first reported by Aaslid et al. (1982), TCD provides non-invasive evaluation of cerebral 
blood flow velocity in major intracranial vessels (middle, anterior and posterior cerebral arteries) 
(Aaslid R. et al. 1982). TCD uses an ultrasound pressure wave, typically 2MHz, to penetrate the skin 
and superficial tissue and reflect the traveling velocity of the red blood cells in a given vessel (Panerai 
R.B. 2009; Evans D.H. & McDicken W.N. 2000). This causes varying increases or decreases in 
frequency, known as the phase shift (Panerai R.B. 2009).  By determining the phase shift and 
insonation angle, the velocity of red blood cells can be determined (Equation 1-2), and converted into 
an electronic signal used for further analysis (Panerai R.B. 2009). The use of TCD to measure relative 
cerebral blood flow velocity has been validated against single photon emissions tomography (SPECT) 
(Sorteberg W. et al. 1989), Xenon133 clearance technique (over a wide range of PaCO2) (Clark J.M. et al. 
1996), and functional magnetic resonance imaging (MRI) (high resolution match, r=0.95) (Deepe M. et 
al. 2000). 
    
Velocity of reflector =    fd . C    
(Red blood cells) 2ft . cos θ   
    
fd is the transmitted Doppler shift frequency, Cos θ is the correction factor based on the 
insonation angle, C is the speed of sound in soft tissue (in TCD it is constant at 1540 ms-1), ft is 
2 MHz (for TCD) (Hoskins P.R. 1990).  Thus, fd and cos θ are the determinants of red blood cell 
velocity.  
Equation 1-2. Doppler Frequency Shift Equation  
 
TCD relies on a constant arterial diameter to assume brain blood flow (Equation 1-1).  Previous 
work using MRI, did not observe a change in middle cerebral artery (MCA) diameter during moderate 
changes in end-tidal carbon dioxide (ETCO2) or simulated orthostatic stress (lower body negative 




resolution MRI (3 Tesla versus 1.5 tesla) demonstrate an increased MCA cross sectional area of 16±7% 
during hypercapnia (+10mmHg) and a decrease of 8±6% during hypocapnia (-15mmHg) (Coverdale 
N.S. et al. 2014).  The changes in diameter during hypo- and hypercapnia suggest an overall 0.4% 
change in MCA diameter for a given change in mmHg ETCO2 (Coverdale N.S. et al. 2014).  Similarly, 
studies evaluating internal carotid artery (ICA) diameters demonstrate a change in cross sectional area 
of 11.5±% during hypercapnia (50 to 65 mmHg PaCO2), -6.6±2.9%  during hypocapnia (15 to 30 mmHg) 
and 6.3±8.1% during hypoxia (35 mmHg PaO2 matched with SaO2 70%) (Willie et al. 2012).  In 
consideration of these discrepancies findings, caution should be taken when forming conclusion 
around TCD measures as cerebral blood flow velocity values may be underestimated in the presence 
of manipulated arterial gas concentrations.   
Another consideration when using TCD, is the ability to insonate the MCA through the 
transtemporal window. Successful window insonation is dependent on temporal bone thickness which 
in turn is affected by age, sex, and ethnicity (Halsey J.H. 1990).  Studies have found failure to record an 
MCA waveform in 3% of Caucasian males, 11% of Caucasian females, 4% of Black males, and 42% of 
Black females (51 to 99 years) (Halsey J.H. 1990).  In comparison, a study involving 597 Japanese 
volunteers (16 to 89 years old), demonstrate the inability to acquire bilateral MCA flow signals in 29% 
of the participants (Itoh T. et al. 1993).  In this sample of Japanese participants, age progressed the 
failure rate, as did being female, where 83% of women aged 70 years and older did not demonstrate a 
feasible MCA signal (Itoh T. et al. 1993). In a group of European participants the failure rate was 
marked at 5% (Aaslid R. et al. 1982), suggesting those of Black or Asian ethnicity prove to have a lower 






Flow = velocity *π*diameter2/4   
Equation 1-3. Blood Flow 
 
Near Infrared Spectroscopy (NIRS) 
Near infrared spectroscopy (NIRS) is a non-invasive device used to monitor relative changes in 
hemodynamic and metabolic activity of the brain. Near infrared light (700-1300 nm wavelength) is 
relatively transparent in biological tissues, making it possible for photons to reflect, scatter, and 
become absorbed into a tissue medium (Jobsis F.F. 1977).  NIRS is used to evaluate cerebrovascular 
hemodynamics in the 650-950 nm wavelength range (Perrey S. 2008). The development of NIRS is 
based on the Beer-Lambert law which marks the relationship between absorption of light photons and 
the concentration of emitting photons through a coloured substance, known as chromophores  
(Perrey S. 2008). Chromophores are a construct of the heme molecule which absorb energy from 
visible light causing colouration. They have an absorption spectrum where the extinction coefficient is 
extracted as a specific wavelength which attenuates light, and is referred to as optical density (NIRS 
review by  (Pellicer A. & Bravo M.C. 2011)).   Optical density, or the attenuation of light due to 
absorption, can be calculated using the Beer-Lambert law (Equation 1-2) (Perrey S. 2008; Pellicer A. & 
Bravo M.C. 2011).       
 
A = log (l0/l) = ε*c*d  OR 
 
   Optical density  = log   incidence of light  =  extinction    chromophore       optical pathlength 
(Absorption of light)  transmitted light     coefficient   concentration    (thickness of solution) 






Photons used in tissue spectroscopy travel in an arc or elliptical trajectory rather than the 
traditional straight line (Perrey S. 2008; Okada E. et al. 1997; van der Zee P. et al. 1990).  The arc 
trajectory is in part attributed to the photons traveling through various tissue mediums at different 
depths causing photon reflection of varying degrees (Perrey S. 2008).  To account for inhomogeneous 
tissues a differential pathlength (DPF) factor is added to the Beer-Lambert law which accurately 
accounts for tissue differences (Equation 1-4b) (Hiraoka M. et al. 1993; Delpy D.T. et al. 1988; 
Patterson M.S. et al. 1989).  DPF calculations are based on age and range from 4-6.5 in cerebral tissue 
(Pellicer A. & Bravo M.C. 2011; Duncan A. et al. 1995).  
 
A = log (l0/l) = ε*c*d*DPF + G 
Equation 1-4b. Beer-Lambert Law 
 
In addition to DPF, light attenuation rate is impacted by the source to detector spacing, where 
a greater distance results in a deeper site for sampling (Pellicer A. & Bravo M.C. 2011; Patterson M.S. 
et al. 1989).   A short source-detector distance would result in a shallow arc trajectory which would 
largely sample superficial tissue (scalp and skull). By increasing the source-detector spacing, the 
relative contribution of surface tissue and extra-cerebral blood flow to the NIRS signal decreases 
(Hiraoka M. et al. 1993).    Thus, source-detector differences less than 2.5 to 3 cm are not 
recommended (Pellicer A. & Bravo M.C. 2011).  
NIRS use for cerebral tissue was first published by Jobsis (1977) who monitored relative OxHb, 
deoxygenated hemoglobin (DeoxHb), and total hemoglobin (TotHb) concentrations (Equation 1-5) in 




(tSO2) termed tissue saturation index (TSI) (Artinis 2011). TSI is measured as the percentage of OxHb 
relative to TotHb(Equation 1-6) and will be referred to as tSO2 (Artinis 2011).  
 
  TotHb = Oxygenated Hemoglobin + Deoxygenated Hemoglobin 
  DiffHb = Oxygenated Hemoglobin – Deoxygenated Hemoglobin 
Equation 1-5. Total Hemoglobin and Hemoglobin Difference (NIRS) 
 
 
tSO2  =  Oxygenated Hemoglobin                        x 100% 
Deoxygenated Hemoglobin + Oxygenated Hemoglobin 
Equation 1-6. Cerebral oxygenation (tSO2) 
 
NIRS is used as an index of cerebral blood flow as it demonstrates very similar hemodynamic 
responses to TCD during motor tasks, exercise and hypo- and hypercapnic exposure (Hirth C. et al. 
1997; Ide K. & Secher N.H. 2000; Smielewski P. et al. 1995).  NIRS has also been significantly correlated 
to 133Xenon clearance changes in cerebral flow (Skov L. et al. 1991).  However, NIRS is a local (at the 
arteriole and capillary level) not a global measure of cerebrovascular hemodynamics.  Anatomically 
70% to 80% of the cerebral blood is located in the venous system (~5% in capillaries, ~20% in 
arterioles, and the rest lies in post-cellular vessels) suggesting most of the detected hemoglobin is 
found in post-cellular vessels (Ide K. & Secher N.H. 2000; Ogoh S. & Ainslie P.N. 2009).  Blood-oxygen-
level-dependent functional MRI maps neuronal activity by imaging concentration changes of 
paramagnetic deoxHb (magnetic field differs if oxygen is bound or unbound to the heme molecule) 
(Sakatani K. et al. 2007).  NIRS is significantly correlated to blood-oxygen-level-dependent functional 




et al. 2001; Strangman et al. 2002; Huppert et al. 2006), and has been significantly correlated to 
position emission tomography (PET, requires radioactive isotope) during a verbal fluency task (Hock C. 
et al. 1997).  Thus, NIRS is a viable tool for measuring local neurovascular coupling and metabolic 
demand.   
During neuronal activation, neurovascular coupling changes local OxHb, DeoxHb and TotHb, 
where OxHb typically increases and DeoxHb decreases (Kono T. et al. 2007; Sakatani K. et al. 2007; 
Schroeter M.L. et al. 2002; Moghimi S. et al. 2012). An increase in OxHb or a decrease in DeoxHb 
would result from either an increase in blood flow or a decrease of oxygen extraction (Schroeter M.L. 
et al. 2002). Although this is the typical response to neurovascular coupling, some studies report an 
increase in OxHb without any reductions in DeoxHb, or a decrease in OxHb (Quaresima V. et al. 2012). 
A decrease in OxHb and an increase in DeoxHb would be the consequence of a decrease in blood flow 
or an increase in oxygen extraction/consumption (Sakatani K. et al. 2007; Smielewski P. et al. 1995). In 
such a case, it is speculated that the tissue site is negatively activated and blood flow is reallocated to 
the area of cognitive processing (Quaresima V. et al. 2012; Boorman L. et al. 2010; Lague-Beauvais M. 
et al. 2013).   
Brain function is tightly coupled with brain metabolism and brain blood flow, even during 
resting conditions (Li Z et al. 2012). It is widely accepted that during wakeful resting conditions the 
human brain is highly active (review by  (Binder JR 2012)).  The brain spontaneously activates when 
not engaged in a goal directed task (Safonova et al. 2004; Obrig H. et al. 2000), such as a cognitive or 
motor task, making it difficult to establish a baseline condition for neural function (review by  (Binder 
JR 2012)).  Baselines or control conditions are essential in scientific experimentation as they provide a 
foundation for all comparisons. At present there are no established procedures to determine a 




resting levels are to subsequent tasks, and if a goal directed task can minimize baseline variability in 
the NIRS signals (see Chapter 3 for more details).  
 
Cerebral Autoregulation 
According to Ohm’s law, alterations in perfusion are accommodated by changes in 
cerebrovascular resistance (Equation 1-1) (van Beek A. et al. 2008).  Cerebrovascular resistance index 
(Equation 1-7) can be used as a measurement of cerebral blood flow resistance  (Hughson R.L. et al. 
2001).  Cerebral autoregulation (CA) is the cerebral vasculature’s ability to modulate resistance in 
order to maintain steady blood flow despite alterations in arterial blood pressure (Paulson O.B. et al. 
1990; Lassen N.A. 1964). This relationship ensures relatively constant cerebral blood flow from 60 
mmHg to 150 mmHg of mean arterial pressure (Paulson O.B. et al. 1990). Outside of the 60 mmHg to 
150 mmHg range cerebral blood flow becomes passive to alterations in blood pressure. There are two 
ways to evaluate cerebral autoregulation: static and dynamic.   
 
CVRi = mean arterial pressure – (distance*0.78) 
    mean cerebral blood flow velocity 
 
   distance = length in cm from the heart to the middle cerebral artery  
Equation 1-7. Cerebrovascular Resistance index (CVRi) mmHg/cm/s 
 
Static cerebral autoregulation measures the overall efficiency of the cerebrovascular 
resistance response.  It can be tested by comparing cerebral blood flow at two steady states, one after 




manipulation, then cerebral autoregulation is intact.  Conversely, if cerebral blood flow is significantly 
changed then cerebral autoregulation is impaired (Tiecks F.P. et al. 1995).  
Dynamic cerebral autoregulation adapts to abrupt changes in arterial blood pressure, 
providing a rapid response (within a few seconds) to cerebral blood flow regulation (Zhang R. et al. 
2002; Ainslie P.N. & Duffin J. 2009).  TCD has a high temporal resolution for monitoring human 
cerebral blood flow, and when simultaneously combined with a noninvasive blood pressure recording 
device (finger-cuff plethysmography), dynamic cerebral autoregulation can be easily evaluated.  It is 
important to note the significant impact PaCO2 has on cerebral blood flow velocity and cerebral 
autoregulation (Edwards M.R. et al. 2004; Lennox WG & Gibbs EL 1932; Aaslid R. et al. 1989; Panerai 
R.B. et al. 1999).  It is paramount to have estimates of ETCO2 (infrared capnography), particularly 
during protocols involving postural transitions, mental activation, or physical activity, which are known 
to alter PaCO2 (Panerai P.B. 2009).  Dynamic cerebral autoregulation can be evaluated at rest (transfer 
function analysis) (Zhang R. et al. 2000; Zhang R. et al. 2002), or with manipulation of blood pressure 
by utility of a posture change (Kim Y.S. et al. 2008), thigh cuff release (Tiecks F.P. et al. 1995), head-up 
tilt (Carey B.J. et al. 2003), or lower body negative pressure (Guo H. et al. 2006).   
Static and dynamic autoregulation measurements are significantly correlated for both intact 
and pharmacologically impaired autoregulation (r=.93, P<.0001)  (Tiecks F.P. et al. 1995). Although the 
protocols result in the same outcome, dynamic measures of autoregulation are preferred as they 
expose the time in which cerebrovascular resistance is achieved (response time or latency) (Tiecks F.P. 
et al. 1995), and closely mimics a physiological stimulus experienced during activities of daily living. 






Cerebral blood flow critically relies on the ability of the cerebrovascular beds to respond to 
changes in PaCO2 (Lennox WG & Gibbs EL 1932).  The quantitative change of cerebral blood flow for a 
given change in PaCO2 marks an index of cerebrovascular function, termed ‘cerebrovascular CO2 
reactivity’ (CRCO2) (Ainslie P.N. & Duffin J. 2009).  Generally, to quantify CRCO2 cerebral blood flow is 
monitored at rest in a normocapnic condition and during inhalation of a 5% CO2 gas mixture or 
intravenous administration of acetazolamide (Bishop et al. 1986; Zhang R. et al. 2000). The stimulus 
driven response results in an increase in cerebral blood flow, and thus, the ability of the vascular bed 
to dilate represents an index of vasomotor function (Bishop et al. 1986).  CRCO2 is also characterized as 
a marker of cerebral vasomotor reserve. Cerebral vasomotor reserve is the capability of the cerebral 
vessels to alter resistance in response to a stimulus, such as hypercapnia.  For example, when carotid 
stenosis is present, cerebral perfusion pressure is reduced, causing the cerebral vasculature to 
maximally dilate in order to ensure adequate cerebral blood flow.  The dilated vasculature yields a 
reduced vasodilatory reserve and this is demonstrated by an impaired response to inhalation of a 
hypercapnic gas (Markus H. & Cullinane M. 2001). A low reserve would suggest a greater risk for 
hypoperfusion during transient drops in CBF (posture change). CRCO2 is impaired in individuals known 
to have endothelial dysfunction (hypertension or diabetes mellitus), suggesting CRCO2 may serve as an 
indicator of endothelial function (Lavi S. et al. 2006).    Numerous methods have been utilized to 
assess CRCO2 including blood oxygen level depend MRI (Hare H.V. et al. 2013), positron emission 
tomography (Herold S. et al. 1988), TCD (Piepgras A. et al. 1990) and NIRS (Smielewski P. et al. 1995; 
Totaro R. et al. 1998). Various pathological conditions such as Alzheimer’s disease (den Ableelen As 
M.V. et al. 2013), hypertension (Maeda H. et al. 1994), Diabetes mellitus  (Fulesdi B. et al. 1999), and 




vasodilator properties of PaCO2 also appear to depreciate with age (Galvin S.D. et al. 2010), suggesting 
cerebrovascular health is reduced in older adult populations.  It is important to note that CRCO2 is also 
influenced by wakefulness (review on CRCO2 by  (Ainslie P.N. & Duffin J. 2009)).  During sleep CRCO2 is 
reduced compared to wakeful hours, which contributes to lower levels of cerebral blood flow during 
sleep (Meadows G.E. et al. 2003).  CRCO2 has a cut off value of 1.3%/mmHg which can be used as an 
indicator of poor cerebrovascular health (Kleiser B. & Widder B. 1992). Overall, CRCO2 has clinical 
importance (Markus H. & Cullinane M. 2001; Galvin S.D. et al. 2010; Maeda H. et al. 1994), and is an 
excellent means of evaluating cerebrovascular health.  
 
Cerebral Blood Flow and Age 
The relationship between reduced cerebral blood flow with increasing age is well established 
(Lipsitz L.A. 1985; Grolimund P. & Seiler R.W. 1988; Purkayastha S. & Sorond F. 2012; Kamper A.M. et 
al. 2004).  Cerebral blood flow velocity, measured by TCD, decreases 0.3% to 0.5% per year from 20 to 
70 years old (Leenders K.L. et al. 1990; Purkayastha S. & Sorond F. 2012; Vriens E.M. et al. 1989; 
Arnolds B.J. & von Reutern G.M. 1986; Grolimund P. & Seiler R.W. 1988).  This results in a decrease of 
cerebral blood flow of 15% to 20% from 20 to 65 years of age (de la Torre 2012; Leenders K.L. et al. 
1990; Chen Y. et al. 2011). Correspondingly, cerebrovascular resistance is higher in older adults (79±7 
years) as compared to younger adults (25±7 years) (Kamper A.M. et al. 2004).  The age related 
differences in cerebral blood flow can be attributed to age related changes in vessel geometry. In a 
patient population of adults (40-60 years, n=66) and older adults (60 years and older, n=34), ICA 
diameter (site 1: cavernous ICA, site 2: ICA terminus) and MCA diameter (site: M1 origin) significantly 
increased with age (Rai A.T. et al. 2013).   Vessel structure (diameter and wall thickness) is largely 




neurohumoral environment) which are known to change with age (Mitchell GF 2008). Sex differences 
of cerebral blood flow are noted between the ages 20 to 60 years (women have higher levels of blood 
flow velocity); however, these differences dissipate after 70 years of age, presumably due to 
menopause and lowering of hematocrit levels (Purkayastha S. & Sorond F. 2012; Vriens E.M. et al. 
1989; Grolimund P. & Seiler R.W. 1988).  The sex differences of cerebral blood flow correspond with 
sex differences in vessel geometry.  In a patient population of 32 females and 17 males (14-86 year 
old, mean age 53), MCA diameter (site 1: M1 segment largest branch, site2: M1 segment smallest 
branch, site3: M1 segment parent vessel) and ICA diameter (site 1: terminal bifurcation largest branch, 
site2: terminal bifurcation smallest branch) were significantly larger in females compared to males 
(Lindekleiv H.M. et al. 2010).  The female participants also had increased wall shear stress in both the 
MCA and ICA bifurcations as a result of smaller vessel diameters (Lindekleiv H.M. et al. 2010).  
In addition to an age effect on cerebral blood flow velocity, OxHb and tSO2 are lower in older 
adults (85±6 years) versus younger adults (28±4 years) (Hallacoglu B. et al. 2012). Hallacoglu et al. 
(2012) observed OxHb and tSO2 decreases with increasing age and the authors suggest an age 
dependent impairment in cerebral metabolism and perfusion (Hallacoglu B. et al. 2012).  The lower 
OxHb supply in older adults has also been associated with decreased neuronal activation and 
performance on cognitive tests (Hock C. et al. 1995; Herrmann M.J. et al. 2006; Hock C. et al. 1996).   
Endothelial derived NO causes vasodilation, increases in flow, and acts to prevent 
atherosclerosis (Fisher J.P. et al. 2013).  With age the capacity of the endothelium to produce NO 
declines (Toda N 2012) and the amount of reactive oxygen species, known to reduce NO 
bioavailability, increase  (Donato A.J. et al. 2007; Ungvari Z. et al. 2010).  These age related-changes in 
NO are thought to contribute to the lower resting cerebral blood seen with age  (Thomas S.R. et al. 




and Kamper et al. (2004) have both demonstrated this impaired NO-mediated flow pathway in older 
adults.  After 30 minutes of L-arginine infusion (which generates NO via NO synthase) in older (70 ±3 
years) and younger (29±2 years) adults Okamoto et al. (2001) observed no between-group changes in 
blood pressure; however, cerebral blood flow velocity increased to a greater extent in the young 
adults, suggesting a diminished NO mediated cerebral blood flow response (Okamoto M. et al. 2001).   
Similarly, Kamper et al. (2004) administered L-NMMA (inhibits synthesis of NO by NOS) in young (25±3 
years) and older (78±3 years) adults and found only the older adults had a significant decreased 
cerebral blood flow and increased cerebrovascular resistance; therefore, suggesting endothelial 
properties contribute to reduced cerebral blood flow with age  (Kamper A.M. et al. 2004).   
Several studies comparing cerebral autoregulation in young and older adults report an intact 
autoregulatory system with age (Carey B.J. et al. 2000; Carey B.J. et al. 2003; Lipsitz L.A. et al. 2000; 
Narayanan K. et al. 2001; Sorond F.A. et al. 2005; van Beek A.H. et al. 2008; Hernandez J.P. et al. 2010; 
Yam A.T. et al. 2005; Heckmann J.G. et al. 2003; Franke W.D. et al. 2006). Lipsitz et al. (2000) used a 
sit-stand posture change, as well as transfer function analysis during sitting and during standing to 
measure dynamic cerebral autoregulation in three adult groups (young adults: 24±1 year, older adults: 
72±3 years, and older adults on antihypertensive medications: 72±2 years) (Lipsitz L.A. et al. 2000). In 
response to the transition, older adults on hypertensive medications were able to maintain cerebral 
autoregulation by reducing cerebral vascular resistance significantly more than the young adults or 
other older adult group.  Moreover, transfer function analysis revealed no differences in gain between 
groups.  In addition to measures of cerebral autoregulation, Lipsitz et al. measured cerebrovascular 
reactivity, and found the hyperemic response to CO2 was significantly diminished in both older adult 
groups (Lipsitz L.A. et al. 2000).   They concluded that although CO2 reactivity was reduced in older 




al. 2000).  As well as age, fitness level does not impact cerebral autoregulation (Franke W.D. et al. 
2006).  Franke et al. (2006) looked at cerebral blood flow velocity in response to lower body negative 
pressure in younger (23 years) and olderer (71 years) adults (Franke W.D. et al. 2006).  The adults 
were grouped into either fit or unfit categories, and the researchers found no differences of cerebral 
autoregulation between groups (Franke W.D. et al. 2006).     
When using NIRS to evaluate cerebrovascular hemodynamics, cerebral autoregulation of the 
prefrontal cortex is intact in older adult groups (Kim Y.S. et al. 2011; Edlow B.L. et al. 2010).  Edlow et 
al. (2010) found a continuous effect of age (20-78 years) on the postural decreases in OxHb from a 
supine-stand transition (Edlow B.L. et al. 2010).  It was determined that with increased age the 
magnitude of the postural decrease in OxHb was significantly less (Edlow B.L. et al. 2010).  
Additionally, a sex effect for the response to a change in posture was observed for all NIRS parameters 
(Edlow B.L. et al. 2010).  As such, the supine-stand posture change would decrease OxHb in 30 year 
old males and females by −4.59 μmol L−1 and−3.75 μmol L−1, respectively, and by −2.85 μmol L−1 and 
−2.01 μmol L−1, in 60 year old male and female respectively (Edlow B.L. et al. 2010). The drop in OxHb 
was halved in older adults.   Likewise, Kim et al. (2011) found smaller postural decreases in cerebral 
blood flow velocity and OxHb in older adults  (52-65 years) compared to younger adults (27-33 years) 
(Kim Y.S. et al. 2011).  The trending in cerebral blood flow velocity was significantly correlated to that 
of the mean arterial pressure at the level of the brain (Kim Y.S. et al. 2011).  The OxHb signal was not 
correlated to the mean arterial pressure as it had a 3 second latency or delay from the cerebral blood 
flow trends (Kim Y.S. et al. 2011). The smaller postural decrease in OxHb with age has been attributed 
to either lower baseline cerebral blood flow measures or reduced capacity to redistribute cerebral 




Structural and functional alterations of the vasculature contribute to altered cerebrovascular 
hemodynamics.  With increasing age, vessels become stiffer. A stiffer vessel is less able to cushion 
arterial pulses, resulting in an augmented pressure wave form and a faster pulse wave velocity (PWV)  
(Mitchell GF 2008).  With a stiff vessel and raised pulse pressure, the microcirculation (particularly the 
brain and kidneys) are threatened by encroaching excessive capillary pressures (Mitchell GF 2008).  
Arterial aging has been shown to influence cerebral hemodynamics in older adults (Robertson A.D. et 
al. 2010a).  Robertson et al. (2010) found individuals (77±12 years) with higher ankle-brachial pulse 
wave velocity also have increased cerebrovascular resistance indexes which are significantly 
correlated to lower cerebral blood flow (r= -0.89) (Robertson A.D. et al. 2010a).   Moreover, Tarumi et 
al. (2013) found lower central artery stiffness in middle aged endurance-trained (52±1 years) men, 
compared to sedentary men(54±1 years), which was significantly correlated to better 
neuropsychological scores (total composite memory and attention-executive function), carotid 
stiffness, and occipitoparietal perfusion by MRI (Tarumi T. et al. 2013).  These findings indicate that 
lower arterial stiffness may attenuate or minimize the pathological process of reduced cerebral 
perfusion and cognitive decline in later life (Tarumi T. et al. 2013).   
Although studies of healthy older adults indicate cerebral autoregulation is maintained with 
age  (Carey B.J. et al. 2000; Carey B.J. et al. 2003; Lipsitz L.A. et al. 2000; Narayanan K. et al. 2001; 
Sorond F.A. et al. 2005; van Beek A.H. et al. 2008; Hernandez J.P. et al. 2010; Yam A.T. et al. 2005; 
Heckmann J.G. et al. 2003; Franke W.D. et al. 2006) some older adults who exhibit lower resting 
cerebral blood flow (Lipsitz L.A. 1985; Grolimund P. & Seiler R.W. 1988; Purkayastha S. & Sorond F. 
2012; Kamper A.M. et al. 2004), tSO2, OxHb (Hallacoglu B. et al. 2012), cerebrovascular reserve, as 
demonstrated by reduced CRCO2 (Galvin S.D. et al. 2010), and higher cerebrovascular resistance 




impairment and have an increased risk of hypoperfusion during events of orthostatic stress, such as a 
posture change.  
 
Orthostatic Hypotension 
Orthostatic hypotension (OH) is defined as a sustained reduction of systolic blood pressure 
(SBP) equal to or great than 20 mmHg or a reduction of diastolic blood pressure (DBP) equal to or 
greater than 10 mmHg within three minutes of standing (The Concensus Committee of the American 
Autonomic Society and the American Academy of Neurology 1996). The first clinical reports of OH 
date back to 1864 when Liebermeister talks about syncopal episodes experienced after rising 
(Liebermeister C. 1864).  OH can be asymptomatic, or it can be accompanied by numerous symptoms, 
such as lightheadedness, confusion, blurred vision, weakness, fatigue, and dizziness (Tilvis R.S. et al. 
1996; The Concensus Committee of the American Autonomic Society and the American Academy of 
Neurology 1996). Although, the most significant symptoms are cerebral hypoperfusion and syncope 
(Stewart J.M. 2002) (reviews by  (Meadow M.S. et al. 2008) and  (Perlmuter L.C. et al. 2012)).  The 
prevalence of OH varies due to discrepancies of the definition.  Generally OH ranges between 5% to 
30% in community dwelling adults, and higher incidence rates are correlated with increased age 
(Masaki K.H. et al. 1998; Gupta V. & Lipsitz L.A. 2007; Tilvis R.S. et al. 1996).  In nursing home 
residence and acute care patients, OH affects 50-68% of older adults (Ooi W.L. et al. 1997; Weiss A. et 
al. 2002).  The prevalence of OH increases with age because of various age-related changes in blood 
pressure regulation (increased vascular stiffness, and decreased baroreflex sensitivity, α-1-adrenergic 
vasoconstrictor response to sympathetic stimuli, parasympathetic activity, renal and salt water 
conservation and left ventricular diastolic filling) (Gupta V. & Lipsitz L.A. 2007). OH is also associated 




fibrillation (Agarwal S.K. et al. 2013), increased rate of mortality (Masaki K.H. et al. 1998) and is a risk 
factor for future falls (Finucane C. et al. 2017) 
 
Mechanisms Behind The Posture Transition  
Transitioning from a supine to seated posture, positions the heart and brain in a vertical plane 
rather than a horizontal plane.  This increases the gravitational force placed on the cardiovascular 
system and causes blood volume redistribution (Rowell L.B. 1993).  To maintain arterial pressure, 
baroreflex-mediated increases in total peripheral resistance and heart rate compensate for the 
reduction in venous return (Rowell L.B. 1993).  Additionally, stimulation of the otolith organs 
(vestibular apparatus) affects cerebral blood flow regulation (independent of blood pressure and 
PETCO2), thus aiding in cerebral perfusion (Serrador J.M. et al. 2009).   
Upon assuming the upright posture with standing, approximately 500 to 700 mL of blood is 
redistributed (Hainsworth R. 1985; Sclater A. & Alaqiakrishnan K. 2004).  With standing, the lower 
limbs are loaded, causing muscle activation and subsequently vasodilation of the working muscle 
(Wieling W. et al. 2007; Sorond F.A. et al. 2009). This vasodilation is marked by up to 40% reductions 
in total peripheral resistance (TPRi) (Sprangers R.L. et al. 1991). The decrease in TPRi causes a 
pronounced drop in blood pressure where the depth of the blood pressure trough is strongly related 
to reductions in TPRi with active standing (Tanaka H. et al. 1996; Wieling W. et al. 2001).   The large 
drop in blood pressure with active standing is more prominent than blood pressure troughs observed 
with passive head-up-tilt tests (Wieling W. et al. 2007) or a double leg thigh-cuff release (Sorond F.A. 
et al. 2009). This suggests that in addition to the gravitational effects on blood flow re-distribution, the 
working muscle is greatly contributing to the drop in blood pressure.   This theory is supported by 




studies, and found that resistance vessels in the muscles dilate in proportion to the intensity of 
activation, and that this vasodilation peaks at 4 seconds and returns to normal by 10 to 20 seconds 
(Wieling W. et al. 2007; Tschakovsky M.E. & Sheriff D.D. 2004).    
 In addition to lower limb muscle activation, increases in intra-abdominal pressure are thought 
to contribute to the large blood pressure drop in standing.  With the legs and abdomen initially 
contracting during the standing transition, intra-abdominal pressure rises, placing a transient increase 
in venous return and a large increased pressure on the right atrium (10-15 mmHg) (Wieling W. et al. 
1996; Wieling W. et al. 2007).  This leads to activation of the cardiopulmonary mechanoreceptors 
which causes withdrawal of sympathetic vasoconstrictor tone, and lower vascular resistance for 6 to 8 
seconds (Sprangers R.L. et al. 1991; Wieling W. et al. 1996; Wieling W. et al. 2007).  Postural decreases 
in CO2 (hypocapnia) are thought to contribute to the reduced cerebral blood flow when assuming the 
standing position (Serrador J.M. et al. 2006). A 1mmHg decrease in PETCO2 accounts for a 3.5% 
decrease in cerebral blood flow velocity (Immink R.V. et al. 2013). Therefore if a posture change 
evokes a 3.5% decrease in PETCO2, a 12% decrease in cerebral blood flow velocity is expected. In the 
literature, postural reductions in cerebral blood flow velocity of 15% and OxHb of 7% are noted after 
5-minutes of standing  (Immink R.V. et al. 2013).   
The time frame in which reductions in mean arterial pressure are produced by muscle 
activation and right atrial pressure, line up with many reported signs of pre-syncope observed from 5-
10 seconds of standing to within the first 20-30 seconds of standing (Wieling W. et al. 2001; Wieling 
W. et al. 2007).   To counteract these initial hemodynamic responses, heart rate drastically increases 
within the first three seconds of standing (Wieling W. et al. 2007).  Parasympathetic blockade 
demonstrates that this rise in heart rate is due to cardiac vagal withdrawal (Wieling W. et al. 2007; 




central command or feedback from the mechanoreceptors in the contracting muscles (muscle-heart 
reflex) (Hollander A.P. & Bouman L.N. 1975) are responsible for the very rapid cardiac vagal 
withdrawal and significant rise in heart rate (Wieling W. et al. 2007). Following this initial rise in heart 
rate, the baroreflex responds to the drop in blood pressure and mediates increases in sympathetic 
outflow which continues to increase heart rate and total peripheral resistance.  The combination of 
increased heart rate and increased stroke volume results in a distinct transient rise in cardiac output  
(Wieling W. et al. 2007; Tanaka H. et al. 1996; Sprangers R.L. et al. 1991); However, with the large fall 
of peripheral vascular resistance there is still a drop in blood pressure (review by  (Wieling W. et al. 
2007)).  Blood pressure reaches its lowest point approximately 7 to 9 seconds post transition (Kim Y.S. 
et al. 2011; Wieling W. et al. 2007) and then begins to recover.  Blood pressure is typically recovered 
within 30 seconds from the onset of transition (Wieling W. et al. 2007).  It is also important to note, 
that during standing the leg muscles contract which acts as a second pump, propelling blood up 
towards the heart and enhancing venous return. 
 Orthostatic hypotension can result from a disease or condition which prompts deficits in 
hemodynamic responses (Arnold A.C. & Shibao C. 2013).  Physiological changes seen with age, such as 
reduced baroreflex sensitivity, parasympathetic tone, cardiac and venous compliance, hydration, 
blood volume, and impaired α1-adrenergic vasoconstriction, can contribute to OH in older adults 
(Arnold A.C. & Shibao C. 2013). 
 
Orthostatic Hypotension in Older Adults 
Across all ages (13 to 83 year olds), the critical threshold of cerebral blood flow velocity for 
human consciousness lies at approximately 50% below baseline (supine) (Njemanze P.C. 1992). This 




neuronal activity (Njemanze P.C. 1992).  Signs of mental confusion during passive heat-up-tilt tests 
coincide with both a drop in cerebral blood flow velocity and OxHb (Madsen P. et al. 1998; Colier W.N. 
et al. 1997). Colier et al. (1997) performed an 80° head-up tilt test for 15 minutes with and without the 
removal of 500mL of blood (Colier W.N. et al. 1997).  Participants were separated into i) showing signs 
of pre-syncope and ii) no signs of pre-syncope.  The participant group demonstrating signs of pre-
syncope had significantly greater reductions in oxygenation (-1.4±0.5 µM-1) compared to the group 
with no signs of pre-syncope (-0.2±0.2 µM-1).  The authors suggest the inadequate supply of oxygen 
for the required functional demand preceded the onset of pre-syncope (Colier W.N. et al. 1997).  It 
has been suggested by Krakow et al. (2000) that symptoms of pre-syncope during an 80° head-up tilt 
test (n=35, 53±19 years old, n=15 with orthostatic syncope) mainly occur when oxygenation and 
perfusion reach a critical value of less than 60% tSO2 (Krakow K. et al. 2000). In participants with a 
history of orthostatic syncope and who experienced symptoms of pre-syncope or syncope during the 
tilt test, tSO2 was reduced by 10%, OxHb was reduced by 18%, DeoxHb increased by 11% and cerebral 
blood flow velocity decreased by 16% (Krakow K. et al. 2000). When compared to control subjects, 
participants with a history of orthostatic syncope had significantly larger reduction in MAP (-10±11 
mmHg), cerebral blood flow velocity (-13±9 cm/s), and tSO2 (-5±3 %) during the tilt (Krakow K. et al. 
2000). These findings implicate a threshold for cerebral function to be approximately -5% to -10% 
below resting supine tSO2 values.  This level of hypoperfusion represents a moderate to large 
reduction in oxygen saturation where sings of pre-syncope become apparent.   
Although postural hypotension typically results in only transient drops of cerebral blood flow, 
for individuals with OH measureable cognitive deficits are evident (Yap P.L. et al. 2008; Frewen J. et al. 
2013).  In a group of older adults (65.5 years, n=2321) Yap et al. (2008) found that among hypotensive 




(Yap P.L. et al. 2008).  Likewise, Frewen et al. (2013) found older adults (61±6 years) with supine 
hypertension and OH scored significantly less on cognitive tests (accumulated MMSE and MOCA 
scores) compared to older adults without OH (Frewen J. et al. 2013).  Participants with sustained OH 
or unrecovered hypotension (hypotension 30 seconds post-transition) were associated with even 
lower cognitive performance scores (Frewen J. et al. 2013).  Overall associations between OH and 
cognitive performance alone were not observed for either study, but when confounded by either 
hypotension or hypertension impairment is present (Yap P.L. et al. 2008; Frewen J. et al. 2013).  
Following a posture transition, blood pressure recovery has been identified to either 1) quickly 
recover with an overshoot, 2) medium drop/slow recovery, or 3) have a large drop/non-recovery 
pattern (Romero-ortuno R. et al. 2011).  The inability to recover is marked by inadequate cardiac 
output and vasoconstrictor failure (Freeman et al. 2011).  Romero-ortuno et al. (2011) split a sample 
442 hypertensive older adults (~72±7 years) into the three recovery categories described above 
(Romero-ortuno R. et al. 2011).  Twenty-one percent of the sample fell into the third category (large 
drop in BP marked by no recovery), demonstrating the large proportion of hypertensive older adults 
experiencing unrecovered OH.  Orthostatic intolerance symptoms were more prevalent in the non-
recovery category (45%) versus the medium recovery (28%) or quick recovery (18%) groups (Romero-
ortuno R. et al. 2011). Likewise, Frewen et al. (2013) found 15% of middle aged (61±6 years) adults did 
not recover by 30 seconds, and 5% had still not recovered by 90 seconds post stand (Frewen J. et al. 
2013). At 90 seconds post stand Frewen et al. (2013) observed greater incidence rates of OH in 
hypertensive participants (7% incidence rate, 157±15 mmHg SBP, 81±10 mmHg DBP) compared to 
normotensive (3% incidence, 122±13 mmHg SBP, 68±9 mmHg DBP) counterparts (Frewen J. et al. 
2013). These studies suggest non-recovery in 5% to 21% of middle aged and older adult groups 




The literature demonstrates contradicting evidence for an age related difference in postural 
responses of OxHb (Mehagnoul-Schipper D.J. et al. 2000b; Kim Y.S. et al. 2011; Edlow B.L. et al. 2010).  
Mehagnoul-Schipper et al. (2000) (Mehagnoul-Schipper D.J. et al. 2000b) showed that older adults 
(74±4 years) had a significant postural decreases (supine to 2-minute stand) in OxHb and TotHb (-
4.6±2.2 and 3.1±2.2 µmol/L respectively) compared to young adults (27±7 years, -1.2±5.4 and 0.2±4.9 
µmol/L respectively), suggesting cerebral oxygen regulation is altered with age (Mehagnoul-Schipper 
D.J. et al. 2000b).  However more recently, Edlow et al. (2010) (Edlow B.L. et al. 2010) and Kim et al. 
(2011) (Kim Y.S. et al. 2011) have observed smaller postural decreases of OxHb in older adults 
compared to younger adults.  Edlow et al. (2010) had 60 participants (20-78 years old) perform a 
supine-stand transition, where across all ages OxHb and TotHb declined and DeoxHb increased. A 
significant age effect for OxHb indicates a smaller postural decrease in OxHb with increasing age (30 
years OxHb -4.6 to -3.8 µmolL-1, 60 years OxHb -2.9 to -2 µmolL-1) (Edlow B.L. et al. 2010).  Edlow et al. 
(2010) concluded that global cerebral autoregulation is intact with age and the incongruity of OxHb 
with age could be attributed to varied baseline cerebral blood flow volumes with age, or altered 
cerebral blood flow distribution seen with age (Edlow B.L. et al. 2010; Sorond F.A. et al. 2005).  Kim et 
al. (2011) compared the cerebrovascular and cardiovascular responses from baseline to the nadir of 
mean arterial pressure, and from baseline to 5 minutes of standing in older (59 years, IQR 52-65 years) 
and younger adults (29 years, IQR 27-33 years) (Kim Y.S. et al. 2011; Edlow B.L. et al. 2010).  The 
baseline to nadir responses demonstrate significant age differences for mean arterial pressure at the 
level of the brain, cerebral blood flow velocity and OxHb.  The young adults had a significantly larger 
drop in these measures compared to the older adults (Kim Y.S. et al. 2011).  The baseline to 5 minutes 
of standing responses showed significant age differences for mean arterial pressure at the level of the 




had significantly larger changes in magnitude for the cerebrovascular measures (Kim Y.S. et al. 2011). 
Kim et al. (2011) indicated postural reductions of cerebral perfusion were less pronounced with age 
and anterior cerebrovascular control was not a cause for postural dizziness and falls in older adults 
(Kim Y.S. et al. 2011). However, Kim et al. (2011) did not consider varied individual responses, 
demonstrated by Romero-ortuno et al. (2011) (Romero-ortuno R. et al. 2011).  A group average may 
have washed out non-recovery responders because of overshoot responders, and altered cerebral 
blood flow distribution with age may have impacted these results. The incongruent findings between 
Mehagnoul-Shipper et al. (2000) and Edlow et al. (2010) or Kim et al. (2011) could lie in different 
sample sizes and ages or source-detector differences used.   Regardless, age related differences in 
cerebral blood flow and oxygenation in response to an orthostatic stress require further investigation. 
In particular, individual responses or group stratification, as seen by Romero-ortuno et al. 2011, needs 
to be investigated to identify if some older adults are in fact at risk of cerebral hypoperfusion.  
 
Orthostatic Hypotension and Blood Pressure 
The literature presents evidence for a relationship between high blood pressure and the 
incidence rates of OH in older adults.  In 1995 Raiha et al. found that 28% of older adults (~74±6 years) 
had systolic OH (≥ 20 mmHg drop in systolic blood pressure) 3-minutes into standing (Raiha I. et al. 
1995).  Although the majority of participants were hypertensive (>60%) Raiha and colleagues 
reportedly found only higher levels of blood pressure (systolic, diastolic and mean) to significantly 
predispose participants to systolic OH (Raiha I. et al. 1995).  The data from Romero-ortuno et al. 
(2011) indicates that among hypertensives, the portion of participants in the non-recovery group of 
blood pressure has a higher baseline value for systolic and diastolic blood pressure, a lower nadir, and 




that higher blood pressures are more detrimental to older adults when performing a posture change.  
Frewen et al. (2013) elude to the same conclusion, where OH was significantly more prevalent in 
hypertensives versus normotensives at 20, 30, 60, and 90 seconds post transition (Frewen J. et al. 
2013).  Similarly, in a population based study (n=722, MOBILIZE Boston Study) of older adults, the 
prevalence of systolic OH at 1 minute and 3 minutes post transition were significantly higher in 
uncontrolled hypertensives (19% and 11% prevalence, 154±15 mmHg systolic blood pressure) versus 
normotensive (2% and 1% prevalence, 122±11 mmHg systolic blood pressure) and controlled 
hypertensive (5% and 1% prevalence, 122±11 mmHg systolic blood pressure) participants (Gangavati 
A. et al. 2011). This suggests that normotensive blood pressure or normotensive blood pressure 
achieved by pharmaceutical intervention is associated with a lowered occurrence of systolic OH.  
Moreover, in the group of participants with controlled hypertension, there was no difference in fall 
rates between participants with or without OH (20% and 22% fell more than once, respectively) 
(Gangavati A. et al. 2011).  However, for participants with un-controlled hypertension, participants 
with systolic OH fell significantly more than participants without OH (39% and 17% fell more than 
once, respectively) (Gangavati A. et al. 2011).  These findings suggest that if blood pressure is 
uncontrolled (hypertensive) and OH is evident, the risk of falling is significantly more than if OH was 
not present.  Also, controlled hypertension appears to be protective of falls in those with known OH.  
 
Pharmacological Effects  
Medications have been implicated with OH in as many as 66% of orthostatic hypotensive 
cases (Craig G.M. 1994).  Antihypertensive medications cause blood volume depletion, vasodilation, 
reduced myocardial contractility, and diminished sympathetic outflow, amongst other physiological 




clear.  OH is associated with hypertension, and thus, the association of OH and antihypertensive 
medications may lie with the underlying cause of elevated blood pressure (Hajjar I. 2005). The 
association between polypharmacy and OH is much clearer.  Due to multiple medical conditions in the 
elderly, poly medication and/or medications which lead to OH are often prescribed to older adults, 
placing them at greater risk of developing OH.  
 
Blood Pressure Lowering Medications  
Susceptibility to OH with medications is related to the interference by medications with reflex 
responses, such as vasoconstriction, heart rate or cardiac output (seen with alpha- and beta-blockers, 
and calcium channel blockers), as well was volume depletion seen with diuretics (Hopson J.R. et al. 
1993; Kamaruzzaman S. et al. 2010). However, it is unclear if OH is a direct consequence of 
antihypertensive medications or if it is associated with the underlying hypertension (Hajjar I. 2005).   
Thiazide diuretics inhibit reabsorption of sodium (Na+) and chloride (Cl-) ions at the distal 
convoluted tubules in the kidneys.  This increases urinary sodium excretion and extracellular fluid 
excretion.  Loop diuretics act at the loop of Henle by blocking sodium, chloride and potassium co-
transporters, which decreases sodium reabsorption leading to fluid excretion and decreased volume 
(Kaplan N.M. & Lieberman E. 2002).   Use of thiazide diuretics for greater than a month is 
accompanied by decreased peripheral vascular resistance (Conway J. & Lauwers P. 1960).  
The renin-angiotensen-aldosterone system (RAAS) can be inhibited at various points by ACE-
inhibitors or angiotensin-receptor blockers (ARB) (Hajjar I. 2005).  When extracellular fluid volume is 
reduced, granular cells within the kidney produce renin, which activates the circulating 
angiotensinogen (produced by the liver), to angiotensen I.  ACE then converts angiotensen I to 




the kidney to simulate aldosterone release and sodium reabsorption.  Angiotensen II also stimulates 
the cardiovascular control center to increase sympathetic activation to the cardiac tissue and 
vasculature (Silverthorn DU 2007).  These pathways increase blood volume and cardiac output which 
leads to increases in blood pressure.  ARBs block the angiotensen II AT1 receptors (directly blocking 
Angiotensen II), which causes vasodilation, reduces secretion of vasopressin, and reduces the 
production of aldosterone (lowers blood volume).  ACE-inhibitors block the conversion of angiotensen 
I to angiotensen II and also increase NO availability and increase parasympathetic outflow, causing 
vasodilation and lower blood pressure (Hajjar I. 2005; Silverthorn DU 2007).  In a review of 
medications on postural OH in the elderly, Hajjar (2005) states that ARBs and ACE-inhibitors are 
accompanied by low rates of orthostatic intolerance, which may be in part from enhanced baroreflex 
sensitivity seen with taking ACE-inhibitors (Hajjar I. 2005). Hajjar implies ACE-inhibitors and ARBs are 
better antihypertensive medications to take when attempting to avoid OH (Hajjar I. 2005).      
Beta-blockers (β-blockers) block epinephrine and norepinephrine on beta-adrenergic 
receptors, which mediates a reduction in sympathetic activation (smooth muscle, cardiac, pulmonary, 
kidney tissue). There are various types of β-adrenoceptors (β1, β2, β3,) which have varying 
pharmacological effects when blocked. β1-blockers (most commonly used for blood pressure lowering) 
decrease renin section which decreases angiotensin II and reduces cardiac contractility and cardiac 
output. β1-blockers also reduce baroreflex sensitivity by reducing sympathetic outflow (Hajjar I. 2005; 
Kaplan N.M. & Lieberman E. 2002).  Hajjar (2005) suggests β-blocker use is less likely to exacerbate 
OH, conversely, Kamaruzzaman (2010) suggests the use of β-blockers are independently associated 
with OH in elderly women (60-80 years old) (Kamaruzzaman S. et al. 2010; Hajjar I. 2005).   
Alpha-adrenoceptor antagonists (α-blocker) and calcium channel blockers may increase the 




muscle. By blocking catecholamines (epinephrine and norepinephrine) from binding to the receptor, 
sympathetic stimulation is blocked, thus reducing arterial resistance. Calcium channel blockers block L-
channels which inhibit the influx of calcium ions into cardiac and smooth muscle cells.  This reduces 
the strength of the myocardial contraction, decreases conduction of impulses in the cardiac muscle 
and reduces vascular resistance causing vasodilation (Hajjar I. 2005; Kaplan N.M. & Lieberman E. 
2002).  
As mentioned in the previous section, the study by Gangavati et al. (2011) shows the 
association between lower blood pressure (with or without antihypertensive medications) and lower 
incidence rates of OH (Gangavati A. et al. 2011). This suggests that the underlying elevated blood 
pressure can account for the OH and treatment of hypertension can lower incidence rates of OH 
(Gangavati A. et al. 2011).  Conversely, various studies have identified an association between 
antihypertensive medications and prevalence of OH (pepersack T. et al. 2013; Craig G.M. 1994; Poon 
I.O. & Braun U. 2005; Kamaruzzaman S. et al. 2010; Hajjar I. 2005).  A large population based study 
(n=3775) of older women (60-80 years) clearly demonstrates both hypertension and antihypertensive 
medications as a cause of OH (Kamaruzzaman S. et al. 2010).  Of the older women, OH was identified 
in 28% of the participants, and the incidence rate increased with age (Kamaruzzaman S. et al. 2010).  
Both uncontrolled hypertension and taking 3 or more medications (versus none) was significantly 
associated with OH (Kamaruzzaman S. et al. 2010). Regardless of diagnoses of hypertension or 
treatment status, elevated blood pressure was a strongly and significantly associated with OH.  
Additionally, the individuals with OH were proportionately on more beta-blockers, diuretics, ACE 
inhibitors, and alpha-blockers compared to participants without OH (all p<0.05) (Kamaruzzaman S. et 
al. 2010).  The incongruent finding for differentiating the cause of OH (hypertension versus 




Pepersck et al. (2013) were unable to definitively provide evidence for a connection between specific 
medications and OH (pepersack T. et al. 2013).  Clearly there is ample support for both suggested 
causes (hypertension and antihypertensive medication) of OH.   
 
Polypharmacy  
The additive effect of medications can inhibit compensatory mechanisms of blood pressure 
regulation which may increase the development of OH.  If an individual is on both an β-blocker and a 
diuretic, both the sympathetic response and blood volume are reduced, which would increase the risk 
of OH (Poon I.O. & Braun U. 2005).  The incidence of OH increases by taking more causative 
medications (defined by Poon et al. as alpha-blockers, diuretics, anti-depressant and anti-psychotic 
medications) (Poon I.O. & Braun U. 2005).  In a group of older adults (82±5 years), participants not on 
any causative medications had a 35% prevalence rate of OH (Poon I.O. & Braun U. 2005).  However, 
when looking at individuals on 1, 2 or 3+ causative medications  the incidence rates of OH rose to 58%, 
60% and 65% respectively (Poon I.O. & Braun U. 2005). These findings suggest that the prevalence of 
OH increases with the number of causative medications used, which may impact the development of 
OH (Poon I.O. & Braun U. 2005). These findings are supported by a publication by Craig (1994) where 
the average orthostatic hypotensive participant (mean age 80 years) took 2 medications 
(antihypertensive, antidepressant, and anti-Parkinson medications) but the range was in fact between 
0-9 different medications per person (Craig G.M. 1994).  Craig (1994) found 56% of older adults were 
taking diuretics, 26% taking benzodiazepine (psychoactive drug - relaxant), 24% anti-depressants, 22% 
anti-parkinsonian therapy, 12%  beta-blockers, 8% calcium antagonist, 4% angiotensin converting 
enzyme (ACE) inhibitors, and 2% were taking alpha blockers (Craig G.M. 1994).  Since multiple 




adult taking two or more medication may be at risk of OH (Craig G.M. 1994).  More recently, 
Kamaruzzaman et al. (2010) tested 3775 participants between 60 and 80 years old and found the 
prevalence of OH was strongly associated with the number of antihypertensive medications 
(Kamaruzzaman S. et al. 2010).  Kamaruzzaman et al. found participants who were not on any 
antihypertensive medications compared to participants on 3 or more antihypertensive medications 
were more likely to have OH (odds ratio: 2.24 95%CI 1.47-3.4, p<0.001) (Kamaruzzaman S. et al. 2010). 
The findings by Poon and Braun, Craig, and Kamaruzzaman et al. suggest a relationship between OH 
and multiple antihypertensive medications (Kamaruzzaman S. et al. 2010; Craig G.M. 1994; Poon I.O. 
& Braun U. 2005).   
 
Blood Pressure Lowering Medications & Cerebral Blood Flow 
Concerns of cerebral hypoperfusion or compromised cerebral autoregulation with the use of 
blood pressure lowering medications have been challenged over the years (Lipsitz L.A. et al. 2005; 
Zhang R. et al. 2007; Periard D. et al. 2012; Frei A. & Muller-Brand J. 1986; Muller M. et al. 2012).  As 
far back as 1986 when Frei et al. tested 20 hypertensive adults upon study commencement and after 8 
weeks of enalapril (ACE inhibitor), it has been shown that cerebral blood flow (133Xenon) is not 
adversely (significantly) effected by blood pressure lowing medications (Frei A. & Muller-Brand J. 
1986). More recently in 2012, Muller et al. evaluated cerebral blood flow with MRI in 575 participants 
who all had atherosclerotic disease (57±10 years) (Muller M. et al. 2012). Participants were evaluated 
upon the beginning of the study and 3.9 years later (Muller M. et al. 2012). Cerebral blood flow 
declined from 52.3±9.8 to 50.7±10.3 ml/min/100ml over the course of the study, and regression 
analysis (adjusted for age, sex, follow up time and vascular risk) determined untreated and poorly 




cerebral blood flow. Furthermore, successfully treated hypertensive participants, compared to 
participants without hypertension, did not show a significant difference in the decline of cerebral 
blood flow, suggesting treated hypertension is as effective in maintaining cerebral blood flow as aging 
without hypertension. Amongst hypertensive participants (n=469), participants using angiotensin 
receptor blockers did not show a decline in cerebral blood flow where other medications did (Muller 
M. et al. 2012). These findings suggest controlled hypertension by use of antihypertensive medications 
do not cause cerebral hypoperfusion at rest. Not only is cerebral blood flow unaffected by long-term 
use of antihypertensive medications, it has been shown that intensive blood pressure lowering 
(<130/80 mmHg) in hypertensive older adults (75±4 years) may in fact increases cerebral blood flow 
(spin labeling MRI) when compared to a typical blood pressure lowering regime (<140/85 mmHg) 
(Tryambake D. et al. 2013). Tryambake et al. 2013 found that participants on antihypertensive 
medications (ACE inhibitors, ARB, β-Blockers, calcium channel blockers and diuretics, or a 
combination), aiming to achieve a blood pressures of <130/80 mmHg had significantly greater cerebral 
blood flow in whole grey matter compared to participants aiming to achieve a blood pressure of 
<140/85 mHg (Tryambake D. et al. 2013). The authors suggest intensive blood pressure lowering shifts 
the autoregulatory curve upward and leftward whereby reversing the rightward shift observed with 
the development of hypertension (Tryambake D. et al. 2013). Intact cerebral autoregulation has also 
been shown by other researchers to be unaffected by long-term use of antihypertensive medications 
(Lipsitz L.A. et al. 2005; Zhang R. et al. 2007; Periard D. et al. 2012). 
In 2005 Lipsitz et al. tested 51 older adults (70-72±4 years) at study entry and 6 months later 
(Lipsitz L.A. et al. 2005). Participants were separated into one of three groups, normotensive (blood 
pressure <140/90 not suing any blood pressure medications), controlled hypertensive (blood pressure 




blood pressure with or without antihypertensive medications). Uncontrolled hypertensive participants 
were treated with lisinopril, an ACE inhibitor, with or without hydrochlorothiazide, a diuretic (or 
nifedipine, a calcium channel blocker, or an angiotensin receptor blocker if not tolerated). Treatment 
reduced CVRi, did not impair autoregulation and significantly increased cerebral blood flow velocity 
and carotid artery distensibility (Lipsitz L.A. et al. 2005). This study suggested antihypertensive therapy 
may preserve vascular function, cerebral autoregulation and improve cerebral perfusion (Lipsitz L.A. et 
al. 2005). Similarly, Zhang et al. (2007) tested normotensive (SBP 120±7mmHg, DBP 74±6mmHg, 
46±11 years) mild hypertensive (SBP 143±7mmHg, DBP 88±4mmHg, 49±11 years) and moderately 
hypertensive (SBP 163±11mmHg, DBP 101±9mmHg, 47±12 years) adults, and found that long term use 
of blood pressure lowing medications maintain cerebral autoregulation and perfusion (Zhang R. et al. 
2007). All participants in the Zhang et al. 2004 paper were tested during supine rest and during a 10 
minute 70° head-up tilt test. Testing took place before and after 3-4 months of 
losartan/hydrochlorothiazide (an angiotensin receptor2 antagonist/diuretic) use by the hypertensive 
participants.  Prior to the medication intervention, moderate hypertensive participants had 
significantly higher CVRi and TPRi values compared to the control group.  Following the 3-4 months of 
blood pressure lowering, cerebral blood flow velocity and Q were unchanged but CVRi and TPRi 
decreased in the moderate hypertensive group. These study results suggested that following 
losartan/hydrochorothiazide use, cerebral blood flow velocity is unchanged in participants with mild 
and moderate hypertension and when compared to controls, brain perfusion is not compromised 
(Zhang R. et al. 2007). During the head-up tilt test, responses between the control and hypertensive 
groups were similar.  However, transfer function gain between changes in blood pressure and cerebral 
blood flow velocity were significantly reduced in participants with moderate hypertension. The gain 




months of antihypertensive medication, suggesting an improved dynamic autoregulation with blood 
pressure lowering by medication.  
 
Balance Control (Stability)  
Impaired balance is significantly associated with fall risk in older adults (60 years and older) 
(Muir S.W. et al. 2010). Stability measurements or balance activities are therefore often used as a 
screening tool to determine if any balance impairments are evident, and to identify individuals at risk 
of a future fall (Berg K.O. et al. 1992).   
Balance is maintained by the central nervous system which integrates somatosensory, 
vestibular and visual feedback (Johansson R. & Marqnusson M. 1991). With age these sensory systems 
become compromised by the deterioration of cutaneous somatosensory receptors, muscle spindles, 
golgi tendon organs, chondrocytes in cartilage surfaces, visual acuity, contrast sensitivity, dark 
adaption, depth perception, vestibular hair cells, nerve conduction speed, myelination, central 
processing and response initiation, amongst others (review by  (Pasma J.H. et al. 2014)). In addition to 
a diminished sensory systems with age, reduced force production by muscle atrophy and muscle 
remodeling (tendons thicken and stretch causing reduced force production) contribute to balance 
impairments (Pasma J.H. et al. 2014). 
Balance is the relation of the center of mass (COM) to the area of the base of support (Maki 
B.E. & McIlroy W.E. 1997; Pollock A.S. et al. 2000; Hall S. 1991), and balance control is the ability to 
regulate these relationships (Maki B.E. & McIlroy W.E. 1997).  COM displacement out of the base of 
support results in an unbalanced object (Pollock A.S. et al. 2000; Bell F. 1998).  The multiple sensory 
systems used for balance control provide redundancies, where a temporary loss of one system can be 




et al. (1990) demonstrated such redundancies by testing three different participant groups, 
participants with somatosensory loss, vestibular loss, and normal participants (Horak F.B. et al. 1990). 
By using six different combinations of perturbations and compromising either the somatosensory 
system (proprioception), vision, or both, the exposure of redundant systems was evident. 
Maintenance of balance in the normal control group was always present despite compromising two 
balance systems. However, when a condition compromised both vision and proprioception (tilting the 
support platform forward), the group with vestibular loss had a large amount of sway (Horak F.B. et al. 
1990).  When either vision or proprioception alone was compromised, balance was maintained by the 
intact somatosensory and vision systems respectively (Horak F.B. et al. 1990; Winter D.A. 1995).  With 
age, physiological and pathological alterations can affect multiple sensory systems and therefore 
compromise balance and the stability of an individual.  
Postural stability is often measured by the displacement of the center of pressure (COP). COP 
marks the single location on the supporting surface where the vertical reaction vector would act 
(Winter D.A. 1990).  COM marks the point where the mass or weight of a body acts.  Distinction 
between COP and COM is clear when looking at the initiation of walking where the COP moves 
towards the posterior aspect of the ankle, and moves laterally towards the direction of the swing 
extremity (Winter D.A. 1995). COM moves anteriorly and laterally towards the stance extremity used 
to load the body weight (Winter D.A. 1995). With the initiation of walking and other dynamic 
movement tasks, the COM is required to shift from a stable position (alignment with COP) to a less 
stable position where the COP and COM are no longer aligned. The greater the separation distance of 
COP and COM, the greater amount of postural control is required.  Protective distances may represent 
a need to preserve stability (Martin M. et al. 2002).  The anterior-posterior (AP) and medial-lateral 




dominated by hip abductor and adductor muscles, and AP movements are predominantly governed by 
ankle muscles used for plantar- and dorsiflexion (Winter D.A. 1995). If the ankle muscles are unable to 
maintain balance during excessive instability, seen with internal (turning, reaching, bending) and 
external pertuberations (platform translations), the hip flexor and extensor muscles react in order to 
move the COM posteriorly or anteriorly to regain stability (Winter D.A. 1995). Balance control is a 
critical aspect of static balance (standing) and dynamic balance (walking), which are both 
compromised with age.   
 
Gait & Balance with Age 
Normal aging is accompanied by diminished lower extremity strength, slower reaction times, 
various pathological conditions (such as Parkinson’s Disease), visual impairment, polypharmacy, and 
vestibular dysfunction (neural and sensory hair cell deterioration), which all compromise the ability to 
maintain balance, thus increasing fall risk (review by  (Ambrose A.F. et al. 2013)).  Measures of static 
stability, particularly ML sway amplitude, are predictive of future fall risk in older adults with or 
without a recent history of falling (Maki B.E. et al. 1994).  Stability of dynamic walking on a treadmill is 
poorer in fall-prone older adults compared to young adults and healthy aging adults (Granata K.P. & 
Lockhart T.E. 2008). Dynamic movements, such as intra-individual step length variability, double 
support time, gait speed, cadence, and step-time variability, are predictive of multiple falls (Callisaya 
M.L. et al. 2011).  Evidently, various age related postural balance differences and gait differences are 
associated with falls.  
 Age differences (approximately, 20-30 years old and more than 60 years old) in balance 
control are seen by uncoordinated and stiff movements, where step length and height are reduced, 




2009; Ambrose A.F. et al. 2013; Jensen J.L. et al. 2001; Maki B.E. & mcIlroy W.E. 2006). Older adults 
(72±4 years) are more likely to use a compensatory recovery step in response to lower perturbation 
magnitudes when compared to young adults (26±5 years) (Jensen J.L. et al. 2001).  In a 2006 review 
paper on limb movements for balance recovery, Maki and McIlroy identify that older adults are less 
able to control ML stability, are more dependent on arm reactions to aid in rebalancing, but are less 
able to execute rapid reach-to-grasp tasks (Maki B.E. & mcIlroy W.E. 2006).  The authors provide 
evidence supporting the notion of reduced musculoskeletal capacity, sensory function and/or neural 
processing with age (Maki B.E. & mcIlroy W.E. 2006).  These findings indicate age related deficits in 
sensory systems and ultimately balance control (review by  (Maki B.E. & mcIlroy W.E. 1996)).  
 Postural balance control (regulating COM to the area of the base of support) is achieved by 
either compensating/reacting to an unexpected pertuberations, or predicting/anticipating a balance 
disturbance and minimizing the affects via balance strategies (Maki B.E. & McIlroy W.E. 1997).  Many 
of the gait and postural changes seen with age (ex. slower self-selected walking speeds, greater step-
to-step variability or reduced stride length) may be related to fitness (Roma M.F. et al. 2013) and/or 
balance strategies used to prevent, or minimize anticipated balance disturbances (Maki B.E. & McIlroy 
W.E. 1997).  Learned motor control strategies are influenced by various movement patterns and 
represent a ‘chosen’ movement pattern (Cappozzo A. 1983).  The chosen pattern is based on 
functional and structural constraints of the task, as well as choosing the most effective task to 
maintain balance (Cappozzo A. 1983).  The sit-stand transition is an activity of daily living which 





Sit-stand Transition and Age 
Sit-stand posture changes are challenging for many older adults and difficulty performing 
these transitions are reportedly associated with an increased fall risk (Yoshida K. et al. 1983).  A sit-
stand transition requires a great deal of lower limb strength and a wide range of motion in the lower 
limb joints (Wretenberg P. & Arborelius U.P. 1994) to move the center of mass forwards and upwards 
(Riley PlOl et al. 1997).  It is sometimes thought to be physically more challenging than walking or stair 
climbing because of the joint torques and range of motion needed (Lomaglio M.E. & Eng J.J. 2005).  In 
community dwelling older adults (79±4 years), sit-stand transition times are highly dependent on 
lower limb strength; however, sensorimotor, balance, and psychological factors (visual contrast 
sensitivity, lower limb proprioception, tactile sensitivity, simple foot reaction time, postural sway, 
body weight, and reported pain, anxiety, and vitality) can account for almost half of the variance in 
transition times (Lord S.R. et al. 2002).  Selective movement strategies for the sit-stand transition 
varies between older adults (65-81 years) and young adults (22-34 years), and between movement 
strategies in older adults (Papa E. & Cappozzo A. 2000).  Papa and Cappozzo (2000) separated older 
adults into two groups based on starting dorsiflexion or plantar-flexion position of the ankle (Papa E. & 
Cappozzo A. 2000).  When comparing older adults with ankle dorsiflexion to young adults (similar foot 
orientation) at the seat-off position (first stage of the transition), older adults had greater trunk flexion 
and increased velocity than young adults (Papa E. & Cappozzo A. 2000).  This seat-off position allows 
older adults to generate more momentum than young adults and also brings their COM closer to their 
base of support (Papa E. & Cappozzo A. 2000).   After seat-off, older adults had higher whole body 
rotational momentum which reduced muscular effort, and only after the COM was brought over the 
base of support, the older adults began to elevate. The young adults would combine the rotational 




functional capacity of muscular strength and reduced coordination in older adults versus young adults 
with the same starting foot position (Papa E. & Cappozzo A. 2000).  Although transition times are 
similar, motor strategies differ between older adults starting with dorsiflextion of the ankle and 
plantar-flexion of the ankle  (Papa E. & Cappozzo A. 2000). Prior to seat-off, participants starting with 
plantar-flexion had a larger rotational momentum of the head, arms and torso, which causes a large 
counterbalance to the backward gravitational force (Papa E. & Cappozzo A. 2000).  In this same group, 
body elevation was delayed to a greater extent than the older adults starting with dorsiflextion, which 
was assumed to be because of a greater risk for posterior balance instability (Papa E. & Cappozzo A. 
2000).  This study by Papa et al. (2000) identifies some of the strategy-related determinants of the sit-
stand transition (speed, foot positioning, trunk position/movement, and arm movement) which all 
impact performance on the sit-stand task (Janssen W.G.M. et al. 202).  
There are three task-related challenges with the sit-stand transition; moving the COM 
forwards, elevating the COM, and stabilizing the whole body over a much more narrow base of 
support (Riley PlOl et al. 1997).   Papa et al. (2000) identify age related differences in moving the COM 
forwards, and elevating the COM (Papa E. & Cappozzo A. 2000), where Akram and McIlroy (2011) 
identify differences in stabilization following a sit-stand transition (Akram S.B. & McIlroy 2011).  In a 
comparison of young (23±4 years) and older (74 ±8 years) adults with no history of falls, a method of 
quantifying the dynamic kinematics in a sit-stand transition was calculated (Akram S.B. & McIlroy 
2011). Akram and McIlroy (2011) recorded 15-20 seconds of data following the onset of transition. 
The dynamic phase of the transition was marked from the beginning of the transition until participants 
reached a natural quiet stance sway (Akram S.B. & McIlroy 2011).  Natural sway was collected from 
the last two seconds of standing. The time point at which sway was no longer within the 95% CI of the 




beginning of the transition to the end-time point of dynamic stability marks the duration of sway 
stabilization (milliseconds). In both the AP and ML directions, older adults had significantly longer 
stabilization times (AP: 8777±2632 ms, ML:8127±2420 ms) compared to young adults (AP: 6942±1779 
ms ML: 6927±1950 ms), suggesting older adults have a reduced ability to achieve stability (Akram S.B. 
& McIlroy 2011).  Older adults also had significantly larger amplitudes of COP sway excursion (longer 
COP path) in both the AP and ML directions, which reflects the differences in stability control (Akram 
S.B. & McIlroy 2011).   
 
Ambulatory gait monitoring 
Ambulatory gait monitoring is defined as the use of sensors fixed to the body which provide 
an opportunity to both observe and record quantitative gait characteristics while not being restrained 
to a specific location such as a lab (Selles R.W. et al. 2005).  Ambulatory gait monitoring can be 
collected by foot pressure insoles, footswitches, inertial measurement units, electromyography 
signals, gyroscopes for angular velocity and accelerometers for linear acceleration  (Taborri J. et al. 
2016). For the purpose of this thesis accelerometers will be the focus of discussion.  Via use of 
accelerometers, sub-phases of the swing phase can be calculated (initial-swing or toe-off, mid-swing 
and terminal-swing or heel-strike) (Taborri J. et al. 2016). Additional gait characteristics are often 
calculated based off of the toe-off and heel-strike time points. Toe-off marks the beginning of the 
swing phase and heel-strike marks the termination of the swing phase as well as the start of the 
stance phase. The time from toe-off to toe-off or heel-strike to heel-strike constitutes a single gait 
cycle  (Selles R.W. et al. 2005).  
An increase in gait variability is the reduced ability to effectively control gait between strides  




Terrier et al. 2015 differentiated the increase in gait variability associated with age to be due to an 
accelerated rate of instability seen during 40-50 years of age versus a slow and progressive decline of 
stability across the lifespan  (Terrier P. & Reynard F. 2015).   In young adults gait variability has been 
correlated to CBFV while walking on a treadmill and performing a cognitive task  (Gatouillat A. et al. 
2015). Increased step-to-step time variability in older adults is a significant predictor of falls and is 
significantly correlated to strength, balance, gait speed, functional status and metal health  (Hausdorff 
J.M. 2005) and thus a useful, non-invasive tool to predict falls in older adults.  
 
Gait Speed and Age 
The central nervous system reacts to and anticipates balance disturbances by activating 
various muscle groups in order to readjust the COM and regain stability. With a quite static stand the 
COM is always within the base of support (Winter D.A. 1995). During walking the COM is always 
outside the base of support (other than brief double support phases), and the balance is thus archived 
by the swing limb trajectory (Winter D.A. 1995).  During walking the ankle muscles can only fine tune 
accelerations of the body’s COM because the dynamic balance task is governed by the placement of 
the swing foot (Winter D.A. 1995).  Therefore, walking requires greater angular movement, motor 
control and coordination of the hip, knee and ankle joints (Winter D.A. 1995). Walking is a complex 
and dynamic movement which taxes postural control in some older adults.  Consequently, various 
indices of gait are indicative of poor balance control and fall risk.  
Gait speed is associated with falls in older adults (Quach L. et al. 2011).  A nonlinear 
relationship between gait speed (determined by the 4-meter walk test) and falls exists, where slow 
walkers are at risk of falling indoors and fast walkers are at risk of falling outdoors (Quach L. et al. 




future falls (Quach L. et al. 2011).  Slower gait speeds are also associated with cognitive decline in non-
demented older adults (Ble A. et al. 2005). In a study by Ble et al. (2005) executive function in older 
adults (75 years) was strongly and independently associated with walking speed on a 7-meter obstacle 
course which was set at a fast pace (Ble A. et al. 2005). These relationships were not found with a 4-
meter usual-pace walking test, presumably because the obstacle course required more attention (Ble 
A. et al. 2005).  The authors suggest executive function is required and is challenged in more complex 
lower extremity motor tasks versus highly practiced skills (usual-pace 4-meter walk test) (Ble A. et al. 
2005).  The slower gait speeds observed by Quach et al., in relation to fall risk, and Ble et al., in 
relation to cognition, identifies a loss of function and deterioration of motor control centers and 
processing regions of the frontal lobe (Ble A. et al. 2005; Quach L. et al. 2011).  
 
Cardio- and cerebrovascular hemodynamic responses in association to postural stability, gait speed 
and falls  
Acute and prolonged reductions in BP on standing might be associated with cerebral 
hypoperfusion  (Edlow B.L. et al. 2010; Mehagnoul-Schipper D.J. et al. 2000b; Gutkin M. & Stewart 
J.M. 2016). A reduction in CBF large enough to cause postural instability is alluded to in the literature  
(Shaw B.H. & Claydon V.E. 2014; van Wijnen V.K. et al. 2017; Lipsitz L.A. 1985; Hossain M. et al. 2001; 
Shaw B.H. et al. 2015). However, the impact of reduced CBF on postural stability has never been 
thoroughly investigated.  
In a meta-analysis on OH and elderly adults by Pepersack et al. (2013), OH was significantly 
associated with gait disorders (OR: 1.23, CI 1.02-1.46) and frequent falls (OR: 1.54, CI 1.04-2.22) 
(pepersack T. et al. 2013).  OH was also significantly associated with myocardial infarctions (OR:1.24, 




1.09-1.68), cardiac rhythmic abnormalities (OR: 1.21, CI 1.03-1.42), and carotid artery stenosis (OR: 
1.67, CI 1.23-2.26) (pepersack T. et al. 2013).  These findings describe a relationship between poor 
cardiovascular health, poor blood pressure regulation, and poor balance control.  Craig (1994) found 
similar results in a group of elderly adults (n=50, 63-97 years with a mean age of 80 years) with OH, 
where 64% of participants had a fall, 44% had poor mobility, 38% unsteadiness, 22% confusion, 14% 
postural symptoms, 12% fractures, 10% dementia, 8% blackouts, 6% reluctant to stand, 6% pallor or 
tiredness  (Craig G.M. 1994).  These findings suggest OH is accompanied by signs of hypoperfusion in 
the cerebral vasculature (confusion, blackouts, pallor) and poor balance control (falls, poor mobility, 
unsteadiness, postural symptoms). Pepersack et al. and Craig et al. have identified relationships 
between cardio- and cerebrovascular health instability and falls in older adults.      
Various authors have investigated blood pressure responses during an orthostatic stress 
(active posture change or passive tilt test) and its association to falls or balance control.  In the 
absence of measuring cerebral blood flow or oxygenation, blood pressure can lend insight to the 
hemodynamic responses which may be occurring at the level of the brain. Heitterachi et al. (2002) 
investigated blood pressure responses to a 60° head-up tilt test and fall rates over a 12-month period 
(Heitterachi E. et al. 2002).  The blood pressure response of a passive head-up tilt test differs from an 
active stand, yet both maneuvers challenge the cardiovascular system and provide information about 
the system’s function. Heitterachi et al. found 51% of the older adults (n=70, 77±6 years) fell one or 
more times during a one year follow up (Heitterachi E. et al. 2002).  When comparing fallers to non-
fallers, fallers demonstrated significantly larger reductions in SBP when tilted, and poorer SBP 
recovery (3-minutes post tilt). Where 22% of the fallers had a decrease of SBP equal to or greater than 
20 mmHg at 3-minutes post tilt and only 6% of the non-fallers demonstrated this hypotension.  The 




increased risk of falling (RR=1.71, 95%CI=1.14-2.59). Five percent of the fallers reported ‘fainting’ or 
blacking-out’ as the cause of at least one fall. These same participants (fainting/blacking-out) 
demonstrated significantly larger SBP drops with tilting compared to fallers not reporting signs of pre-
syncope as the cause of a fall.  These findings indicate that reductions in SBP and unstable SBP 
recovery to a tilt test are predictors of falls in older adults (Heitterachi E. et al. 2002).   
Relative to a passive tilt test, an active stand exaggerates the transient reduction in blood 
pressure and better mimics activities of daily living. Finucane et al. 2017 collected beat-beat 
continuous recordings of BP during an active stand protocol in older adults (50+ years) (Finucane C. et 
al. 2017).  It was found that delayed OH recovery and sustained OH were both independent risk 
factors for a future fall, unexplained fall and injurious fall in adults 50+ years old  (Finucane C. et al. 
2017).  Kario et al. (2011) investigated the relationship between blood pressure responses during a 
supine-to-stand transition and falls in older adults (n=266, 76±5 years)  (Kario K. et al. 2001). By means 
of a manual sphygmomanometer, blood pressure was measured in the supine position, immediately 
after standing and 2-minutes after standing. A battery of postural control tests assessing responses to 
surface perturbations and altered visual conditions were conducted, as well as a 12-month follow-up 
of fall history were also collected.  When separating fallers (31% of participants) from non-fallers, SBP 
was significantly lower in fallers at all time points (Kario K. et al. 2001). When participants were 
separated into 5 different SBP groups, falls occurred 2.8 times more often in the lower blood pressure 
groups (<140 mmHg) (Kario K. et al. 2001).  Falls were less common in hypertensives (treated or not) 
versus normotensives. This finding is in opposition to much of the literature which supports an 
association of hypertension and higher prevalence of OH, where OH is associated with fall risk (Frewen 
J. et al. 2013; Gangavati A. et al. 2011; Duschek S. et al. 2009; Romero-ortuno R. et al. 2011; Ooi W.L. 




postural balance tests (p=0.1) however, standing SBP was a negative predictor of falls (Kario K. et al. 
2001).  A 10 mmHg increase in standing SBP reduced falls by 22%, implying that a lower standing SBP 
is seen to be a predictor of falls in older adults (Kario K. et al. 2001).  Kario and colleagues’ study 
results support the observations made by Romero-ortuno et al. (2011). Romero-ortuno et al. found 
that a lower standing SBP was indicative of poorer blood pressure recovery and increased prevalence 
of OH symptoms (Romero-ortuno R. et al. 2011). Kario and colleagues’ findings are also 
complemented by Mehagnoul-Schipper et al. (2000) who found a significant association between 
smaller postural decreases in OxHb (by an active stand) and higher baseline SBP (r=0.4) and DBP 
values (r=0.51) (Mehagnoul-Schipper D.J. et al. 2000a). Smaller OxHb decreases and smaller DeoxHb 
increases were also significantly associated to higher postural DBP increases (r=0.52, r=-0.46, 
respectively) (Mehagnoul-Schipper D.J. et al. 2000a).  During an active stand protocol in older adults 
(75±7 years), Mehagnoul-Schipper et al. 2001 found that two participants experienced dizziness and 
light-headedness without an OH decrease in BP but they did have pronounced reductions in both 
OxHb  (Mehagnoul-Schipper D.J. et al. 2001). The authors suggested that cerebrovascular 
hemodynamics may fail to compensate fully for postural changes in BP, placing some older adults at 
risk of cerebral hypoperfusion following an active stand  (Mehagnoul-Schipper D.J. et al. 2001). 
Sorond et al. (2010) examined the relationships between cerebrovascular function and gait 
speed in community-dwelling older adults (n=765, age: 78±5 years) (Sorond F.A. et al. 2010).  Gait 
speed is a known predictor of falls in older adults (Quach L. et al. 2011; Sorond F.A. et al. 2011), and 
slow gait speed has been associated with poor cerebrovascular regulation  (Sorond F.A. et al. 2011).  In 
the study by Sorond et al. 2010, CRCO2 was used to measure cerebrovascular function and gait speed 
was evaluated using a 4-meter walk test. Slower gait speed was significantly associated with a reduced 




the CRCO2 responses were split into quintiles, the lowest quintile group had significantly more falls 
compared to the highest quintile group (Sorond F.A. et al. 2010).  The authors concluded, impaired 
cerebral blood flow regulation was associated with slower gait speed and falls in their sample of older 
adults (Sorond F.A. et al. 2010).  
More recently, soluble vascular cell adhesion molecule-1 (sVCAM-1), a biomarker of 
endothelial dysfunction has shown to be associated with impaired cerebrovascular function in older 
adults (Tchalla A.E. et al. 2015). Elevated sVCAM-1 is significantly associated with reduced resting 
CBFV, cerebral vasomotor reserve, slower gait speed and increased odds of an injurious fall in older 
adults (78±5 years old)  (Tchalla A.E. et al. 2015).  Lower resting CBFV, marked by a combined left and 
right anterior and middle cerebral arteries in older adults (81±6 years of age) has also shown to be 
associated with slower gait speed and chair rise time  (Ezzati A. et al. 2017).  Yet to date CBF during 
over-ground walking and its’ relationship to gait speed has not been assessed in older adults.  
The aforementioned studies imply that inadequate blood pressure regulation and insufficient 
blood pressure recovery from a posture change are related to greater reduction in cerebral 
oxygenation, higher prevalence of OH and increased risk of falls in older adults.  Furthermore, lower 
resting cerebrovascular hemodynamics were also associated with reduced gait speed, a known 
predictor of future falls. Yet to date there have not been any studies investigating cerebral perfusion 
during an active transition (to standing or walking) and its relationship to balance control, gait speed 
and falls in older adults.   
 
Summary 
Orthostatic hypotension is an impended risk factor for future falls  (Finucane C. et al. 2017).  
Syncope, and signs of it, suggests moments of cerebral hypoperfusion, yet cerebral blood flow and 




The mechanisms underlying transient cerebral hypoperfusion require further investigation to identify 
if cerebral hypoperfusion is associated with postural instability, altered gait characteristics, gait speed 






The purpose of this thesis was to investigate relationships between cerebral hypoperfusion and postural 
instability and compromised gait strategies, with implications for future falls in older adults. This study 
will improve baseline knowledge regarding reductions in blood pressure and the risk of cerebral 
hypoperfusion in older adults with the hopes to distinguish mechanisms that might underlie a greater 
risk for some older adults of having a future fall and with the goal of improving the health of older 
adults. 
 
Specific questions and hypotheses Chapter 3: 
A. Do older adults have varied cerebrovascular responses to a transition to standing? 
It is hypothesized that some older adults will have cerebral hypoperfusion while standing. 
B. Do individuals with posture related reductions of tSO2 have impaired postural stability? 
It is hypothesized that older adults with cerebral hypoperfusion will also have greater measures 
of postural instability.  
C. Do different posture transitions (supine-sit-stand and sit-stand compared to supine-stand) 
reduce the impact of reduced tSO2 resulting in enhanced postural stability? 
It is hypothesized that a brief sitting pause time (supine-sit-stand) will increase tSO2 nadir values 
and improve postural stability. It is also hypothesized that a sit-stand will result in a higher tSO2 
value and be associated with better postural stability compared to a supine-stand transition.  
D. Is reduced tSO2 associated with falls (within 6-months of testing)? 
It is hypothesized that older adults with cerebral hypoperfusion will have an increased likelihood 





Specific questions and hypotheses Chapter 4:  
A. Do older adults have varied cerebrovascular responses to a transition to walking? 
It is hypothesized that some older adults will have cerebral hypoperfusion during walking. 
B. Do older adults with posture related reductions of tSO2 during walking have increased step-step 
variability or slower gait speeds? 
It is hypothesized that older adults with cerebral hypoperfusion will have increased step-step 
variability, compromised gait strategies and slower gait speeds. 
C. Is vascular stiffness associated with cerebral hypoperfusion while walking?  





CHAPTER 2. GENERAL METHODS AND MATERIALS 
This chapter describes the participant populations and experimental measurements used throughout 
the study protocols (Table 2). Methodologies specific to each study will be described in each 
corresponding chapter.  
Table 2-1. Overview of Study Population, Equipment and Procedures  
Study Title Population Equipment  
Additional 
Procedures 
1. Cerebrovascular hemodynamics and 
postural stability in older adults 
 











2. Cerebral hypoperfusion during over-
ground walking is related to increased 
gait variability and vascular stiffness in 
older adults 













    
ECG electrocardiogram, NIRS near-infrared spectroscopy, NWBB Nintendo Wii balance boards, TCD transcranial 
Doppler ultrasound, PETCO2 end-tidal CO2, CRCO2 cerebrovascular reactivity to Carbon dioxide, cfPWV carotid-
femoral pulse wave velocity, IMT intima medial thickness, cCC carotid artery compliance coefficient, cDC carotid 






The target population for each study is described in detail within each pertaining chapter. 
However, in general, older adults recruited were ≥65 years old. With the exception of 3 community 
dwelling older adults all other older adults were from conjugate living at one of the Schlegel 
Villages in Ontario Canada. All participants were asked to avoid moderate to strenuous levels of 
exercise 24 hours prior to testing  (Pescatello L.S. & Kulikowich J.M. 2001), to refrain from consuming 
alcohol or caffeine  (Kurtz A.Ml et al. 2013)  within four hours of testing and to arrive to testing 2-h 
postprandial. Upon arrival to the testing location, participants completed a brief health 
questionnaire (Appendix A). The health questionnaire was a self-report questionnaire which 
was used to identify the exclusion criteria (neuromuscular and neurological conditions, 
diabetes, stroke or any recent (within 3 months) myocardial infarctions). The health 
questionnaire also included additional information from participants including past and current 
health, physical activity habits, history of smoking, balance confidence and fear of falling, recent 
nutritional intake and current medications.  
 
Experimental Measurements 
Multiple Schlegel Villages locations were used for the studies involving older adult participants. 
The intent of having multiple testing locations was to maximize recruitment by limiting the amount of 






Assessment of Cardiovascular Hemodynamics  
Heart rate was continuously monitored using a 3-lead electrocardiogram (ECG, Finapres 
Medical Systems, Amsterdam, The Netherlands). Arterial blood pressure (ABP) was recoded 
continuously using noninvasive finger-cuff photoplethysmography (Portapres, Finometer, Medical 
Systems, Amsterdam NL), where the cuff was placed on the right-hand middle finger.  The Portapres 
does not differ substantially from invasive intra-arterial pressure during rest or posture transitions and 
represents a reliable means for collecting ABP during orthostatic stress  (Imholz BPM et al. 1990).  The 
Portapres has an off-line analysis (Beatscope) program, and the Finometer has a real time analysis 
system to reconstruct the finger arterial pressure waveform to a brachial arterial pressure waveform.  
These photoplethysmography devices also used a glycerine-filled pressure transducer to account for 
differences in hydrostatic pressure between the finger and brachial arterial sites. The Finometer further 
reduced pressure differences between finger arterial pressure and brachial pressure by using a return-
to-flow function which is known to reduce pressure differences to less than 4 mmHg (±8 mmHg) 
between the two methods  (Guelen I et al. 2008). Both photoplethysmography devices used a technique 
called Modelflow to calculate stroke volume (SV). Modelflow integrated a three-element model of 
arterial impedance with the arterial pressure wave to reliably track beat-to-beat differences in stroke 
volume  (Harms M et al. 1999).  Estimates of SV were used to calculate an output measure of cardiac 
output (Q) in real time by the Finometer and offline by the Portapres. To minimize the effects of body 
size on differences in blood volume and hemodynamic responses, Q was normalized (Qi) to body surface 
area (BSA)(Equation 2 -1) (DuBois D & DuBois EF 1916; Wang Y et al. 1992). Stroke volume (SV) and total 
peripheral resistance (TPR) were calculated (Equation 2-2, Equation 2-3) and adjusted to BSA (SVi, TPRi) 
when using the Portapres. Arterial blood pressure was collected with a manual sphygmomanometer and 




pressure if a difference of five or more millimeters of mercury existed between the manual ABP and the 
Finometer/Portapres device.   Manual blood pressures were collected in duplicate or triplicate if there 
existed large variability within the measure. Mean arterial pressure (MAP) and pulse pressure (PP) were 
calculated (Equation 2-4, Equation 2-5).  To account for the differences in hydrostatic pressure from a 
supine to an upright position, MAP at the level of the brain (BPMCA) was adjusted according to the 
distance from the heart to the level of the middle cerebral artery (Equation 2-6). It is important to note 
that this calculation relies on the assumption that intracranial and venous pressures are relatively low 
and constant, and that they are proportional to the arterial pressure for a closed circulatory system  
(Zhang R. et al. 2007).   
 
Body surface area = (W 0.425 x H 0.725) x 0.007184 
W: weight in kilograms  H: height is in centimeters 
Equation 2-1. Body Surface Area (kg*cm) 
 
Stroke volume = cardiac output/heart rate*1000 
Equation 2-2. Estimate of Stroke Volume (ml/beat) 
 
Total peripheral resistance = mean arterial pressure/cardiac output 
Equation 2-3. Estimate of Total Peripheral Resistance (mmHg/L/min) 
 
MAP = systolic blood pressure + 1/3 diastolic blood pressure 






Pulse pressure = systolic blood pressure – diastolic blood pressure 
Equation 2-5. Pulse Pressure (mmHg) 
 
BPMCA = mean arterial pressure - (heart to MCA distance in cm * 0.78) 
The constant 0.78 represents the density of blood 
Equation 2-6. MAP at the MCA Level (mmHg/cm) 
 
 
The Powerlab acquisition system and the Chart 7 software (PowerLab; AD Instruments, Colorado 
Springs CO USA, 2003) were used to sample beat-by-beat RRI, ABP, and TCD (described below) data at 
1000 Hz, providing a basic resolution of 1 millisecond.  The data was subsequently transferred into Excel 
(Microsoft Corp., Redmond WA USA, 2010) for further analysis. The R-R sequences was visually 
inspected, and the data considered as artifacts was manually removed.   
 
Assessment of Cerebrovascular Hemodynamics  
A 2-MHz range gated (pulse wave) Transcranial Doppler ultrasound (TCD) system was used 
(Multigon Industries, Elmsford, NY, USA, TCD-X; Atys medical, Soucieu en Jarrest, France) to insonate the 
MCA and collect a peak flow velocity tracing.  The MCA travels laterally and slightly anteriorly, thus the 
probe was placed over the transtemporal window, slightly facing the anterior direction (giving it a zero-
angle insonation), and at a depth of 35 to 55 mm (Panerai R.B. 2009; Purkayastha S. & Sorond F. 2012; 
Aaslid R. et al. 1982). The angle of insonation is a determinant of cerebral blood flow velocity (Equation 
1-2), where an angle greater than 60° significantly increases the resultant calculated velocity and should 
therefore was not used.  In addition to depth and probe placement, tone and pitch (strength of the 




probe was always placed on the right side of the head, unless a TCD signal was only found on the left 
side of the head.   
 In addition to the limitations of Doppler ultrasound mentioned above (turbulent flow, pulsatility, 
angle of insonation) the assumption of having a circular vessel can impact blood flow calculations (Eq. 1-
3).  Vessel area is quantified by using the vessel diameter, which is assumed to be circular.  With age 
structural changes to the vessels may cause changes in geometry, whereby significantly larger internal 
carotid artery and middle cerebral artery diameters are seen with age (Rai A.T. et al. 2013).    
 NIRS provides non-invasive, continuous sample (10 Hz) of cerebral tissue oxygenation. NIRS was 
used to collect OxHb, DeoxHb, TotHb, and tSO2 (PortaLite: Artinis Medical Systems BV, Netherlands).  
The PortaLite NIRS device has three optodes (LED light sources) which alternate between 760 and 850 
nm wavelengths.  The NIRS device has a single detector which constructs three source-detector 
distances (2, 3, and 4 cm).  All source-detector distances were collected, however only the source-
detector distance of 4 cm was used for analysis.  Source-detector distances less than 3 cm are not 
recommended as they are greatly contaminated by scalp and skull tissue (Kohri S. et al. 2002; Pellicer A. 
& Bravo M.C. 2011; Pellicer A. & Bravo M.C. 2011; Hare H.V. et al. 2013). In a study by Kohri et al. (2002), 
the contribution ratio of the cerebral tissue to the optical signals was 33%, 55% and 69% at source 
detector distances of 2, 3 and 4 cm respectively (Kohri S. et al. 2002).  A source-detector distance of 4 
cm resulted in a tissue sampling of 2 cm below the skins surface which reduced the contribution of 
extracerebral tissue.  This sampling depth was restricted to the outer cortex and hence there was an 
inability to monitor deep brain regions (basal ganglia – often performed during cognitive stimulation) 
(review by  (Quaresima V. et al. 2012)).  
 The NIRS device was positioned alongside the TCD probe and placed on the forehead.  The 
exact positioning of the NIRS device was in accordance with the international 10-20 EEG electrode 




sampled Brodmann Area 10 (Anterior prefrontal cortex: executive function), Brodmann Area 8 (Frontal 
eye field: visual attention), and Broadman areas 45 and 47 (Inferior frontal gyrus: inhibition and 
language), which are supplied by the MCA and ACA.   
Small changes in the optode-to-skin contact can lead to large changes in the NIRS signal  (Pellicer 
A. & Bravo M.C. 2011).  Movement artifacts (caused by head movement) lead to alterations in light 
coupling and add noise to the signal (Scholkmann F. et al. 2010).   The movement artifacts, often seen in 
neonates and animals, affect the quality of the NIRS signal and can be resolved using various processing 
techniques (for a review see  (Cui X. et al. 2010)).   To ensure continuous optode-to-skin contact, the 
NIRS device was secured with a tenser bandage wrapped around the head.   
The differential pathlength factor accounts for scattering of the near infrared light.  Due to 
changes in tissue properties with age (ex. brain atrophy), the differential pathlength factor increases 
with age (Claassen J.A.H.R. et al. 2006). To date there are no set differential pathlength factors 
established for adults older than 50 years (Duncan A. et al. 1996). However, Classen and Colier (2006), 
report using a set differential pathlength factor of 6.6 (set to that of a 50 year old) for adults 68-87 
(Claassen J.A.H.R. et al. 2006). The same differential pathlength factor of 6.6 was used in the current 
thesis for all adults.  
 
      Y = yi –yavg  
   Equation 2-7 Relative Change in NIRS Signals 
 
It is also important to acknowledge the effects of thermoregulation on changes and flow 
redistribution in the skin of the forehead  (Miyazawa T. et al. 2013; Kirilina E. et al. 2012). Miyazawa et 
al. (2013) demonstrate significant increases in oxygenated hemoglobin (OxHb) during cycling at a work 




exercise, cooling was applied to the forehead, cerebral blood flow velocity (TCD) remained elevated yet 
OxHb and skin blood flow significantly diminished (Miyazawa T. et al. 2013).  This implies that the OxHb 
can be impacted by skin blood flow (Miyazawa T. et al. 2013). It has also been shown that task-evoked 
changes in OxHb contain extra-cranial artifacts of venous volume (Kirilina E. et al. 2012).  The decrease 
in venous volume during the task was confirmed by the MRI signal and attributed to alterations in 
sympathetic outflow observed with cognitive and emotional processes (Kirilina E. et al. 2012). These 
findings suggest caution should be taken when interpreting results which employ dynamic exercises 
(equal to or greater than 60% of age predicted max heart rate) or activities which may cause additional 
stress (Miyazawa T. et al. 2013; Kirilina E. et al. 2012). 
NIRS software (Oxysoft: Artinis Medical Systems BV, Netherlands) was used to convert the NIRS 
signals into Excel and then uploaded to Chart 7 to extract beat-to-beat data. Once all the cardiovascular 
and cerebrovascular beat-to-beat data were cleaned and time aligned, the data was resampled at 1 Hz 
(MatLab, mathWorks, Natick MA, USA) to allow between participant comparisons and construction of 
group averaged graphs.   
 
Vascular Properties 
 With age, central elastic arteries become stiffer and the prevalence of systolic hypertension 
becomes greater, consequently central pulse pressure widens (Swaminathan R.V. & Alexander K.P. 
2006).  The pulse wave of the carotid artery is a valid estimate of aortic pulse pressure (Kelly R.P. et al. 
1989; Chen C.H. et al. 1996), and it represents a gauge of pulse pressure entering the cerebral 
circulation.  Central pulse pressure was collected by a high-fidelity tonometer (SPT-301, Millar 
Instruments, Houston TX USA) over 20-30 cardiac cycles.  The tonometer was placed 1cm below the 
internal and external carotid artery bifurcation. The carotid distension waveforms were calibrated 




holding pressure of the tonometer and to obtain an accurate carotid pressure waveform (Hirata K. et al. 
2006b).  
 The speed of a pressure wave traveling along an arterial segment was determined by the density 
of blood, the arterial diameter and the stiffness of the elastic material (Nichols W.W. & O'Rourke M.F. 
2005). As the structure of an elastic vessel becomes stiffer blood travels through it at a greater velocity. 
The calculated distance a pulse pressure wave travels between two sites along the arterial tree, for a 
given amount of time, is referred to as the pulse wave velocity (PWV) (Equation 2-8) (Nichols W.W. & 
O'Rourke M.F. 2005; Hirata K. et al. 2006a).  PWV is informative of arterial stiffening and can represent 
central (carotid-femoral) or peripheral (brachial-ankle) vasculature.  Central PWV progressively increases 
with age, suggesting elastic degeneration and stiffening of central vessels (Hirata K. et al. 2006a).   
 
  PWV = (LD – LP) / (TD – TP) 
L is the length/distance, T is the arrival time of the pulse wave, subscript P is the 
proximal site and subscript D is the distal site  
Equation 2-8 Pulse Wave Velocity 
 
Carotid-femoral PWV was collected simultaneously at the carotid (below common carotid 
bifurcation) and femoral artery sites. Pulse pressure waves were recorded for 20-30 cardiac cycles by 
Doppler ultrasound (Doppler Box, Compumedics DWL, Singen DE). To clearly identify the foot of each 
pressure wave, a low-pass 5-30 Hz filter was applied  (Robertson A.D. et al. 2010a) and the maximum 2nd 
derivative of each waveform was calculated (Chiu Y.C. et al. 1991). The distance in cm was measured 
from the suprasternal notch to each corresponding measurement site (carotid and femoral). The surface 




carotid  (Wong A.K. et al. 2014).  The distance between sites was then divided by the difference in arrival 
time from the R-peak in the cardiac cycle to the foot of the arterial pressure wave.  
 
Measures of Stability 
Nintendo Wii Balance Boards 
The Nintendo Wii Balance Board (NWBB) (Nintendo, Koyoto, Japan) was developed as a gaming 
controller but has recently been used in place of force plates.  The NWBB is a portable (3.5 kg, L 25cm, 
W 26.5cm, and H 5.3cm), inexpensive device (less than 1% of a force plate cost), which uses Bluetooth 
technology to wirelessly transmit data to a customized nearby software program (Laboratory Virtual 
Instrument Engineering Workbench (LabView, National Instruments, Austin TX USA).  The NWBB is 
comprised of a 16-bit pressure sensor in each corner which detects vertical ground reaction forces on 
the surface of the board.  The COP path can be calculated by the weighted average of the vertical forces. 
The data collected by the NWBB is sampled at 100 Hz which is sufficient to record movements seen with 
quiet standing (0.01 – 10Hz).  Less than 2 Hz of COP fluctuations are reportedly based on visual and 
vestibular information, and greater than 2 Hz of COP postural sway is based on proprioceptive 
information (Tanabe H. et al. 2012).   
The NWBB demonstrates good to excellent COP path length test-retest reliability (intraclass 
correlation coefficient = 0.66 – 0.94) during a quiet stand with eyes open/closed and during 
single/double limb supports (Clark R.A. et al. 2010).  When compared to a force plate, the NWBB 
demonstrates excellent COP path length accuracy (intraclass correlation coefficient = 0.77 – 0.89) during 
eyes open/closed and with a single/double support, making it a valid (>0.75) (Lee J. et al. 1989) means of 
calculating COP  (Clark R.A. et al. 2010).  The NWBB also demonstrates sensitivity to subtle movement 
variations associated with visual tasks (magnitude and dynamics of body sway) in older adult (73±7 




Wear and tear of a NWBB (tested up to 4 years of use) does not significantly affect the 
performance of the board  (Bartlett H.L. et al. 2014). However, using the same board(s) for all protocols 
within a study reduces uncertainty of the force measurements and produce a relative measure with the 
same device  (Bartlett H.L. et al. 2014).  Thus, the same NWBB was used across all participants and 
studies.   COP displacement was characterized as the root mean square (RMS) (Lafond D. et al. 2004), 
which is the magnitude of the COP excursion.  The RMS was calculated (Matlab) from the COP in both 
the AP and ML directions.   
 Limitations of the NWBB includes the inability to collect sheer forces and moments. Shear forces 
are known to increase as a task becomes more dynamic. Although this is less important during a quiet 
stand, the data collected during the dynamic phase of the posture transitions likely presented with non-
vertical loads, and these data lacked shear force information. Furthermore, the calculation of COP 
traditionally incorporates shear forces and moments, and therefore the COP calculation may be less 
accurate.  However, the first 2-s of standing data (marked by upright posture) were removed from 
analysis and thus should not include highly dynamic movement from the transitions and thus sheer 
force data.  
A second limitation of the NWBB is that it cannot be used interchangeably with a force plate  
(Pagnacco G. et al. 2013; Lee J. et al. 1989; Huurnink A. et al. 2013; Clark R.A. et al. 2010; Pagnacco G. et 
al. 2014). Simultaneous measurement of vertical forces by the NWBB placed on top of a force plate has 
demonstrated linearity (r=0.99) and similar errors between device outcomes  (Huurnink A. et al. 2013).  
These findings suggest the NWBB can be a useful measure of COP and that it is unlikely the estimates of 
COP sway will produce false balance test conclusions (as seen during a single-leg balance task) (Huurnink 
A. et al. 2013). However, the NWBB has demonstrated biases towards higher mean COP path length 
values  (Clark R.A. et al. 2010), and overestimates of the COP path velocity and mean absolute COP sway 




NWBB from use in research, although caution should be considered when interpreting results (Clark R.A. 
et al. 2010).   
 
Accelerometer Data 
To capture gait variables, a tri-axial accelerometer (16g accelerometer data logger x16-mini, Gulf 
Coast Data Concepts, LLC, Waveland, MS, USA) was placed on the lateral plane of the left ankle and 
sampled at 50 Hz. The accelerometer data loggers were small (0.6 oz, L 2cm, W 1cm, H 0.5cm), portable 
(2GB flash memory), and were transfer compatible with Windows via a universal serial bus (USB) 
interface.  With use of accelerometers it is important to note some concerns of the device, primarily, i) 
the requirement of gravity to account for acceleration, ii) post processing load, iii) drift error iv) 
placement of sensors on body segments  (Taborri J. et al. 2016). 
A customized Matlab program (Matlab R2015a; The Mathworks Inc, Natick, MA, USA) was used 
for feature extraction (toe-off, mid-heel swing and heel-strike, figure 5-1), cropping of turns, computing 
gait variable and time aligning data to beat-to-beat measures (e.g. BP and CBF).  To identify the timing of 
each gait feature the data were filtered at 100 Hz and the timing and amplitude of toe off, mid heel 




All statistical analysis was completed using IBM SPSS version 20 (IBM SPSS Statistics 20; IBM 






Participant Grouping- Participants demonstrated varying tSO2 response to a transition to upright 
posture (supine-stand and supine-walk).  As in previous studies Romero-Ortuno et al. 2011  (Romero-
ortuno R. et al. 2011), the participants were split into groups (regulators and impaired-regulators) based 
on their tSO2 values from delta baseline to nadir and initial standing (Chapter 4 – supine-stand 
experiment) and tSO2 values from baseline and nadir (Chapter 5 – supine-walk experiment). A TwoStep 
cluster analysis (k-cluster) was used to automatically create the number of clusters (participant groups) 
and only a good cluster quality (silhouette measure of cohesion and separation of 0.5 to 1.0) were 
considered acceptable. 
 
Sample Size -  A sample size could not be calculated in the traditional manner as the current 
investigations were comparing responses within group. In reference to the comprehensive population 
study titled The Irish Longitudinal Study on Ageing (TILDA), it was anticipated that three distinct 
morphological responses in BP and tSO2 would be evident following a supine-stand transition (Romero-
ortuno R. et al. 2011). As mentioned above, a k-means cluster analysis was performed and we 
hypothesized that two groups with unequal numbers in each cluster would be identified.  Given the 
percent distribution of participants in the TILDA study (small drop/overshoot = 33%, medium drop/just 
recovery = 50% and large drop/no recovery = 17%) we had aimed to recruit 100 participants so that the 
number of participants in the large drop/no recovery cluster would = 17 or greater.  We recruited 77 
participants and thus 2 clusters were identified resulting in 19% of participants being part of the 
susceptible group.  
 
Effect of group, condition and time -  Two-way mixed ANOVAs (general linear model in SPSS) 
were used to assess the main effect of condition, group and time.  The supine-stand experiment 




walk experiment (Chapter 5) assessed two levels for condition and two levels for group. For all ANOVAs 
if Mauchly’s test of Sphericity was significant the Greenhouse-Geisser correction was used.  If a 
significant interaction was found, Tukey’s honest significance test (HSD) was used to further evaluate 
significant levels.  
For group comparisons of gait variability data, a Mann-Whitney U Test and a Levene’s Test for 
equality of variance was performed.  Corrections for multiple tests were not applied, thus not all 
variables with a p≤0.05 are truly significant. A correction was not applied as this is an exploratory study 
requiring additional power to accurately assess multiple comparisons on non-continuous data. A 
Friedman’s Test was used to analyze differences between conditions.  
Group characteristics comparisons –All nominal data were tested using a Chi-square test with 






CHAPTER 3. CEREBROVASCULAR HEMODYNAMICS AND POSTURAL STABILITY IN 
OLDER ADULTS 
Introduction 
 Impaired blood pressure (BP) recovery on standing following supine rest occurs in 
approximately 21% of older adults  (Romero-ortuno R. et al. 2011) and is an independent risk factor for 
future falls, unexplained falls and injurious falls in older adults  (Finucane C. et al. 2017). Impaired 
balance is also significantly associated with fall risk in older adults and measures of stability are 
therefore often used to identify older adults at risk of a future fall  (Muir S.W. et al. 2010); (Berg K.O. et 
al. 1992).   
Older adults who experience significant and/or sustained postural reductions in BP may also 
demonstrate reduced cerebral blood flow (CBF) (Novak P. 2016) which could lead to a subsequent fall  
(Finucane C. & Kenny R.A. 2017). Although cerebral autoregulation is considered intact in older adults 
(Lipsitz L.A. et al. 2000), the posture related drop in CBF is compounded by age-related declines in CBF  
(de la Torre 2012; Leenders K.L. et al. 1990; Chen Y. et al. 2011), and this might also place some older 
adults at risk of cerebral hypoperfusion. The impact of the initial drops in, and recovery of, CBF and or 
cerebral oxygenation (tSO2) on balance control in older adults is unknown. 
Introduction of a sitting-pause time during a supine-stand transition has been shown to improve 
postural stability in older adults  (Johnson EG. & Meltzer J.D. 2012) yet it is unknown if this is due to the 
increased allotted time for BP, CBF and tSO2 to recover before standing.  Therefore, the purpose of the 
present investigation was to test the hypotheses: i) that individuals with posture related reductions of 
tSO2 will have impaired postural stability, and ii) that posture transitions including adaptation to upright 
posture (supine-sit-stand and sit-stand compared to supine-stand) will reduce the impact of posture 




the posture related reductions in tSO2 were investigated with respect to subsequent falls over the next 




Seventy-seven older adults aged 69-100 years old (57 females; age 86.6±6.6 years; height 160±9 
cm; weight 68±14 kg) gave written and informed consent to volunteer in the present study which was 
reviewed and approved by the Office of Research Ethics at the University of Waterloo and the Schlegel-
University of Waterloo Research Institute for Aging. Seventy-four of the participants were in conjugate 
living at one of the Schlegel Villages in Ontario Canada while three participants were community 
dwelling. Participants arrived 2 h postprandial to testing where they completed a brief health 
questionnaire (past health, current health, physical activity levels, medications). The health 
questionnaire indicated that all participants were free of neuromuscular and neurological conditions as 
well as free of diabetes, stroke or any recent (within 3 months) myocardial infarctions. Participants were 
also required to complete a minimum of 1-min of unassisted static standing.  
 
General Protocol 
All participants randomly completed three active transitions: i) supine-stand, ii) supine-sit-stand 
(with a 10-s sitting pause time), iii) sit-stand. The three transitions were preceded by a practice 
transition (supine-stand) to ensure familiarity and tolerance to the testing.  All transitions began with 10 
min of supine rest, followed by an assisted transition into the standing position. Assistance to a sitting 
position was provided by the research team whereby one researcher placed a hand behind the 
participants’ left shoulder and another behind the left elbow. As the participant moved to the standing 




(across conditions) 10.8±2.1 cm apart. If assistance for the sitting-standing transition was required, each 
researcher placed one hand under the upper arm but released the upper arm once the participant was 
in the seat-off position.  Participants were asked to stand for 180-s but could terminate the test at any 
time by siting down or grabbing a hold one of the research assistants spotting them. At 1-min of 
standing no participant had terminated the testing for any condition. By 2-min, 8 participants had 
terminated testing for the supine-stand and sit-stand conditions, and 7 participants had terminated the 
test for the supine-sit-stand condition.    
Total body water was (TBW) was estimated using a body impedance analysis (MF-BIA QuadScan 
4000: Bodystat LTD, Isle of Man, UK) with electrodes placed on the right wrist, middle finger, ankle and 




Continuous monitoring of heart rate (HR; electrocardiogram, Finapres Medical Systems, 
Amsterdam, The Netherlands) and continuous arterial finger BP by plethysmography (Finometer Pro; 
Finapres Medical Systems, Arnheim, The Netherlands) were recorded at 1kHz (PowerLab, 
ADInstruments, Colorado Springs, CO, USA) and processed (LabChart 7,  ADInstruments, Colorado 
Springs CO). Estimates of stroke volume from analysis of the finger pulse wave, and calculated cardiac 
output and total peripheral resistance were normalized to body surface area  (DuBois D & DuBois EF 
1916)(SVi, Qi and TPRi respectively).  
A near infrared spectroscopy device (NIRS; PortaLite, Artinis Medical Systems BV, Netherlands) 
was used to collect relative changes in oxygenated, deoxygenated, and total hemoglobin content (OxHb, 
DeoxHb, and TotHb respectively) as well as cerebral oxygenation (tSO2) was calculated from OxHb and 




EEG land marking system (right: Fp2, F4, F8.  left: Fp1, F7, F3) (Perrey S. 2008).  A source detector 
distance of 4 cm was used for the OxHb, DeoxHb and TotHb signals to reduce signal contamination from 
surrounding tissues  (Kohri S. et al. 2002). The NIRS signal was later processed into beat-by-beat data 
points where the mean hemoglobin values were extracted from each beat. 
Resting arterial blood pressure and calculated central SBP and DBP (cSBP and cDBP) as well as 
arterial stiffness (augmentation index, AI; augmentation index at 75 bpm, AI@75; pulse wave velocity, 
PWV) were assessed in the supine resting position using the Mobil-O-Graph cuff placed over the 
brachialis artery (Mobil-O-Graph, I.E.M. GmbH, Strolberg, Germany). The Mobil-O-Graph detects the 
oscillometric waveform and uses customized software (ARCSolver) to apply transfer function analysis 
and reconstruct the central waveform. Subsequently, the shape and timing of the central pulse wave are 
used to calculate AI, AI75 and PWV. The Mobil-O-Graph has been validated against a well-established 
non-invasive estimation of central BP known as SphymoCor for both central hemodynamics and 
measures of arterial stiffness (Weiss W. et al. 2012; Luzardo L. et al. 2012).  
 
Self-reported questionnaire 
The self-reported health status questionnaire, modified from Robertson 2013 (Appendix A,  
(Robertson A.D. 2013)), was verbally administered to each participant upon arrival to the testing 
session.  Participants reported on vision, past health behaviours such as smoking status and physical 
activity, health conditions such as heart failure, kidneys or liver disease (listed in table 3-1), current 
health concerns such as irregular heart beats and pain with walking, current medications (prescribed 







Time scale and averaging  
Resting baseline values were averaged over 30-s of supine or seated rest (from -45-s to -15-s 
prior to a transition). Time at zero seconds indicates upright posture. Nadir signifies the average of the 
three lowest tSO2 beats following upright posture. Delta nadir represents the differences between the 
resting baseline average and the nadir.   Initial standing is characterized by a 20-s average starting 2-s 
after upright posture. At one-min, two-min and three-min of standing a 20-s average was calculated (40 
to 60-s, 100 to 120-s and 150 to 170-s respectively, Fig. 3-1).   
To identify the presence of initial orthostatic hypotension (IOH) the difference in BP from the 
30-s baseline average to the lowest single interpolated 1-s of standing data was calculated. A drop in 
SBP ≥40 mmHg or a DBP drop ≥20 mmHg within the first 15-s of standing classified an individual to have 
IOH  (Wieling W. et al. 2007; Finucane C. et al. 2014). To characterize participants with orthostatic 
hypotension (OH) and sustained OH (SOH) BP was calculated into 5-s averages between 30-s to 175-s 
after standing (30 values). OH was then determined from a postural drop from baseline to the lowest 
single 5-s average in BP where a drop ≥20 mmHg for SBP or ≥10 mmHg for DBP classified an individual to 
have OH. SOH was defined as a reduction in SBP ≥20 mmHg or DBP ≥10 mmHg during 12 of the 24 5-s 
averages following 1-m of upright posture  (Finucane C. et al. 2014).   
  
Postural Stability 
A single Nintendo Wii Balance Board (Nintendo, Koyoto, Japan) collected (100Hz) center of 
pressure (COP) displacement. Bluetooth technology was used to wirelessly transmit the data from the 
Nintendo Wii Balance Board to a customized nearby software program (LabView, National Instruments, 
Austin TX USA). Postural stability measures were later analyzed alongside cardio- and cerebrovascular 
variables by means of a customized Matlab program (Matlab R2012a; The Mathworks Inc, Natick, MA, 




ML directions. Measures of postural stability were calculated as the root mean square (RMS; Eq. 1) and 
total path length (TPL; Eq. 2) over a 20- s during initial standing and at 1-min, 2-min and 3-mins of 
standing (Fig. 3-1).  
 
Fall History Reports 
 Fall history reports encompassed a 104 item report completed by a Schlegel Village team 
member where the participants resided. Fall reports included information regarding location and time of 
day of falls as well as questions surrounding pre-existing medical conditions, medical explanation for fall 
or being pushed or bumped by someone.  The 3 participants who did not reside in a Schlegel Village 
reported never having any previous falls however no follow-up was conducted to investigate 
retrospective falls. Therefore, 74 participants were included for fall analysis. The total number of fall 
reports recorded within 6 months after testing included 23 reports (excluding 1 slip relating to a known 
cause) pertaining to 12 individuals. One additional faller (2 falls) was removed from further analysis due 
to developing an intracranial bleed during the follow-up period. 
 
Statistical analysis 
All statistical analysis was completed using IBM SPSS version 20 (IBM SPSS Statistics 20; IBM 
Corp, Armonk, NY, USA), and all tests were considered significant at p≤0.05 and trends were considered 
at p≤0.1. 
 
Participant Grouping- Participants demonstrated varying abilities to maintain cerebral oxygenation 
during the transitions and while standing. Therefore, participants were split into two groups (regulators 
and impaired-regulators). The regulators had a higher baseline and higher standing tSO2 as well as a 




cluster) was used to automatically create the number of clusters (participant groups) and only a good 
cluster quality (silhouette measure of cohesion and separation of 0.5 to 1.0) was considered acceptable. 
The three-point delta nadir and 1-min average of tSO2 during the supine-stand transition were used as 
the continuous k-clustering variables, similar to the grouping based on blood pressure regulation 
described by Romero-Ortuno et al.  (Romero-ortuno R. et al. 2011), to separate participants into the two 
groups. The first group was able to regulate tSO2 by demonstrating minimal decreases in tSO2 with 
standing (regulators n=62) and the second group included individuals with a marked decrease in tSO2 to 
nadir and/or impaired regulation of tSO2 in the first minute of standing (impaired-regulators, n=15).  
 
Effects of group, condition and time -  Three two-way mixed ANOVAs (general linear model in SPSS) were 
used to assess the main effect of i) transition type and group for all hemodynamic and stability 
measures, ii) group and time for tSO2 and all postural stability measures, iii) transition type and time for 
tSO2 and all postural stability measures. Three levels of repeated measures were used for within-subject 
evaluation for the type of transition (transition: supine-stand, supine-sit-stand, sit-stand), two levels of 
between-subject factors were used to evaluate group effects (group: regulators vs. impaired-regulators) 
and four levels of within-subject factors were used asses the effects of time (time: delta nadir for tSO2 
and initial 20-s average for postural stability, as well as 1-min, 2-min and 3-min averages for tSO2 and 
postural stability measures). For all ANOVAs if Mauchly’s test of Sphericity was significant the 
Greenhouse-Geisser correction was used.  If a significant interaction was found, Tukey’s honest 
significance test (HSD) was used to further evaluate significant levels.  
 
Group comparisons – An ANOVA in SPSS version 20.0 was run for all group comparisons.  All nominal 
data were tested using a Chi-square test with the Fisher’s Exact Test correction factor (Phi was used to 





Group characteristics (Table 3-1) 
There were no significant differences between the regulator and impaired-regulator groups for 
age, BSA, or TBW, however BMI was higher and there were more women (p=0.037 and p=0.018 
respectively) in the regulators group compared to the impaired-regulators group. Although not 
significant, the impaired-regulators had a trend (p=0.091) for increased prospective falls within 6-
months after testing. The regulators group had a higher supine HR, central SBP, central PP, AI and AI75 
(all p<0.05). According to the self-reported questionnaire there were no group differences in physical 
activity however there were trends for higher incidence rates of heart failure, congenital heart disease, 
kidney/liver disease, irregular heart beats and lower reports of joint pain in the impaired-regulators 
compared to the regulators (p=0.048, p=0.095, p=0.022, p=0.042 and p=0.065 respectively).  There were 
significantly more impaired-regulators prescribed aldosterone antagonists (p=0.022) and proton pump 
(p=0.006) inhibitors and a trend for more impaired-regulators prescribed ≥3 BP lowering medications 
(p=0.097).  There were no significant differences in the occurrence of IOH, OH or SOH between groups.   
 
– Group and condition effects – 
Resting baseline hemodynamics (Table 3-2) 
 Heart rate and tSO2 were higher at baseline in the regulators (p=0.085 and p=0.001) compared 
to impaired-regulators. There was an effect of condition on HR, SBP, DBP, MAP, PP, Qi, SVi, and TPRi (all 
p≤0.05) where the differences lie between all conditions with the exception of HR, SBP and PP 







Delta resting to nadir hemodynamics (Table 3-2) 
  An interaction (p=0.001) was observed for tSO2 where the impaired-regulators had 
progressively lower tSO2 delta values during the supine-stand compared to the supine-sit-stand and the 
supine-sit-stand versus the sit-stand (Fig 3-3 and 3-4). Tukey’s HSD post-hoc analysis did not reveal any 
differences between conditions for the regulators group. There were significant group differences 
observed for tSO2 during the supine-stand and supine-sit-stand posture changes but not during the sit-
stand transition (Fig. 3-3 and Fig 3-4). A larger discrepancy between OxHb and DeoxHb (marked by 
DiffHb) was observed between groups (p=0.032, greater differences noted in the impaired-regulators) 
and between all transitions (p<0.001, Table 3-2). When investigating changes in TotHb, OxHb and 
DeoxHb, post-hoc analysis describes a constant nadir value for regulators but effects of condition for the 
impaired-regulators (differences noted between sit-stand transition and the other two transitions 
beginning with a supine baseline).   
Heart rate had an interaction effect (p=0.012) whereby the impaired-regulators had a smaller 
HR response upon standing with the supine-stand transition versus the supine-sit-stand and sit-stand 
(Fig. 5-2).  Both SVi and Qi increased upon standing, SVi had a trend (p=0.093) to increase more during 
the sit-stand versus the supine-sit-stand and Qi tended to increase (p=0.055) to a greater extent during 
the supine-stand versus the supine-sit-stand transition. Systolic BP, MAP, PP, MAPmca and TPRi 
decreased (all p≤0.05) more during the supine-stand compared to the supine-sit-stand and sit-stand 
transitions. DBP also decreased (p=0.006) more during the supine-stand versus the supine-sit-stand 
transition.  
 
Initial standing (2 to 22-s) postural stability (Table 3-3) 
 Both RMS AP and ML demonstrated a main effect of condition (p=0.094 and p=0.039) with 




AP and TPL ML (p=0.009, 0.035 and 0.007 respectively) suggested the impaired-regulators have poorer 
postural stability than the regulators following all three transitions. Furthermore, the regulators did not 
have any differences in TPL, TPL AP or TPL ML between transition types but the impaired-regulators had 
poorer postural stability following the supine-stand versus sit-stand. The impaired-regulators also had 
longer TPL AP following the supine-sit-stand compared to the sit-stand and longer TPL ML following the 
supine-stand versus supine-sit-stand (Fig. 3-4).   
 
1-minute (40 to 60-s) (Table 3-2, 3-3 and Figures 3-2 and 3-3) 
 The sit-stand transition resulted in a lower HR (p=0.058) and a higher SBP, DBP, MAP, PP and 
MAPmca (all p≤0.05) compared to the supine-stand and supine-sit-stand transitions (Table 3-2). It was 
also found that the impaired-regulators had lower PP (p=0.027), PPTotHb (0.084) and tSO2 (p<0.001) 
versus the regulators at 1-min. Significant interactions for TotHb, OxHb, and DeoxHb revealed that there 
were no observed differences between transition types for the regulators group. However, the 
impaired-regulators had differences between supine-sit-stand and sit-stand transitions for TotHb as well 
as the sit-stand transition compared to the other two transitions for DeoxHb. There were no post-hoc 
differences for OxHb. Measures of postural stability reveal impaired-regulators have greater instability 
compared to regulators for TPL, TPL AP and TPL ML (p=0.006, 0.013 and 0.006 respectively, Table 3-3). 
 
2-minute (100 to 120-s) (Table 3-2, 3-3 and Figures 3-2 and 3-3) 
 Diastolic BP, Qi, SVi, and TPRi had main effects of condition (p=0.052, 0.007, 0.03, and 0.041 
respectively) where a higher DBP and TPRi and a lower Qi were observed following the sit-stand versus 
supine-stand as well as a lower SVi and Qi during the sit-stand versus the supine-sit-stand transition 




At 2-min of standing tSO2 was significantly (p=0.002) lower in the impaired-regulators group 
throughout all transition types. There was also a trend for a lower PPTotHb (p=0.086) in the impaired-
regulators group across transitions. Significant interactions for TotHb, OxHb and DeoxHb suggest 
differences between conditions for the impaired-regulators but no differences between transition types 
for the regulators (Tbl 3-2). Furthermore, post-hoc analysis identified group differences in OxHb and 
TotHb following the supine-stand and supine-sit-stand transitions (Tbl 3-2).  
 Measures of postural stability suggest impaired-regulators have poorer TPL, TPL AP and TPL ML 
(p=0.002, 0.015 and 0.002 respectively) across all three transition types. Main effects of condition for 
TPL, TPL AP and TPL ML (p=0.024, 0.081 and 0.044 respectively) suggest the supine-stand versus sit-
stand resulted in greater measures of instability (TPL, TPL AP and TPL ML) as well as the supine-sit-stand 
versus sit-stand (TPL and TPL AP). An interaction effect was observed for RMS AP (p=0.065) however 
Tukey HSD post-hoc analysis did not reveal any significant group or condition differences.  
 
3-minute (150 to 170-s) (Table 3-2, 3-3 and Figures 3-2 and 3-3) 
 At the 3-min point after standing, an interaction (p=0.033) for HR revealed impaired-regulators 
had a lower HR following all three transition types compared to regulators. As well, the impaired-
regulators had a lower HR during the supine-sit-stand versus supine-stand transition (Table 3-2).  Main 
effects of condition for BP measures identified a lower DBP, MAP, PP, and MAPmca during the supine-
stand compared to the sit-stand. Cardiac output and SVi were lower and TPRi were higher following the 
sit-stand transition compared to the other two transition types (main effect condition p=0.046, 0.045 
and 0.026 respectively).  
The impaired-regulators had lower (p=0.011) tSO2 during all three transitions.   Interactions for 
TotHb, OxHb and DeoxHb (p=0.014, 0.037 and 0.023 respectively) identified group differences in TotHb 




were observed for the regulators group however the impaired-regulators had decreases in TotHb and 
DeoxHb between the supine-sit-stand and sit-stand transitions as well as the supine-stand versus sit-
stand transition for DeoxHb.   
 At three minutes of standing the impaired-regulators had poorer postural stability throughout 
all three transition types, this was marked by increased TPL, TPL AP and TPL ML (p=0.023, 0.025 and 
0.077 respectively).  
 
– Condition by time effects – 
 An interaction (p=0.028) was found for tSO2. Post hoc analysis identified an effect of time where 
delta nadir had a lower tSO2 value compared to 2-minutes, as well during the supine-stand the delta 
nadir was significantly lower than any of the other time points and during the supine-sit-stand the delta 
nadir was significantly lower than it was at 3-min.  
Effects of time (p<0.001) were observed for RMS ML, RMS AP, TPL, TPL AP and TPL ML. Tukey 
HSD analysis suggested initial standing had great measures of instability compared to 1-min, 2-min and 
3-min of standing as well as 1-min of standing has greater postural instability compared to 2-min of 
standing.  
 
– Group by time effects – 
A significant interaction for tSO2 was found for all three transition types (Fig. 3-5).  Tukey HSD analysis 
identified significant differences between regulators and impaired-regulators at all four time points 
(delta three-point nadir, 1-min, 2-min and 3-min) throughout all three transitions.  No differences were 
observed between various time intervals for the regulators group. To the contrary, the impaired-




they also demonstrated a lower delta nadir compared to all other time points during the sit-stand 
transition.  
Significant group differences (p<0.05) at all time points (initial, 1-min, 2-min and 3-min standing) 
identify reduced tSO2 and increased TPL in the impaired-regulators compared to the regulators when 
compressing data from the three conditions into time by group averages and standard deviations (Fig. 3-
6); these results confirmed the hypothesis that impaired regulators with lower levels of tSO2 had 
significantly poorer postural stability not only in the first 20-s after standing, but also in continued 
standing at 1-min, 2-min and 3-min.The root mean square for AP and ML had significant (p<0.001) main 
effects of time during all three transitions. A significant interaction was found for TPL during all three 
transitions where differences between regulators and impaired-regulators occurred during initial 
standing (Fig 3-5). Additionally, during the supine-sit-stand at 1-min and 2-min significant differences in 
TPL were evident between groups and during the sit stand at 1-min significant differences were present 
between groups. For the impaired-regulators group, TPL during initial standing was larger than any other 
20-s average for all three transitions. For regulators, TPL during initial standing was larger than any other 
time point during the supine-stand, and sit-stand and it was larger than the two-min average during the 
supine-sit-stand. Total path length in the ML plane had an interaction (p=0.002) for the supine-stand 
transitions where group differences were observed during initial standing and for both the regulators 
and impaired-regulators had greater TPL ML values during initial standing versus 1-min, 2-min and 3-min 
time intervals. During the supine-sit-stand and sit-stand transitions a main effect for time (initial 
standing versus all other time points) and group (greater TPL ML for impaired-regulators) were found. 
Total path length in the AP plane had an effect of time (p<0.001, different between all time points) for 
the supine-stand and interactions for the supine-sit-stand (p=0.022) and sit-stand (o=0.002) transitions. 




initial standing and at 1-min compared to regulators as well as in the impaired-regulators they had 
greater instability at initial standing compared to 1-min, 2-min and 3-min time points. 
 
Discussion  
In this study, we identified two groups of older adults based on the magnitude of the initial drop 
in tSO2 and the absolute values of tSO2 after standing for 1-min. This analysis classified the groups as 
regulators and impaired-regulators. The results confirmed the first hypothesis that impaired-regulator 
participants, with lower levels of tSO2, had significantly poorer postural stability not only in the first 20-s 
after standing, but also in continued standing at 1-min, 2-min and 3-min. Further, and consistent with 
the second hypothesis, brief 10-s, or longer, sitting preceding the stand in the impaired-regulator group 
resulted in significantly less impact on tSO2 and improved measures of postural stability. In a follow-up 
over the next 6-months, there was a trend (p=0.091) in the data suggesting that older adults who had 
poorer regulation of the cerebral oxygenation (tSO2) had an increased risk of falling compared to older 
adults with higher levels of tSO2. 
 
Postural reductions in tSO2 and stability 
This is the first study to show that approximately 20% of older adults had a reduction in tSO2 on 
standing that was associated with greater, quantitatively assessed, postural instability. The drop to nadir 
in tSO2 from baseline was significantly greater in the impaired-regulators compared to the regulators 
group for the supine-stand and supine-sit-stand conditions, but not for the sit-stand condition (Figure 3-
4). Similarly, during initial standing, TPL, TPL AP and TPL ML were significantly greater in the impaired-
regulators group compared to the regulators group for all three conditions (Figure 3-4). A significant 
group effect for reduced tSO2 and increased TPL in the impaired-regulators group was found at initial, 1-




trend), a significant group effect for increased TPL, TPL AP and TPL ML remained at 1-min, 2-min and 3-
min.   
A lower HR and BP was found in the impaired-regulators group (Figure 3-2) which contributed to 
the lower Qi (p>0.05, figure 3-2). Total peripheral resistance index was higher in the impaired-regulators 
and is likely maintaining blood pressure despite it still being low. Arterial blood pressures demonstrate 
large group differences and large standard deviations (at nadir - regulators vs impaired-regulators, SBP: 
122.80 ± 28.71 and 104.28 ± 24.47, DBP: 54.54 ± 20.46 and 61.09 ± 16.05). This suggests a large range 
and variability between participants for the blood pressure response.  Although, lower CBF can occur in 
spite of a maintained arterial pressure  (Novak P. 2016), the lower blood pressure response in the 
impaired-regulators potentially contributes to lower CBF and tSO2. It is also noteworthy to point out that 
in spite of the impaired-regulators having a lower HR response upon standing MAP was still lower, 
suggesting there could be some impairment of the baroreflex or a possible resetting of the baroreflex to 
a new blood pressure point. Alterations of the baroreflex can be the result of diminished sensing and 
processing of the neural signals to central command centers or increased stiffening of the arterial 
vasculature resulting in reduced distension required to trigger the mechanoreceptors  (Kornet L. et al. 
2005).  
There are varied causes for individuals to have low tSO2 and be classified as an impaired-
regulator. As mentioned above, alterations in the function of the baroreflex could contribute to reduced 
arterial blood pressure and thus CBF. Conditions such as heart failure (HF) and different blood pressure 
lowering medications can also have equal implications on reduced CBF and tSO2. Studies have shown 
that individuals with HF have lower levels of CBF velocity  (Loncar G. et al. 2011) and significantly greater 
reductions in CBF velocity while upright compared to age and sex matched controls  (Fraser K.S. et al. 
2015).  The current study found tSO2 to be significantly reduced at rest (supine and seated) as well as 




had a significantly larger reduction in tSO2 compared to the regulators group from baseline to upright 
posture. Therefore, not only did the impaired-regulators exhibiting lower tSO2 during supine rest but 
they also demonstrated larger postural reductions and lower tSO2 while standing. 
Significantly more participants in the impaired-regulators group were on aldosterone 
antagonists (p=0.022) which are known to significantly reduce blood pressure  (Wolf R.I. et al. 1966; 
Johnston L.C. & Grieble H.G. 1967). A trend (p=0.097) for more impaired-regulators to be on 3 or more 
blood pressure lowering medication was also found suggesting some older adults may compromise their 
orthostatic response for the control of hypertension. These results suggest the lower arterial blood 
pressures could be attributed to blood pressure lowering medications which could have a similar effect 
on reduced tSO2 as an impaired baroreflex or a condition such as HF. The increased pervasiveness of BP 
lowering medications in the impaired-regulators group likely reflects both the prevalence of 
hypertension and the effect on BP reduction in participants with low tSO2. Although, aggressive BP 
lowering in uncontrolled hypertension (from >160 mmHg SBP to < 140 mmHg SBP) has been shown to 
improve CBF velocity (Lipsitz L.A. et al. 2005), the BP values of the impaired-regulators had a much lower 
SBP (125±15 mmHg), potentially contributing to cerebral hypoperfusion.  
 
Interventions to minimize change in tSO2 and stability 
Cerebral oxygenation at delta nadir and TPL AP and TPL ML during initial standing were not 
different between conditions for the regulators group (Figure 3-4). These results suggest that the 
regulators were able to regulate cerebral oxygenation despite greater orthostatic stress imposed upon 
them by the supine-stand condition.  Similarly, the regulators group did not demonstrate differences in 
initial postural stability among conditions despite being required to move their center of mass through 




In contrast, the effect of condition positively impacted both delta tSO2 and initial postural 
stability for the impaired-regulators. The delta tSO2 progressively improved between the supine-stand 
vs. supine-sit-stand and the supine-sit-stand vs the sit stand. Likewise, TPL ML significantly improved for 
the impaired-regulators during the supine-sit-stand and sit-stand compared to the supine-stand. These 
results suggest that even a short 10-s sitting pause time can minimize the postural reduction of tSO2 
with positive implications on postural stability. Postural stability, marked by changes in TPL AP, also 
improved for the impaired-regulators when comparing the supine-stand and supine-sit-stand vs. the sit-
stand condition. The significantly reduced tSO2 in the impaired-regulators may be causing reduced 
oxygen delivery to the cerebral centers responsible for processing postural stability or it may be causing 
light-headedness and dizziness leading to greater measures of postural instability. These results support 
Johnson and Meltzer 2012 findings of a positive effect on postural stability following a sitting-pause time 
(Johnson EG. & Meltzer J.D. 2012). These results also suggest the impaired-regulators are at increased 
risk of a future fall compared to the regulators group because of their significantly increased measures 
of postural instability (Muir S.W. et al. 2010; Berg K.O. et al. 1992), however a sitting-pause time may 
minimize such outcomes.  
 
Falls risk and tSO2 
To date the majority of research has focused on the relationship between postural BP responses 
and falls in older adults  (Finucane C. et al. 2017; Finucane C. & Kenny R.A. 2017; Juraschek S.P. et al. 
2017). Juraschek et al. 2017 reported BP responses within 1-min of standing to be most strongly related 
to dizziness and falls in older adults while Finucane et al. 2017 identified OH at 40-sec and 2-min to be 
better predictors of falls than BP within the first 15-sec of standing (Finucane C. et al. 2017; Juraschek 
S.P. et al. 2017). These associations of BP to falls suggest a link between cerebral hypoperfusion causing 




therefore this can sometimes be misleading. Sorond et al. 2010 identified a link between impaired 
cerebrovascular regulation and increased fall rates in older adults and this has since been supported by 
Ezzati et al. 2017 and Tchella et al. 2015 who have found gait speed, a predictor of falls  (Callisaya M.L. 
et al. 2011), to be associated with reduced and impaired cerebral blood flow (Ezzati A. et al. 2017; 
Tchalla A.E. et al. 2015). However, this is the first study to show that cerebral hypoperfusion was 
associated with an increased likelihood (p=0.091) of having a future fall.   
 
Limitations 
Despite a sample size of n=77 older adults, the current study was relatively under powered due 
to the large variability in the cardiovascular and cerebrovascular hemodynamic responses. The protocol 
involved only a single performance of each condition all taken on a single day/time of day, where the 
orthostatic responses are known to be variable; this suggests a different response could be rendered on 
a different day/time  (Vara-Gonzalez L. et al. 2006). The current study collected cerebrovascular 
hemodynamics with a NIRS device where different devices are likely to utilize varied algorithms to 
construct the outcome variables associated with relative changes in hemogolobin. Therefore, comparing 
absolute values between studies should be a consideration.  The estimated SV calculated by the 
Modelflow algorithm of the plethysmography devices integrates a three-element model of arterial 
impedance with the arterial pressure wave to track beat-to-beat differences in stroke volume during 
rest  (Harms M et al. 1999).  However, recent data suggests the Modelflow method does not accurately 
estimate SV during dynamic fluctuations in SV, such as during orthostatic stress  (Gibbons T. 2017). Thus, 






Older adults with posture related reductions of tSO2 had impaired postural stability. A 10-s 
sitting pause time minimized the impact of the posture related reduction in tSO2 and enhanced postural 
stability.  In a prospective follow-up over the subsequent 6-months, there was a trend suggesting older 
adults with impaired-regulation of tSO2 also had an increased risk of falling compared to older adults 
with higher levels of tSO2. It is unknown what the implications of a low tSO2 upon standing and while 





Tables and Figures 
 







Age, years 86.3±6.9 87.6±5.0 N.S. - 
Sex (women), % (n) 80.6 (50) 46.7 (7) 0.018 0.307 
BMI (kg/m2) 27.2±5 24.2±3.4 0.037 - 
Height (cm) 159.8±8.8 163.3±10.6 N.S. - 
Weight (kg) 69.3±13.9 65.1±14.1 N.S. - 
BSA (m2) 1.72±0.18 1.70±0.22 N.S. - 
TBW (L): control n=51, hypoperfusion n=10 28.7±5.2 29.8±6.6 N.S. - 
Brachial SBP, mmHg 136±22 125±17 0.071 - 
Brachial DBP, mmHg 68±9 65±11 N.S. - 
Brachial PP, mmHg 68±19 60±11 N.S. - 
Retrospective fallers within 6 months before 
data collection (past falls), % within group (n) 
10 (6) 13 (2) N.S. - 
Prospective fallers within 6 months after data 
collection (future falls), % within group (n) 
10 (6) 28 (4) 0.091 0.211 
Mobil-O-Graph Data      
     Central hemodynamics     
     Heart rate, bpm 69±10 63±10 0.048  
     Central SBP, mmHg 123±19 111±14 0.020  
     Central DBP, mmHg 78±10 76±12 N.S.  
     Central PP, mmHg 46±13 35±7 0.004  
     Augmentation Index @75 [90%CI], % 35.4±12.3 24.6±17.2 0.008  
     Augmentation Pressure, mmHg 19.2±10.5 12.4±8.2 0.025  
     Reflection Magnitude  67±6 64±9 N.S.  
     PWV 13.6±1.6 13.5±1.0 N.S.  
Physical Activity (Self-report questionnaire)     
          Sedentary, % (n) 30 (15) 23 (3) N.S. - 
          Active, % (n) 48 (24) 46 (6) N.S. - 
          Highly Active, % (n) 22 (11) 31 (4) N.S. - 
Past Health (Self-report questionnaire)     
     Heart attack, % (n) 11 (7) 27 (4) N.S. - 
     Heart failure, % (n) 3 (2) 20 (3) 0.048 0.270 
     Open heart surgery, % (n) 3 (2) 7 (1) N.S. - 
     Congenital heart disease, % (n) 2 (1) 13 (2) 0.095 0.240 
     Atrial Fibrillation, % (n) 13 (8) 20 (3) N.S. - 
     Hypertension, % (n) 42 (26) 40 (6) N.S. - 
     High cholesterol, % (n) 29 (18) 27 (4) N.S. - 
     Sleep Apnea, % (n) 3 (2) 7 (1) N.S. - 
     Emphysema/pneumonia, % (n) 15 (9) 20 (3) N.S. - 
     Asthma/bronchitis, % (n) 13 (8) 7 (1) N.S. - 




     Smoking (never), % (n) 54 (33) 64 (9) N.S. - 
     Smoking (ex-smoker), % (n) 46 (28) 36 (5) N.S. - 
Current Health (Self-report questionnaire)     
     Irregular heart beat, % (n) 6 (4) 27 (4) 0.042 0.262 
     Persistent cough, % (n) 15 (9) 13 (2) N.S. - 
     Wheezing/shortness of breath, % (n) 13 (8) 27 (4) N.S. - 
     Memory complaints, % (n) 15 (9) 0 (0) N.S. - 
     Fatigue (general) , % (n) 29 (18) 13 (2) N.S. - 
     Headaches, % (n) 13 (8) 7 (1) N.S. - 
     Dizziness/light-headedness, % (n) 18 (11) 33 (5) N.S. - 
     Any pain (joint pain always recorded), % (n) 45 (28) 20 (3) 0.065 -0.203 
     Fear of falling (score 0 to 10) 3.3±2.4 3.0±2.6 N.S. - 
     Balance confidence (score 0 to 10) 5.2±2.4 5.1±2.7 N.S. - 
Medications      
     Aldosterone antagonist % (n) 1.6 (1) 20.0 (3) 0.022 0.328 
     Alpha adrenoreceptor antagonist % (n) 9.7 (6) 0.0 (0) N.S. - 
     Angiotensin receptor blocker % (n) 19.4 (12) 13.3 (2) N.S. - 
     ACE inhibitor % (n)  17.7 (11) 33.3 (5) N.S. - 
     Beta blocker % (n) 21.0 (13) 33.3 (5) N.S. - 
     Calcium channel blocker % (n) 32.3 (20) 13.3 (2) N.S. - 
     Proton pump inhibitor % (n) 33.9 (21) 73.3 (11) 0.006 0.317 
     Polypharmacy (≥ 3 BP lowering meds) % (n) 14.5 (9) 33.3 (5) 0.097 0.193 
BMI body mass index, BSA body surface area, TBW total body water, BP blood pressure, SBP systolic BP, 





Table 3-2: Cardiovascular and cerebrovascular hemodynamics between groups and conditions 
Characteristic Supine-stand Supine-sit-stand Sit-stand Significance 
 Regulators Impaired-reg. Regulators Impaired-reg. Regulators Impaired-reg.  
Baseline: supine or seated  (-45 to -15 sec average of beat-beat data) group*con 
     HR, bpm 68.78 ± 10.28 64.04 ± 10.11 68.56 ± 9.48 63.44 ± 9.67 71.29 ± 10.94††‡ 66.26 ± 8.00 **con*gr 
     SBP, mmHg 
144.65 ± 37.91 135.80 ± 24.89 
145.75 ± 
37.89† 140.87 ± 23.27 
152.98 ± 
40.99††‡ 152.18 ± 26.55 
**con 
     DBP, mmHg 72.05 ± 17.25 70.71 ± 17.32 72.77 ± 17.23† 74.22 ± 16.24 78.30 ± 19.46††‡ 81.00 ± 17.80 **con 
     MAP, mmHg 
96.25 ± 23.26 92.40 ± 19.23 97.10 ± 23.23† 96.43 ± 17.96 
103.19 ± 
25.85††‡ 104.73 ± 19.88 
**con 
     PP,mmHg 72.60 ± 24.75 65.09 ± 12.84 72.98 ± 24.83 66.65 ± 12.34 74.68 ± 25.48††‡ 71.18 ± 15.13 **con 
     Qi, L/min/m2 2.45 ± 0.95 2.29 ± 0.89 2.45 ± 0.94† 2.07 ± 0.62 2.18 ± 0.84††‡ 1.93 ± 0.62 **con 
     SVi, mL/m2 36.12 ± 14.66 36.80 ± 14.84 36.11 ± 14.54† 34.25 ± 14.41 31.01 ± 12.59††‡ 30.58 ± 12.23 **con 
     TPRi, 
mHg/L/min/m2 15.42 ± 8.45 17.52 ± 9.40 15.67 ± 8.81† 19.47 ± 9.75 18.87 ± 11.53††‡ 23.34 ± 12.98 
**con 
     Skin temp 
(Celcius) 34.54 ± 5.83 35.24 ± 0.87 34.56 ± 6.07 35.18 ± 1.02 34.52 ± 5.92 34.67 ± 1.68 
**int:- 
     tSO2, percent 62.94 ± 5.14 57.76 ± 8.46 62.81 ± 4.94 57.33 ± 9.01 62.76 ± 4.52 56.86 ± 9.07 **gr 
     DiffHb, µMol 4.04 ± 2.92 2.68 ± 1.63 4.01 ± 2.97 2.58 ± 1.47 2.58 ± 2.44††‡ 2.15 ± 1.86 **con 
     TotHb, µMol 0.02 ± 0.15 0.00 ± 0.00 0.00 ± 0.02 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 - 
     PPTotHb, µMol 0.69 ± 0.31 0.55 ± 0.27 0.68 ± 0.28 0.54 ± 0.29 0.73 ± 0.38 0.59 ± 0.28 N.S. 
     OxHb,µMol 0.01 ± 0.06 0.00 ± 0.00 0.00 ± 0.01 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 - 
     PP OxHb, µMol 0.59 ± 0.25 0.47 ± 0.24 0.58 ± 0.23 0.45 ± 0.27 0.63 ± 0.31 0.52 ± 0.25 N.S. 
     DeoxHb, µMol 0.01 ± 0.09 0.00 ± 0.00 0.00 ± 0.01 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 - 
     PP DeoxHb, µMol 0.12 ± 0.06 0.12 ± 0.06 0.11 ± 0.06 0.13 ± 0.08 0.12 ± 0.08 0.09 ± 0.04 **int:- 
Three point nadir (lowest three tSO2 values averaged)  
     HR, bpm 77.52 ± 11.87 74.99 ± 12.73 76.41 ± 11.46 68.38 ± 10.94 77.37 ± 12.53 69.93 ± 10.61 **int:d,e,g,h 
     SBP, mmHg 
122.80 ± 28.71 104.28 ± 24.47 
135.03 ± 
35.78† 126.37 ± 25.71 141.28 ± 30.23†† 133.67 ± 22.06 
**con 
     DBP, mmHg 61.09 ± 16.05 54.54 ± 20.46 67.91 ± 16.21† 63.78 ± 19.20 69.51 ± 15.82†† 66.14 ± 19.44 **con 
     MAP, mmHg 81.66 ± 18.70 71.12 ± 21.12 90.28 ± 21.16† 84.64 ± 20.03 93.43 ± 19.17†† 88.65 ± 19.31 **con 




     MAPmca, mmHg 57.97 ± 19.41 46.73 ± 21.71 66.71 ± 21.69† 59.97 ± 20.58 69.75 ± 19.61†† 63.98 ± 19.92 **con 
     Qi, L/min/m2 3.24 ± 1.52 2.77 ± 1.14 2.94 ± 1.20† 2.64 ± 1.34 2.79 ± 1.02†† 2.64 ± 1.04 **con 
     SVi, mL/m2 42.44 ± 20.01 38.54 ± 18.13 39.36 ± 18.06 39.40 ± 20.36 37.25 ± 14.99 39.00 ± 17.31 *con 
     TPRi, 
mHg/L/min/m2 11.98 ± 10.97 12.37 ± 8.91 13.43 ± 9.32† 16.08 ± 10.89 14.60 ± 10.62 15.96 ± 11.25 
**con 
     Skin temp 
(Celcius) 35.60 ± 1.07 35.17 ± 0.91 35.60 ± 1.07 35.09 ± 1.06 35.57 ± 1.04 34.64 ± 1.68 
**int:e,f,h,i 
     tSO2, percent 61.02 ± 5.22 50.65 ± 5.94 61.29 ± 4.97 52.11 ± 6.38 61.25 ± 4.71 53.64 ± 8.25 **con,**gr,*int:e 
     DiffHb, µMol 2.59 ± 2.86 0.36 ± 1.88 2.59 ± 2.92 0.85 ± 1.46 2.02 ± 2.58 1.25 ± 1.82 **int:e 
     TotHb, µMol -1.11 ± 2.57 -0.69 ± 1.31 -0.97 ± 2.73 0.02 ± 1.58 -0.67 ± 0.98 -1.40 ± 0.93 **int:j 
     PPTotHb, µMol 0.68 ± 0.39 0.49 ± 0.29 0.65 ± 0.31 0.47 ± 0.28 0.66 ± 0.34 0.58 ± 0.36 *gr 
     OxHb,µMol -1.28 ± 1.87 -1.50 ± 1.12 -1.20 ± 1.94 -0.85 ± 0.91 -0.61 ± 0.79 -1.15 ± 0.83 *con 
     PP OxHb, µMol 0.57 ± 0.31 0.42 ± 0.25 0.55 ± 0.25 0.43 ± 0.23 0.56 ± 0.28 0.50 ± 0.25 N.S. 
     DeoxHb, µMol 0.18 ± 0.85 0.81 ± 0.91 0.23 ± 0.94 0.88 ± 0.90 -0.06 ± 0.42 -0.25 ± 0.34 **int:e,f,g,h 
     PP DeoxHb, µMol 0.14 ± 0.10 0.15 ± 0.12 0.12 ± 0.07† 0.10 ± 0.07 0.11 ± 0.07 0.15 ± 0.16 *con 
Three point Delta nadir (nadir average minus supine average) 
     HR, bpm 7.51 ± 11.90 10.95 ± 9.91 7.85 ± 5.99 4.94 ± 6.60 6.01 ± 5.48 3.66 ± 6.58 **int:d,e 
     SBP, mmHg -27.92 ± 17.50 -33.80 ± 13.62 -15.58 ± 27.05† -14.50 ± 15.98 -19.16 ± 25.18†† -18.51 ± 9.67 **con 
     DBP, mmHg -14.97 ± 13.30 -18.20 ± 10.63 -7.29 ± 13.15† -10.44 ± 11.13 -12.56 ± 15.91 -14.86 ± 8.66 **con 
     MAP, mmHg -19.28 ± 13.97 -23.40 ± 11.14 -10.05 ± 16.84† -11.79 ± 11.80 -14.76 ± 18.63 -16.08 ± 8.00 **con 
     PP,mmHg -12.95 ± 10.58 -15.60 ± 7.67 -8.06 ± 17.91† -4.06 ± 11.35 -6.60 ± 12.22†† -3.65 ± 8.81 **con 
     MAPmca, mmHg -19.28 ± 13.97 -23.40 ± 11.14 -9.95 ± 16.64† -11.79 ± 11.80 -14.37 ± 16.23†† -16.08 ± 8.00 **con 
     Qi, L/min/m2 0.72 ± 1.02 0.72 ± 0.87 0.41 ± 0.79† 0.58 ± 0.95 0.49 ± 0.63 0.70 ± 0.68 *con 
     SVi, mL/m2 5.41 ± 12.47 5.27 ± 10.39 2.05 ± 12.44 5.14 ± 12.03 4.59 ± 8.67‡ 8.42 ± 10.67 *con 
     TPRi, 
mHg/L/min/m2 -4.66 ± 6.90 -6.68 ± 6.24 -2.76 ± 5.27† -3.39 ± 3.99 -5.14 ± 8.76‡ -7.38 ± 4.55 
**con 
     Skin temp 
(Celcius) 0.04 ± 0.43 -0.07 ± 0.08 -0.04 ± 0.09 -0.09 ± 0.11 -0.00 ± 0.03 -0.03 ± 0.05 
N.S. 
     tSO2, percent -1.92 ± 1.37 -7.12 ± 4.70 -1.52 ± 1.67 -5.21 ± 6.36 -1.51 ± 1.40 -3.22 ± 4.83 **int:d,e,f,g,h 
     DiffHb, µMol -1.37 ± 1.15 -2.32 ± 1.56 -1.36 ± 1.25† -1.73 ± 0.89 -0.54 ± 0.79††‡ -0.90 ± 0.87 **con,*gr 
     TotHb, µMol -0.93 ± 2.02 -0.69 ± 1.31 -0.78 ± 2.25 0.02 ± 1.58 -0.63 ± 0.94 -1.40 ± 0.93 **int:f 




     OxHb,µMol -1.15 ± 1.48 -1.50 ± 1.12 -1.07 ± 1.63† -0.85 ± 0.91 -0.59 ± 0.76†† -1.15 ± 0.83 *con 
     PP OxHb, µMol -0.02 ± 0.19 -0.05 ± 0.13 -0.03 ± 0.16 -0.02 ± 0.15 -0.06 ± 0.20 -0.02 ± 0.15 N.S. 
     DeoxHb, µMol 0.22 ± 0.71 0.81 ± 0.91 0.29 ± 0.80 0.88 ± 0.90 -0.04 ± 0.42 -0.25 ± 0.34 **int:e,f,g,h 
     PP DeoxHb, µMol 0.02 ± 0.07 0.04 ± 0.13 0.00 ± 0.07 -0.02 ± 0.06 -0.00 ± 0.07 0.07 ± 0.15 **int:f,i 
1-minute (40-60 sec)  
     HR, bpm 75.55 ± 15.22 71.38 ± 10.62 76.02 ± 14.98 70.75 ± 9.61 74.86 ± 15.18 70.04 ± 9.08 *con 
     SBP, mmHg 
150.04 ± 32.66 132.34 ± 27.44 150.91 ± 33.23 136.98 ± 28.95 
155.49 ± 
30.30††‡ 146.70 ± 24.63 
**con 
     DBP, mmHg 76.90 ± 15.56 69.20 ± 17.22 76.28 ± 15.72 72.32 ± 19.12 79.33 ± 14.21††‡ 75.92 ± 16.54 **con 
     MAP, mmHg 
101.28 ± 20.24 90.25 ± 19.45 101.16 ± 20.35 93.88 ± 21.27 
104.71 ± 
18.44††‡ 99.52 ± 17.77 
**con 
     PP,mmHg 73.14 ± 21.99 63.14 ± 17.76 74.62 ± 23.11 64.66 ± 17.84 76.16 ± 21.29††‡ 70.78 ± 17.60 **con,**gr 
     MAPmca, mmHg 77.61 ± 20.75 65.57 ± 20.11 77.49 ± 20.79 69.20 ± 21.96 81.04 ± 18.84††‡ 74.84 ± 18.53 **con 
     Qi, L/min/m2 2.53 ± 0.97 2.45 ± 0.91 2.65 ± 0.99 2.36 ± 0.96 2.43 ± 0.83 2.33 ± 0.83 N.S 
     SVi, mL/m2 33.91 ± 14.86 35.38 ± 14.74 35.52 ± 16.50 34.45 ± 15.23 32.85 ± 12.79 34.42 ± 14.39 N.S 
     TPRi, 
mHg/L/min/m2 17.87 ± 13.01 16.73 ± 11.03 16.21 ± 10.57 19.26 ± 13.84 17.89 ± 10.79 19.51 ± 12.75 
N.S. 
     Skin temp 
(Celcius) 35.59 ± 1.04 35.13 ± 0.85 35.59 ± 1.07 35.07 ± 1.03 35.57 ± 1.04 34.65 ± 1.66 
**int:e,f,i 
     tSO2, percent 62.27 ± 4.47 54.75 ± 9.14 61.76 ± 4.51 54.00 ± 8.68 61.98 ± 4.54 54.91 ± 8.76 **gr 
     DiffHb, µMol 2.27 ± 2.55 1.01 ± 1.51 2.24 ± 2.63 1.24 ± 1.15 2.19 ± 2.55 1.87 ± 1.50 **int:e,g,h 
     TotHb, µMol -1.04 ± 3.28 0.54 ± 1.55 -0.91 ± 3.29 0.74 ± 1.92 -0.54 ± 0.84 -1.06 ± 0.84 **int:f 
     PPTotHb, µMol 0.60 ± 0.31 0.46 ± 0.22 0.58 ± 0.27 0.46 ± 0.19 0.65 ± 0.35‡ 0.49 ± 0.25 *con,*gr 
     OxHb,µMol -1.40 ± 2.33 -0.57 ± 1.00 -1.34 ± 2.35 -0.31 ± 1.27 -0.47 ± 0.79 -0.67 ± 0.72 **int:j 
     PP OxHb, µMol 0.51 ± 0.25 0.41 ± 0.20 0.50 ± 0.22 0.41 ± 0.17 0.55 ± 0.28 0.45 ± 0.21 *con 
     DeoxHb, µMol 0.37 ± 1.20 1.10 ± 0.92 0.43 ± 1.21 1.04 ± 1.01 -0.07 ± 0.44 -0.39 ± 0.28 **int:e,f 
     PP DeoxHb, µMol 0.10 ± 0.06 0.11 ± 0.10 0.09 ± 0.05 0.09 ± 0.07 0.10 ± 0.07 0.11 ± 0.08 **con 
2-minute (100-120 sec)  
     HR, bpm 73.83 ± 14.99 70.89 ± 11.34 73.79 ± 15.08 69.80 ± 9.64 72.97 ± 15.07 70.20 ± 8.99 N.S. 
     SBP, mmHg 155.05 ± 30.24 138.54 ± 23.71 153.22 ± 27.86 146.47 ± 28.82 156.40 ± 29.24 145.39 ± 23.10 N.S. 
     DBP, mmHg 78.26 ± 13.41 73.02 ± 17.38 77.71 ± 12.37 76.03 ± 18.05 79.42 ± 13.85 76.73 ± 17.44 *con 




     PP,mmHg 76.79 ± 21.77 65.52 ± 15.31 75.52 ± 20.82 70.44 ± 17.69 76.98 ± 20.60 68.66 ± 14.58 N.S. 
     MAPmca, mmHg 80.12 ± 18.20 69.84 ± 18.70 79.14 ± 16.46 74.84 ± 21.29 81.37 ± 18.30 74.71 ± 18.81 N.S. 
     Qi, L/min/m2 2.60 ± 0.92 2.38 ± 0.94 2.68 ± 0.89 2.29 ± 0.87 2.49 ± 0.85†† 2.21 ± 0.81 **con 
     SVi, mL/m2 35.13 ± 13.36 34.55 ± 15.96 36.16 ± 13.13 33.73 ± 14.75 34.14 ± 12.64‡ 32.72 ± 14.71 **con 
     TPRi, 
mHg/L/min/m2 16.63 ± 10.06 17.61 ± 12.56 15.53 ± 9.33 20.52 ± 13.82 17.15 ± 10.33 20.58 ± 13.74 
**con 
     Skin temp 
(Celcius) 35.75 ± 0.97 35.28 ± 0.78 35.78 ± 0.96 35.07 ± 1.01 35.70 ± 1.00†† 34.64 ± 1.72 
**con,*int:e,f 
     tSO2, percent 61.59 ± 4.31 55.41 ± 8.40 61.14 ± 4.60 55.37 ± 8.84 61.78 ± 4.60 56.47 ± 8.47 *con,**gr 
     DiffHb, µMol 2.19 ± 2.54 1.32 ± 1.49 2.14 ± 2.66 1.59 ± 1.41 2.24 ± 2.63 2.09 ± 1.54 **int:e,g 
     TotHb, µMol -0.92 ± 3.33 1.13 ± 1.71 -0.75 ± 3.35 1.46 ± 2.35 -0.37 ± 0.88 -0.72 ± 0.88 **int:f,g,h 
     PPTotHb, µMol 0.65 ± 0.32 0.50 ± 0.29 0.63 ± 0.28 0.49 ± 0.22 0.68 ± 0.36 0.53 ± 0.27 *gr 
     OxHb,µMol -1.41 ± 2.37 0.01 ± 1.15 -1.31 ± 2.42 0.17 ± 1.57 -0.36 ± 0.78 -0.33 ± 0.67 **int:g,h 
     PP OxHb, µMol 0.55 ± 0.26 0.44 ± 0.26 0.54 ± 0.23 0.43 ± 0.20 0.58 ± 0.29 0.46 ± 0.22 N.S. 
     DeoxHb, µMol 0.49 ± 1.34 1.12 ± 0.86 0.56 ± 1.31 1.29 ± 1.04 -0.01 ± 0.58 -0.40 ± 0.43 **int:e,f 
     PP DeoxHb, µMol 0.10 ± 0.07 0.08 ± 0.06 0.10 ± 0.06 0.08 ± 0.04 0.11 ± 0.08 0.11 ± 0.08 *con 
3-minute (150-170 sec)  
     HR, bpm 72.99 ± 14.63 71.42 ± 11.06 75.51 ± 10.53 68.94 ± 9.81 75.29 ± 11.44 70.20 ± 8.92 **int:d,g,h,i 
     SBP, mmHg 155.92 ± 30.38 138.42 ± 22.55 152.87 ± 29.70 143.46 ± 25.77 156.60 ± 29.00 146.72 ± 23.21 N.S. 
     DBP, mmHg 78.22 ± 12.79 72.69 ± 17.71 77.19 ± 12.06 74.83 ± 18.23 79.69 ± 13.84 76.96 ± 18.20 **con 
     MAP, mmHg 104.12 ± 17.45 94.60 ± 17.87 102.42 ± 16.63 97.71 ± 19.80 105.32 ± 17.73 100.22 ± 18.87 **con 
     PP,mmHg 77.70 ± 22.45 65.73 ± 16.34 75.68 ± 22.71 68.64 ± 15.14 76.91 ± 20.57 69.76 ± 14.09 N.S. 
     MAPmca, mmHg 80.40 ± 17.89 69.77 ± 18.10 78.67 ± 16.94 72.80 ± 20.28 81.60 ± 18.19 75.31 ± 19.45 *con 
     Qi, L/min/m2 2.68 ± 0.92 2.50 ± 0.95 2.69 ± 0.96 2.30 ± 0.91 2.54 ± 0.90 2.23 ± 0.82 **con 
     SVi, mL/m2 36.32 ± 13.36 36.26 ± 16.33 36.24 ± 13.29 34.45 ± 15.90 34.48 ± 12.91 33.01 ± 14.75 **con 
     TPRi, 
mHg/L/min/m2 15.48 ± 8.13 16.04 ± 12.19 15.27 ± 8.47 19.95 ± 13.97 16.41 ± 8.40 20.58 ± 13.97 
**con 
     Skin temp 
(Celcius) 35.81 ± 0.93 35.33 ± 0.80 35.85 ± 0.93 35.10 ± 1.04 35.77 ± 0.97 34.65 ± 1.72 
**int:e,f 
     tSO2, percent 61.56 ± 4.26 56.78 ± 6.78 61.41 ± 4.49 55.73 ± 8.95 61.85 ± 4.84 55.96 ± 7.74 **gr 
     DiffHb, µMol 2.34 ± 2.61 1.56 ± 1.49 2.46 ± 2.69 1.87 ± 1.50 2.45 ± 2.71†† 2.23 ± 1.70 **con 




     PPTotHb, µMol 0.66 ± 0.31 0.52 ± 0.29 0.66 ± 0.30 0.51 ± 0.20 0.68 ± 0.36 0.51 ± 0.23 N.S. 
     OxHb,µMol -1.24 ± 2.48 0.27 ± 1.13 -1.02 ± 2.51 0.36 ± 1.58 -0.26 ± 0.92 -0.19 ± 0.64 **int:g,h 
     PP OxHb, µMol 0.56 ± 0.25 0.46 ± 0.26 0.56 ± 0.24 0.44 ± 0.19 0.59 ± 0.29 0.45 ± 0.21 N.S. 
     DeoxHb, µMol 0.60 ± 1.45 1.23 ± 0.81 0.58 ± 1.41 1.20 ± 0.92 -0.07 ± 0.66 -0.40 ± 0.44 **int:e,f 
     PP DeoxHb, µMol 0.11 ± 0.07 0.08 ± 0.06 0.10 ± 0.06 0.09 ± 0.05 0.11 ± 0.08 0.09 ± 0.05 N.S. 
Abbreviations: SBP systolic blood pressure, DBP diastolic blood pressure, MAP mean arterial pressure, PP pulse pressure, MAPmca mean arterial pressure at 
the level of the middle cerebral artery, Qi cardiac output index, SVi stroke volume index, TPRi total peripheral resistance index,  tSO2 cerebral 
tissue saturation, TotHb total hemoglobin, PPTotHb pulse pressure total hemoglobin, OxHb oxygenated hemoglobin, PPOxHb pulse pressure 
oxygenated hemoglobin, DexHb deoxygenated hemoglobin, PPDeoxHb pulse pressure deoxygenated hemoglobin. 
 
Statistical analysis: in reference to the following comparisons, * denotes p≤0.1, ** denotes p≤0.05. gr denotes group effect, con denotes effect 
of condition, int denotes interaction effect. Effect of condition: † denotes differences between supine-stand and supine-sit-stand, †† denotes 
difference between supine-sit-stand and sit-stand, ‡ denotes differences between supine-sit-stand and sit-stand. 
 
Group by condition interaction (int) comparisons for within group: int:a regulator group: supine-stand vs. supine-sit-stand, int:b regulator group: 
supine-stand vs. sit-stand, int:c regulator group: supine-sit-stand vs. sit-stand, int:d impaired-regulator group: supine-stand vs. supine-sit-stand, 
int:e impaired-regulator group: supine-stand vs. sit-stand, int:f impaired-regulator group: supine-sit-stand vs. sit-stand,  
 
Group by condition interaction (int) comparisons between groups int:g supine-stand: regulator group vs. impaired-regulator group, int:h supine-
sit-stand: regulator group vs. impaired-regulator group, int:i sit-stand: regulator group vs. impaired-regulator group, int:j Tukey’s HSD did not 










Table 3-3: Postural stability by group and condition 
Characteristic Supine-stand Supine-sit-stand Sit-stand Significance 
 Regulators Impaired-reg. Regulators Impaired-reg. Regulators Impaired-reg.  
Initial standing (2-22 sec) 
     RMS AP, cm 0.617 ± 0.274 0.673 ± 0.179 0.597 ± 0.193 0.662 ± 0.278 0.548 ± 0.160 0.609 ± 0.152 **con 
     RMS ML, cm 0.494 ± 0.256 0.560 ± 0.211 0.475 ± 0.204 0.508 ± 0.176 0.437 ± 0.191†† 0.444 ± 0.153 *con 
     TPL, cm 41.947 ± 16.878 67.098 ± 30.214 40.639 ± 18.224 59.992 ± 27.418 39.543 ± 16.741 53.299 ± 19.480 **int:e,g,h,i 
     TPL AP, cm 31.742 ± 13.294 48.863 ± 23.890 30.770 ± 13.524 46.528 ± 23.568 30.293 ± 13.799 41.478 ± 17.150 **int:e,f,g,h,i 
     TPL ML, cm 20.775 ± 9.570 35.672 ± 15.430 20.224 ± 10.980 28.565 ± 11.452 19.116 ± 9.181 25.200 ± 8.885 **int:d,e,g,h,i 
1-minute (40-60 sec) 
     RMS AP, cm 0.445 ± 0.167 0.475 ± 0.160 0.429 ± 0.165 0.422 ± 0.100 0.457 ± 0.239 0.466 ± 0.110 N.S. 
     RMS ML, cm 0.332 ± 0.170 0.354 ± 0.144 0.327 ± 0.176 0.290 ± 0.103 0.324 ± 0.183 0.364 ± 0.202 N.S. 
     TPL, cm 30.788 ± 12.804 45.064 ± 20.322 31.378 ± 14.566 39.953 ± 19.173 31.352 ± 16.177 41.148 ± 14.879 **gr 
     TPL AP, cm 24.451 ± 11.289 35.154 ± 16.593 24.832 ± 11.711 31.047 ± 16.712 25.242 ± 12.552 33.004 ± 12.375 **gr 
     TPL ML, cm 13.831 ± 6.157 21.042 ± 11.289 14.267 ± 7.982 19.001 ± 9.353 13.476 ± 8.589 18.134 ± 7.820 **gr 
2-minute (100-120 sec) 
     RMS AP, cm 0.392 ± 0.136 0.412 ± 0.105 0.377 ± 0.123 0.425 ± 0.145 0.394 ± 0.141 0.356 ± 0.108 *int:j 
     RMS ML, cm 0.274 ± 0.144 0.328 ± 0.156 0.260 ± 0.131 0.288 ± 0.114 0.255 ± 0.126 0.329 ± 0.211 N.S. 
     TPL, cm 28.180 ± 12.270 40.100 ± 20.563 27.265 ± 10.340 39.072 ± 16.080 26.398 ± 9.815†† 33.270 ± 11.240 **con**gr 
     TPL AP, cm 22.473 ± 10.615 30.861 ± 18.533 21.692 ± 8.124 30.505 ± 14.963 21.546 ± 8.784 25.801 ± 10.086 *con**gr 
     TPL ML, cm 12.442 ± 6.513 19.018 ± 9.601 12.207 ± 6.680 18.011 ± 7.342 11.166 ± 5.061 15.628 ± 6.061 **con**gr 
3-minute (150-170 sec) 
RMS AP, cm 0.400 ± 0.163 0.460 ± 0.155 0.433 ± 0.288 0.402 ± 0.114 0.415 ± 0.238 0.441 ± 0.147 N.S. 
RMS ML, cm 0.270 ± 0.248 0.300 ± 0.120 0.290 ± 0.204 0.320 ± 0.130 0.305 ± 0.256 0.341 ± 0.178 N.S. 
TPL, cm 27.432 ± 11.365 36.487 ± 19.642 28.800 ± 12.336 39.950 ± 17.910 28.268 ± 13.802 34.568 ± 12.757 **gr 
TPL AP, cm 21.921 ± 9.198 29.210 ± 18.955 23.011 ± 10.145 31.533 ± 15.928 22.223 ± 9.681 26.946 ± 10.084 **gr 
TPL ML, cm 12.118 ± 6.717 16.093 ± 5.600 12.739 ± 7.002 18.165 ± 7.543 12.937 ± 9.218 16.323 ± 7.166 *gr 





Statistical analysis: in reference to the following comparisons, * denotes p≤0.1, ** denotes p≤0.05. gr denotes group effect, con denotes effect 
of condition, int denotes interaction effect. Effect of condition: † denotes differences between supine-stand and supine-sit-stand, †† denotes 
difference between supine-sit-stand and sit-stand, ‡ denotes differences between supine-sit-stand and sit-stand. 
 
Group by condition interaction (int) comparisons for within group: int:a regulator group: supine-stand vs. supine-sit-stand, int:b regulator group: 
supine-stand vs. sit-stand, int:c regulator group: supine-sit-stand vs. sit-stand, int:d impaired-regulator group: supine-stand vs. supine-sit-stand, 
int:e impaired-regulator group: supine-stand vs. sit-stand, int:f impaired-regulator group: supine-sit-stand vs. sit-stand,  
Group by condition interaction (int) comparisons between groups int:g supine-stand: regulator group vs. impaired-regulator group, int:h supine-
sit-stand: regulator group vs. impaired-regulator group, int:i sit-stand: regulator group vs. impaired-regulator group, int:j Tukey’s HSD did not 






Figure 3-1: Cerebral tissue saturation (tSO2) and center of pressure (COP) for a single participant in the 
regulators group (black filled circles) and a single participant from the impaired-regulators group 
(white circles), during a supine-stand transition. Upper panel represents tSO2 response and the grey 
filled rectangles represent the initial, 1-min, 2-min and 3-min time points used to extract a 20 sec 
average for analysis of postural stability. The lower panels represent COP sway in the anterior 






Figure 3-2: Cardiovascular responses to a supine-stand, supine-sit-stand and sit stand transition. Time 
at zero marks upright posture, negative time represents rest and active transition, positive time 
represents standing. Black filled circles mark mean values of second-by-second data of regulators 
group (n=62); white circles mark the postural response of the impaired-regulators group (n=15). HR 
heart rate, MAP mean arterial pressure, Qi cardiac output index, SVi stroke volume index, TPRi total 






Figure 3-3: Cerebrovascular hemodynamic responses to a supine-stand, supine-sit-stand and sit stand 
transition. Time at zero marks upright posture, negative time represents rest and active transition, 
positive time represents standing. Black filled circles mark mean values of second-by-second data of 
regulators group (n=62); white circles mark the postural response of the impaired-regulators group 
(n=15).tSO2 cerebral tissue saturation, TotHb total hemoglobin, OxHb oxygenated hemoglobin, 









Figure 3-4: Delta cerebral tissue 
saturation (tSO2) and initial 
standing total path length (TPL) 
during the supine-stand, supine-sit-
stand and sit-stand conditions.  TPL 
in the anterior-posterior (AP) and 
medial-lateral (ML) planes are 
displayed. Data represents mean 
and standard deviations for the 
regulators (black filled bars) and 
impaired-regulators (grey filled 
bars) groups.  
 
Significant group by condition 
interactions were found for all 
three measures. Tukey’s HSD test 
identified comparison differences 
where ** denotes significant group 
differences, ^^ denotes significant 
differences between conditions for 
the impaired-regulators group.  
 
No significant difference across 
transitions were observed for the 
regulators group but the impaired-
regulators demonstrated a 
progressive improvement of their 
delta tSO2 from supine-stand, to 
supine-sit-stand to sit-stand 
transitions. Similarly, when looking 
at TPL AP and ML the regulators 
had no differences between 
conditions but the impaired-
regulators had significantly 
different measures of postural 







Figure 3-5: Cerebral tissue saturation (tSO2) and total path length (TPL) during the supine-stand, 
supine-sit-stand, and sit-stand transitions. The tSO2 nadir was calculated as the three-point average of 
lowest values while the initial TPL was taken over the first 20s. All subsequent values at 1-min, 2-min 
and 3-min for tSO2 and TPL were averages of 20-s. Data are the mean and standard deviation for the 
regulators (black bars) and impaired-regulators (grey bars) groups. Significant group by time 
interactions were found for all tSO2 and TPL transitions. * marks Tukey’s HSD differences p≤0.05 
between groups.  
 
*             *           *          *                  *            *            *            *                  *            *           *           * 





Figure 3-6: Collapsed data from the three conditions for cerebral tissue saturation (tSO2) and total 
path length (TPL) between groups. The responses to the three conditions (supine-stand, supine-sit-
stand and sit-stand) were averaged/collapsed to represent a single average and standard deviation for 
each group at each time point. The initial, 1-min, 2-min and 3-min for tSO2 and TPL values were 
averages of 20-s. Data are the mean and standard deviation for the regulators (black bars) and 
impaired-regulators (grey bars) groups. Significant (p≤0.05) group differences (**) were found for all 




CHAPTER 4. CEREBRAL HYPOPERFUSION DURING OVER-GROUND WALKING IS 
RELATED TO INCREASED GAIT VARIABILITY AND INCREASED VASCULAR 
STIFFNESS IN OLDER ADULTS 
Introduction 
Posture-related cerebral hypoperfusion is related to impaired arterial blood pressure (BP) 
regulation and is thought to contribute to a large proportion of falls in older adults  (Finucane C. et al. 
2017). The previous study (Chapter 3) demonstrated that lower arterial BP and reduced cerebral 
oxygenation (tSO2) during a transition to standing were associated with postural instability and an 
increased likelihood of having a future fall. However, transitioning from rest to walking better reflects 
a typical activity of daily living. During exercise cerebral blood flow (CBF) increases  (Fisher J.P. et al. 
2013) and with age CBF becomes progressively reliant on cardiac output (Qi) to maintain flow  
(Bronzwaer A.G.T. et al. 2017).  It is unknown how tSO2 and CBF of older adults respond when going 
from a resting position to walking and if cerebral hypoperfusion still exists in light of an active muscle 
pump to assist venous return and elevate cardiac output while walking  (O'Hare C. et al. 2017).   
Walking is a complex and dynamic movement  (Winter D.A. 1995) which taxes postural control 
in some older adults.  Balance strategies are often used by older adults to minimize balance 
disturbances and prevent falls  (Maki B.E. & McIlroy W.E. 1997).  Adapted strategies are seen by 
altered gait  such as greater step-step variability and slower self-selected walking speed (Ko Su et al. 
2009; Ambrose A.F. et al. 2013; Jensen J.L. et al. 2001; Maki B.E. & mcIlroy W.E. 2006; Papa E. & 
Cappozzo A. 2000; Akram S.B. & McIlroy 2011). Dynamic movements, such as gait speed and step-time 
variability, are predictive of multiple falls in older adults  (Callisaya M.L. et al. 2011).  It is unknown 





Stiffer arterial vessels marked by increased pulse wave velocity (PWV) have been correlated to 
lower CBF and higher cerebrovascular resistance, suggesting a relationship between stiffer vessels and 
altered cerebrovascular hemodynamics and an increased risk of cerebral hypoperfusion  (Robertson 
A.D. et al. 2010a).  Increased PWV has also been found in fallers when compared to non-fallers  (Wong 
A.K. et al. 2014). However, the link between vascular stiffness and balance strategies has yet to be 
determined.  
Slower gait speeds have been associated with reduced resting CBF  (Ezzati A. et al. 2017), but 
it is unknown whether cerebral hypoperfusion is observed during walking in persons with slow gait 
speeds or those who employ adaptive strategies resulting in greater step-step variability. The purpose 
of the present investigation was to i) examine the posture-related reductions in tSO2 and CBF during a 
transition from supine and seated rest to walking, ii) to examine the relationships between walking 
related reductions of tSO2 with step-step variability and features of gait, iii) to examine whether 
reduced tSO2 and CBF are related to stiffer arteries and features of gait (including slower gait speed). 
It is hypothesized that, i) a sub-population of older adults will be at greater risk of low tSO2 
and CBF with walking, ii) older adults with reduced tSO2 will have increased step-step variability and 
compromised gait features, iii) older adults with reduced tSO2 and CBF will have stiffer arteries and 




Twenty-seven older adults age 71-101 years old (17 females; age 86.8±5.3; height 162.3±8.5 
cm; weight 70.7±12.8 kg) gave written and informed consent to volunteer in the present study which 
was reviewed and approved by the Office of Research Ethics at the University of Waterloo and the 




analysis of 1 participant therefore all of the results and findings to follow are based on a sample size of 
26 older adults.   
All of the participants were previously part of a larger study (Chapter 3) which included 77 
older adults who performed three active transitions to standing, including a supine-stand transition. 
From this previous study, approximately three quarter of the participants for the current study were 
identified as having relatively unchanged cerebral oxygenation and good stability on standing, while 
the other quarter had reductions in oxygenation and poorer stability.  
All of the participants in the current study live in conjugate living at one of the Schlegel 
Villages in Ontario Canada. Participants arrived 2 h postprandial to testing where they completed a 
brief health questionnaire (past health, current health, physical activity levels, medications). The 
health questionnaire indicated that all participants were free of neuromuscular and neurological 
conditions as well as free of diabetes, stroke or any recent (within 3 months) myocardial infarctions.  
 
Self-reported questionnaire 
The self-reported health status questionnaire, modified from Robertson (Appendix A,  
(Robertson A.D. 2013)), was verbally administered to each participant upon arrival to the testing 
session.  Participants reported on vision, past health behaviours such as smoking status and physical 
activity, past health conditions such as heart failure, kidneys or liver disease (listed in table 2), current 
health concerns such as irregular heart beats and pain with walking, current medications (prescribed 
and over-the-counter) and perceived balance (fear of falling).  
 
Fall History Reports 
 Fall history reports encompassed a 104 item report completed by a Schlegel Village staff 




of day of falls as well as questions surrounding pre-existing medical conditions, medical explanation 
for fall or being pushed or bumped by someone. All 26 participants were included for fall analysis. The 
total number of fall reports recorded within 6-months before (3 fall reports pertaining to 2 individuals) 
and after testing (10 fall reports pertaining to 5 individuals).  One fall prior to testing was remove from 
analysis as it was attributed to a person-to-person collision, resulting in 2 fall reports pertaining to 2 
individuals. 
 
Cardiovascular and Cerebrovascular Hemodynamics 
Participants rested quietly on a bed for instrumentation of arterial finger BP by 
plethysmography (Portapres, Finapres Medical Systems, Amsterdam, The Netherlands), cerebral tissue 
near-infrared spectroscopy (NIRS; PortaLite, Artinis Medical Systems BV, Netherlands) and a portable 
transcranial Doppler ultrasound (TCD-X; Atys medical, Soucieu en Jarrest, France). The Portapres 
device was placed on a walker that was moved by the participant, the PortaLite and the TCD-X devices 
were light weight and were carried by the participant during the walking. A brachial return to flow 
calibration was used on the finger arterial BP waveform and beat-to-beat measures of systolic, 
diastolic, and mean BP (SBP, DBP, MAP) were adjusted to a manual BP. BP at the level of middle 
cerebral artery was calculated (BPmca = BP – (distance above heart in cm*0.78)). Estimates of stroke 
volume, cardiac output, and total peripheral resistance (Finometer Pro; Finapres Medical Systems, 
Arnheim, The Netherlands) were normalized to body surface area  (DuBois D & DuBois EF 1916)(SVi, 
Qi and TPRi respectively). The NIRS device was used to collect relative changes in oxygenated, 
deoxygenated, and total hemoglobin content (OxHb, DeoxHb, and TotHb) as well as cerebral 
oxygenation (tSO2=OxHb/TotHb). The NIRS device was also used to estimate heart rate (HR) which was 
derived from the beat-to-beat OxHb interval. The NIRS device was placed over the prefrontal lobe in 




(Perrey S. 2008).  A source detector distance of 4 cm was used for the OxHb, DeoxHb and TotHb 
signals to reduce signal contamination from surrounding tissues  (Kohri S. et al. 2002). The NIRS signal 
was later processed into beat-by-beat data points where the mean hemoglobin values were extracted 
from each beat. A 2 Mz Doppler probe was fastened to the TCD-X head set and the participants’ 
glasses if they wore prescription glasses. The middle cerebral artery was then identified and the vessel 
signal was optimized  (Aaslid R. et al. 1982). The TCD-X software was subsequently used to auto adjust 
the robotic arm and improve signal quality. Peak-systolic (SFV), end-diastolic (DFV) and mean (MFV) 
CBF velocities were used for beat-to-beat analysis, as well as CBFV pulse pressure (CBFVpp=SFV-DFV). 
A reliable CBFV signal with walking was acquired for 20 of the participants.   
 
Dynamic Testing 
All participants completed two active transitions to walking: i) supine-walk-with-walker 
(supine-walk) and ii) sit-walk-with-walker (sit-walk). Transitions were performed in a random order. 
The 2 transitions were preceded by a practice transition (sup-walker) to ensure all participants felt 
comfortable walking with the walker.  All transitions began with 10 min of supine or seated rest, 
followed by an assisted transition into the standing position. Assistance from supine to a seated 
position was provided by the research team whereby one researcher placed hands behind the 
participant’s left shoulder and left elbow while a second guided the participant’s feet to the standing 
position. Participants walked at a self-selected usual pace on an oval track for 1-minute. At the 
different testing sites, the straightway of the track was 20.4±3.9 m and the radius was 0.8 m making 
the arc length approximately 2.5 m. 
To capture gait variables, an accelerometer (16g accelerometer data logger x16-mini, Gulf 
Coast Data Concepts, LLC, Waveland, MS, USA) was placed on the lateral plane of the left ankle and 




participants (2 regulators). For this reason, all analyses are presented on the left ankle accelerometer 
data only. For those participants who had data from both ankles, Pearson’s correlations were 
performed for all gait variables between the left and right ankle. Significant correlations (p≤0.05) were 
found for all supine-walk relationships other than two variables, one of which had a p=0.067 (out of 20 
left and 20 right ankle variables). All but 2 of the total 20 left and 20 right ankle gait variables for sit-
walk had a p≤0.1 where the other 2 p-values were 0.107 and 0.132. 
A customized Matlab program (Matlab R2015a; The Mathworks Inc, Natick, MA, USA) was 
used for feature extraction (toe off, mid-heel swing and heel strike, figure 4-1), cropping of turns, 
computing gait variable and time aligning data to beat-to-beat measures (e.g. BP and CBF).  To identify 
the timing of each gait feature the data were filtered at 100 Hz and the timing and amplitude of toe 
off, mid heel swing and heel strike were extracted from the raw signal and used for further analysis  
(Selles R.W. et al. 2005). Turns around the arc length of the track which demonstrated clear reductions 
of acceleration were cropped from further analysis (typically 4 steps). Indicators of gait variability 
(cadence, gait cycle, swing phase and stance phase) were computed from the end of the third step 
until the closest step 25-sec later (early walking). A second 25-sec interval was extracted from the last 
25-sec of walking (late walking). The early and late walking intervals were then time aligned to the 
cardio- and cerebrovascular beat-to-beat data and the same 25-sec intervals were extracted.   
Gait speed was calculated as the distance traveled during 1-minute, divided by time.  
Participants were also categorized as being slow (< 0.6 m/s), mildly abnormal (0.6->1.0 m/s), normal 
(1.0-<1.3 m/s) and fast (≥1.3 m/s) as per the Task Force of the International Academy on Nutrition and 
Aging  (Abellan van Kan G. et al. 2010; Studenski S. et al. 2003; Quach L. et al. 2011).  Aside from gait 
speed, all other temporal measures of gait were constructed from the toe-off, mid-heel swing and 
heel strike time intervals of early and late walking (Figure 4-1). Gait cycle time was calculated as the 




from toe-off to heel strike, stance time represents the time from heel strike to toe off, fractional mid-
heel swing represents the fraction of time within a gait cycle that mid swing occurs, and fractional 
stance time is the percent of time within a gait cycle that represents stance time (Figure 4-1). Gait 
analysis from one participant from the regulator group, and one from the impaired-regulator group is 
shown in Figure 4-2. Mean and standard deviation values for gait cycle time, swing time, stance time, 
fractional stance time and fractional mid-heel swing time were calculated. The standard deviations 
represent variability of temporal measures and mean values represent gait features to complement 
the gait assessment.  The standard deviation of gait cycle time represents step-step variability.  
 
Time scale and averaging  
Resting baseline values of beat-to-beat data were averaged over 30 sec of supine or seated 
rest (from -45 sec to -15 sec prior to a transition). Time at zero seconds indicates the beginning of the 
first step. Nadir signifies the single lowest tSO2 beat value. With the introduction of walking there was 
greater beat-beat variability thus a single nadir beat was chosen over a 3-beat average used in the 
previous experiment.  Positive time indicates time following the beginning of transition.  
  
Arterial Measures 
Following dynamic testing, participants were instrumented for continuous monitoring of HR 
(electrocardiogram, Finapres Medical Systems, Amsterdam, The Netherlands). Total body water (TBW) 
was then estimated using a body impedance analysis (MF-BIA QuadScan 4000: Bodystat LTD, Isle of 
Man, UK) with electrodes placed on the right wrist, middle finger, ankle and toe with the participant in 
a supine position and arms and legs abducted from the body  (Sun S.S. et al. 2003). 
Arterial stiffness was assessed by carotid pulse pressure (cPP) and compliance coefficient 




velocity (cfPWV), and estimated augmentation index and PWV (AI, ePWV). cPP was measured in the 
left carotid artery by applanation tonometry for 15–20 beats (SPT-301, Millar Instruments, Houston, 
TX, USA). Brightness-mode (B-mode) ultrasound images (M5 system, Mindray Bio-Medical Electronics 
Co., Shenzhen, China) of the carotid artery were taken using an 8–12 MHz linear array transducer 
(L14-6s) to measure arterial diameter with manual electronic calipers in triplicates over three 
consecutive heart beats. The combination of cPP and arterial diameter from ultrasonic images were 
used to calculate cCC and cDC  (van Bortel L.M et al. 2012; van Bortel L.M. et al. 2002; Reneman R.S. et 
al. 2005). The carotid diameter and IMT were measured from B-mode ultrasound images of the right 
carotid within 1–2 cm of the bifurcation. IMT was defined as the distance from the lumen-intimal 
interface to the media-adventitial interface of the far wall of the artery. A set of eight electronic 
calipers were manually placed over a 1 cm segment of images captured at the ECG R-peak over three 
consecutive beats for right carotid, and an average was computed to represent a single mean IMT 
value.  Pulse waves from the right common carotid and femoral arteries were recorded for 20–30 
beats by Doppler ultrasound (Doppler Box, Compumedics DWL, Singen DE). Pulse wave arrival times 
were calculated from the time difference between the ECG R-peak and the foot of the velocity wave. 
To clearly identify the foot of each pressure wave, a low-pass 5–30 Hz filter was applied  (Robertson 
A.D. et al. 2010a) and the maximum 2nd derivative of each waveform was calculated. cfPWV was 
calculated by dividing the difference in the measured superficial distances from the measurement 
sites to the suprasternal notch and the difference in pulse arrival times. Resting central SBP and DBP 
(cSBP and cDBP) as well as AI and ePWV were assessed in the supine resting position using the Mobil-
O-Graph cuff placed over the brachialis artery (Mobil-O-Graph, I.E.M. GmbH, Strolberg, Germany). The 
Mobil-O-Graph detects the oscillometric waveform and uses customized software (ARCSolver 
software) to apply transfer function analysis that reconstructs the central waveform. Subsequently, 




adjusted for HR) and ePWV. The Mobil-O-Graph has been validated against a well-established non-
invasive estimation of central BP known as SphymoCor for both central hemodynamics and arterial 
stiffness measurements  (Weiss W. et al. 2012; Luzardo L. et al. 2012).  
 
cCC (mm2/MPa) = [π•ΔD(mm)•D(mm)] / [2•PPcar(MPa)] 
cDC (10-3/kPa) = [2•ΔD(mm)•D(mm) + ΔD(mm)2] / [D(mm)2•PPcar(kPa)] 
 (van Bortel L.M. et al. 2002; Reneman R.S. et al. 2005)  
 
Statistical analysis 
All statistical analysis was completed using IBM SPSS version 20 (IBM SPSS Statistics 20; IBM 
Corp, Armonk, NY, USA), and all tests were considered significant at p≤0.05 and trends were reported 
at p≤0.1. 
 
Participant Grouping- The current study identified obvious differences between older adults during 
walking which demonstrate reflected abnormalities in tSO2 (Figure 4-2 A), MFV (Figure 4-2 B), gait 
characteristics (Figure 4-2 C-D), step-step variability (Figure 4-2 E), stance time variability (Figure 4-2 F) 
and gait speeds (Figure 4-2 G). In the previous investigation (Chapter 3) participants also 
demonstrated varying abilities to recover tSO2 upon standing (supine-walk condition) and therefore k-
cluster analysis was used to separate participants into two groups (Chapter3).  The small sample size 
(n=26) in the current investigation, combined with varying tSO2 responses in the older adults did not 
allow for any strong cluster groups to be formed. Karkow et al (2002) identified that signs of pre-
syncope mainly occur when oxygenation and perfusion are less than tSO2 of 60%  (Krakow K. et al. 
2000). Therefore, during the supine-walk condition of early walking, a cut off value of tSO2 ≤ 60% was 




the low-tSO2 group from the current investigation also had a tSO2 ≤ 60% during initial standing of the 
supine-stand experiment (Chapter 3). Thus, participants classified as having low cerebral oxygenation 
appear to have a relatively low tSO2 while upright standing or walking.  
 
Effects of group, condition and time -  A two-way mixed ANOVA (general linear model in SPSS) was 
used to assess the main effect of condition and group for gait speed and all hemodynamic and mean 
gait variables.  Two levels of repeated measures were used for within-subject evaluation for the 
condition (supine-walk, sit-walk) and two levels of between-subject factors were used to evaluate 
group effects (high-tSO2 vs. low-tSO2).  For all ANOVAs if Mauchly’s test of Sphericity was significant 
the Greenhouse-Geisser correction was used.  If a significant interaction was found, Tukey’s honest 
significant difference (HSD) test was used to further evaluate significant levels.  
For high-tSO2 vs. low-tSO2, a Mann-Whitney U Test and a Levene’s Test for equality of variance 
was performed on all gait variability data.  Corrections for multiple tests were not applied, thus not all 
variables with a p≤0.05 are truly significant. A correction was not applied as this is an exploratory 
study requiring additional power to accurately assess multiple comparisons on non-continuous data. A 
Friedman’s Test was used to analyze differences in conditions between the supine-walk and sit-walk 
transitions.  
 
Group characteristics comparisons – All data were analyzed using an ANOVA in SPSS version 20.0.  All 
nominal data were tested using a Chi-square test with the Fisher’s Exact Test correction factor (Phi 
was used to estimate the effect size when significance was found).  
 
Relationships comparisons - Pearson Product-moment correlations were used to assess the 




initial standing/early walking, ii) TCD and tSO2 signals during both early and late walking of both 
conditions, iii) cerebrovascular hemodynamics (tSO2, TotHb, OxHb, DeoxHb, PSV, EDV and MFV) and 
all mean and standard deviation gait characteristic as well as gait speed during the supine-walk 
condition, iv) gait speed and gait characteristics (all mean and standard deviation measures), v) 
vascular stiffness and cerebrovascular hemodynamics (all NIRS and TCD signals during baseline, early-
walk and late-walk) and vi) vascular stiffness measures and gait characteristics and gait speed.   
 
Results 
Experiment comparisons (Figure 4-3) 
The tSO2 measurements for the same persons on two different occasions (supine-walk test of 
the current study and supine-stand test in Chapter 3) were not significantly correlated during baseline, 
nadir or early-walking or standing values. The baseline correlation is not significant however there is 
not much variation surrounding the line of identify.  
 
Group characteristics (Table 4-1)  
There were no significant differences between groups for age, sex, BMI, BSA, or TBW. 
However, there were trends for lower brachial DBP and MAP (p=0.085 and p=0.071), as well as 
significantly (p=0.039 and p=0.042) lower central SBP and DBP in the low-tSO2 group. There was a 
higher cfPWV (p=0.057) in the high-tSO2 group, and higher self-reported incidence rates of 
emphysema/pneumonia (p=0.086). Although not significant, the majority of participants in the low-
tSO2 group were considered sedentary. There were no significant differences between groups for 






Beat-to-beat hemodynamic responses (Figures 4-4 and 4-5)  
During the transitions to walking HR slowly but steadily increased. During late-walking HR was 
higher (p=0.059) during the sit-walk condition compared to the supine-walk condition. There were 
differences (p<0.05) in condition for baseline values of SVi, Qi and TPRi estimated from the pulse 
contour analysis ; whereby SVi and TPRi were higher at baseline during the sit-walk condition and Qi 
was higher at baseline during the supine-walk condition.  During late-walking SVi and Qi were higher 
during the supine-walk vs. sit-walk condition. A trend for an interaction for TPRi late walking was 
found but Tukey’s HSD did not identify any significant comparisons. Beat-to-beat SBP, DBP and MAP 
was lower (p<0.05) during supine-walk versus sit-walk baseline. As mentioned above (Table 4-1), the 
low-tSO2 group had a lower DBP and MAP at baseline compared to thehigh-tSO2 group.  
Cerebrovascular responses demonstrated a higher baseline EDV and MFV during the supine-
walk compared to the sit-walk condition (p=0.021 and p=0.073). An interaction (p=0.012) was found 
for baseline CVRi, where the high-tSO2 group had a higher CVRi at baseline compared to the low-tSO2 
group during the sit-walk condition. CVRi was also found to be higher in the sit-walk condition 
compared to the supine-walk condition during early walking. Both RI and PI were higher (p<0.01) at 
baseline during the sit-walk condition compared to the supine-walk condition. The low-tSO2 group had 
lower (p<0.001) tSO2 at baseline, nadir, early-walk and late-walk compared to high-tSO2 group.  The 
low-tSO2 group also had higher TotHb and higher DeoxHb at nadir, early-walking and late walking 
(p<0.1). Trends for OxHb suggest that the supine-walk nadir is lower than the sit-walk nadir and during 
early and late walking the low-tSO2 group have higher OxHb.    
 
Relationships between CBFV and tSO2 (Figure 4-2 and 4-6) 
Although there were no significant correlations between tSO2 and PSV or EDV (Figure 4-6) a 




trends between tSO2 and MFV from supine rest to walking, generally align. Likewise, the low-tSO2 
participant has a lower tSO2 and MFV compared to the high--tSO2 participant (Figure 4-2).  
 
Gait variability relative to cerebrovascular hemodynamics (Figures 4-7 to 4-8) 
Gait cycle variability and stance time variability were significantly greater in the low-tSO2 group 
compared to the high-tSO2 group (Figure 4-7). Correlations were run between cerebrovascular 
hemodynamics (tSO2, TotHb, OxHb, DeoxHb, PSV, EDV and MFV) and all mean and standard deviation 
gait characteristic as well as gait speed. Correlations were run for the supine-walk condition only as 
group differences in cerebrovascular hemodynamics were most prominent during this condition. It 
was found that as relative changes in OxHb increased, from supine rest to early walking, mean stance 
time also increased. Likewise, as relative changes in OxHb increased, from supine rest to late walking, 
mean gait cycle time also increased. During the supine-stand late walking interval, as DeoxHb 
increased mean fractional stance time decreased.  
 
Relationships between gait speed and gait characteristics (Table 4-2) 
Although gait speed was not directly associated to cerebrovascular hemodynamics, it is 
associated with gait characteristics that were related to cerebrovascular responses during walking. 
Gait speeds (supine-walk and sit-walk) were negatively correlated (p<0.05) to mean gait cycle time, 
mean stance time and mean fractional stance time. Gait speed during the sup-walk was significantly 
and positively correlated to cadence, swing variability, variability of fractional stance time.  
 
Cerebrovascular hemodynamics relative to vascular stiffness (Figure 4-9 and Table 4-3) 
Significant relationships between reduced CBF and increased vascular stiffness as well as 




cPP decreased and cDC increased (Figure 4-9). As cerebrovascular resistance index increased so did 
central diastolic blood pressure (Figure 4-9).  The only NIRS signal correlated to vascular stiffness was 
DeoxHb (Table 4-3). As a relative change in DeoxHb increased from baseline to walking cfPWV 
decreased. However, these results are highly dependent on the baseline resting values as DeoxHb 
represents relative changes only.   
 
Gait speed and gait characteristics relative to vascular stiffness (Figure 4-10) 
Increased central arterial stiffness, marked by increased cPP with the Mobil-O-Graph, was 
associated with reduced gait speed for both the supine-walk and sit-walk conditions. As noted above, 
increased carotid PP was significantly correlated to reduced EDV (Figure 4-9). 
As mentioned previously, participants in the low-tSO2 group had higher relative OxHb upon walking 
(Figure 4-5) which was associated with increased mean stance and gait cycle times (Figure 4-8).  
Increased mean stance and gait times were associated with slower gait speed (Table 4-2). 
Furthermore, increased vascular stiffness as associated with reduced CBF (Figure 4-9 and Table 4-3) 
and increased reduced gait speed (Figure 4-10).  
 
Discussion 
The current study is the first to relate changes in cerebral perfusion and oxygenation to gait 
characteristics in older adults who transitioned from supine or seated positions to walking. Consistent 
with the study’s hypotheses, we observed that there is a sub-population of older adults who have low 
tSO2 and CBF during walking. These older adults with cerebral hypoperfusion have increased step-step 
variability. The participants with greater arterial stiffness also had lower CBF and altered 
cerebrovascular hemodynamics, as well as slower gait speeds. Although these data were derived from 




cerebrovascular health, and the slower gait speed and altered gait strategies point to an increased risk 
for falls that might be detected with longer follow up.    
 
Cerebral oxygenation and blood flow  
Previous research has shown that approximately 1 in 5 older adults has an impaired blood 
pressure response on transition from supine to standing positions  (Romero-ortuno R. et al. 2011; 
Finucane C. et al. 2014). This impaired response might lead to cerebral hypoperfusion that could cause 
dizziness and unexplained falls  (Finucane C. et al. 2017) as considered in Chapter 3. In the current 
study design, we recruited individuals from a previous investigation (Chapter 3) who had good 
regulation of cerebral oxygenation and more stable posture on standing, as well as those with poorer 
regulation of cerebral oxygenation and less stable posture. The previous study (Chapter 3) identified 
three quarters of participants to have relatively unchanged tSO2 and good stability whereas the 
current study identified approximately 65% of participants to have higher tSO2, higher BP, and 
reduced step-step variability. The grouping between experiments differed because the performance 
of the task (stand versus walk) resulted in different cardio- and cerebrovascular hemodynamic 
responses. Thus, the new grouping for the current study was based on tSO2 ≤ 60% during walking 
versus the previous experiment that grouped participants based on hypoperfusion with a static stand 
(large postural reductions from baseline and sustained static stand reductions in tSO2). 
The supine-stand and supine-walk responses of TotHb, OxHb and DeoxHb between high- and 
low-tSO2 groups were consistent between experiments. Larger reductions in TotHb, OxHb and larger 
increases in DeoxHb were observed in the high-tSO2 group (Figure 4-5). These findings are in line with 
Mehagnoul-Schipper et al. 2003 where following an active stand healthy older adults had a larger 
reduction (p<0.05) in OxHb and TotHb than older adults with diastolic dysfunction  (Mehagnoul-




from the current investigation are consistent with the age-related trends observed by Edlow et al. in a 
younger population  (Edlow B.L. et al. 2010).  
Recent studies have investigated cerebral oxygenation during walking in older adults, but this 
research did not include postural transitions and focused on challenges such as dual tasking  
(Nieuwhof F. et al. 2016; Maidan I. et al. 2016). This is the first study to demonstrate the response of 
both tSO2 and CBF during transitions from supine or seated postures into over-ground walking in older 
adults.  At first glance of the cerebrovascular responses to walking (Figure 4-5) there is not a clear 
coupling between CBF and tSO2 this is due to the low sample size of participants with acquired TCD 
signals (n=11 high-tSO2 and n=5 low-tSO2). The CBF values of the low-tSO2 group are low (as seen by a 
typical low--tSO2 participant in Figure 4-2) however one of the 5 participants in this group had a high 
CBFV response, leading to a high group average. High CBFV in older adults might reflect a high CBF, or 
it might be a consequence of a smaller diameter middle cerebral artery, or minor cerebral artery 
stenosis that had not been previously diagnosed  (Baumgartner R.W. et al. 1999). As mentioned, when 
looking at the individual responses (Figure 4-2) the trends in the tSO2 response aligns with the trends 
in the MFV response for both the low- and high-tSO2 participants. Generally speaking, participants 
with a low tSO2 also have low CBF (Figure 4-2 and 4-6). Previous reports of combined tSO2 and CBFV 
recordings have found changes in tSO2 with acetazolamide injections (known to increase CBF) to not 
be as large as changes seen in the CBFV signals  (Tachtsdis I. et al. 2008). However overall changes in 
tSO2 were correlated to changes in percent MFV (r=0.77, p<0.01) (Tachtsdis I. et al. 2008).  
Observed differences between individuals (tSO2 of high- vs. low-tSO2 groups) were anticipated 
yet still disconcerting to see a sub-population of older adults experience some degree of 
hypoperfusion when walking. In order for the low-tSO2  group to have increased CBF and tSO2, an 
increase in Qi would be required  (Bronzwaer A.G.T. et al. 2017), this could be derived from either an 




muscle pump is capable of propelling blood towards the heart and increasing venous return despite 
large pressure gradients  (Halliwill J.R. et al. 2014; Stegall H.F. 1966), however this mechanism may be 
failing in some manner for some older adults. During muscle activation, such as with the dynamic 
movement of walking, the cardiovascular system must meet the metabolic demands of the active 
muscle and the brain  (Ichinose M. et al. 2014). During high-intensity dynamic exercise in young adults, 
BP is tightly regulated by alterations in arterial baroreflex controls to ensure that slight changes in TPRi 
do not impact the Qi and oxygen delivery to the working muscle and the delivery of blood to the brain  
(Ichinose M. et al. 2014).   In the older adults who have reduced tSO2 during walking, failure of one or 
more of these mechanisms may be contributing to the reduced tSO2.   
Syncope has been associated with both low BP and CBFV during tilt-test  (Novak P. 2016). 
However, in light of a relatively maintained BP, CBFV has also been show to decrease during a tilt-test  
(Novak P. 2016) and OxHb has been shown to decrease during an active stand  (Mehagnoul-Schipper 
D.J. et al. 2001).  This suggests that although posture related reductions in BP can likely indicate 
cerebral hypoperfusion some older adults may experience cerebral hypoperfusion despite a relatively 
maintained BP.  
Considering the signs of hypoperfusion during late walking in the low-tSO2 group it is 
uncertain how cerebral perfusion responds beyond the 1-minute of walking observed in the current 
study. The trends of the oxygenated and deoxygenated hemoglobin signals recorded by near infrared 
spectroscopy (Figure 4-5) indicate that cerebral hypoperfusion might persist.  Future longer-term 
studies should investigate cerebral oxygenation over longer periods and assess any relationships to 







Cerebrovascular hemodynamics and gait strategies  
In the previous larger study presented in Chapter 3, higher tSO2 was associated with better 
postural stability. The current study has identified differences in tSO2 among older adults during 
walking (Figure 4-2), which were associated with abnormalities in gait strategies (Figure 4-7).  Gait 
cycle variability, also referred to as step-step variability, is a predictor of multiple falls in older adults  
(Callisaya M.L. et al. 2011) and has previously been correlated to CBFV in young adults on a treadmill 
while performing a cognitive task  (Gatouillat A. et al. 2015). The current study is the first to evaluate 
gait variability during over-ground walking in older adults while simultaneously recording 
cerebrovascular hemodynamics. Step-step variability (gait variability), was significantly greater in the 
low-tSO2 group during early walking compared to the high-tSO2 group during the supine-walk 
condition (Figure 4-7).  Additionally, stance time variability was greater in the low-tSO2 group during 
the supine-walk condition for early walking (Figures 4-7). Although the low-tSO2 group had a lower 
group effect of tSO2 and higher group effect of TotHb, OxHb and DeoxHb compared to the high-tSO2 
group, it appears as though most of the group differences are driven by the changes observed in the 
supine-walk condition (Figure 4-5). Likewise, the group differences in gait variability are most 
predominant and only significant during the supine-condition as well (Figure 4-7).  Additionally, other 
compromised gait characteristics marked by increased stance time and gait cycle time during the 
supine-walk condition were significantly associated with increased OxHb (Figure 4-8).  It is important 
to note that OxHb was also significantly higher in the low-tSO2 group suggesting participants with 
lower tSO2 during walking are also more likely to have increased mean stance time and mean gait 
cycle time.  
Slower gait speed at usual pace is a risk factor for falls, mortality, institutionalization, disability 
and cognitive impairment in older adults  (Abellan van Kan G. et al. 2010).  Although there were no 




variables which were found to be associated with tSO2 (Table 4-2).  As mentioned above, an increase 
in OxHb (found in the low-tSO2 group) was associated with increased mean stance time and gait cycle 
time (Figure 4-8), and increased gait cycle time and mean stance time were also significantly (p<0.05) 
correlated (-0.553 and -0.597) to reduced gait speed (Table 4-2).  Therefore, older adults with lower 
tSO2 have higher OxHb which is associated with compromised gait features (increased mean gait cycle 
time and stance time) which are also associated with reduced gait speed. Low CBF (Ezzati A. et al. 
2017; Robertson A.D. et al. 2010b) and impaired endothelial function, marked by sVCAM-1 and 
cerebrovascular reactivity to carbon dioxide (Tchalla A.E. et al. 2015; Sorond F.A. et al. 2010), have 
been reported to be associated with slow gait speed. It is speculated that the areas of the brain which 
control motor function may be exposed to cerebral hypoperfusion or dysregulation, thus contributing 
to reduced gait speed. As mentioned above, a decrease in Qi would contribute to decreased CBF in 
older adults  (Bronzwaer A.G.T. et al. 2017).  With age, greater oxygen consumption is required to 
perform activities of daily living  (Avlund K. 2010) and measures of perceived fatigability have been 
associated with increased cost of oxygen during walking  (Barbosa J.F. et al. 2016). It has been 
suggested that older adults attempt to maintain their fatigue within a comfortable range by 
modulating their levels of physical activity  (Alexander N.B. et al. 2010; Eldadah B.A. 2010).  Therefore, 
an older adult with a reduced Qi and cerebral hypoperfusion would likely feel fatigued and 
consequently modulate their self-selected gait speed to return to a comfortable range of exertion.   
Slower gait speed is also a predictor of frailty  (Abellan van Kan G. et al. 2010). Various definitions of 
frailty exist which include the assessment of physical (ex. inactivity, gait speed, weight loss, 
exhaustion, grip strength) (Fried L.P. et al. 2001), psychological and social attributes (Uchmanowicz I. 
et al. 2017; Fried L.P. et al. 2001); however all frailty indexes and definitions agree that frailty consists 
of the cumulative deficits of multiple systems which result in vulnerability to adverse outcomes 




thesis it has been associated with age related changes in BP, such as orthostatic hypotension  (Ooi 
W.L. et al. 1997) and thus could likely be an underlying condition which contributes to the observed 
cerebral hypoperfusion and poor dynamic postural control during walking in the low-tSO2 participants.  
Vascular stiffness and its associations to cerebrovascular hemodynamics and gait strategies 
Central arteries are structurally built to be highly elastic allowing for distension and recoiling 
of the vessel wall to reduce the pulsatile pressures ejected from the heart. Arterial stiffening is a 
natural consequence of aging, but the rate of increase in stiffness does vary between individuals  
(Gepner A.D. et al. 2014). Increased arterial stiffness lowers the cushioning effect of the arterial 
waveform and increases pulsatility, exposing cerebral tissue to excessive pressures, and consequently 
impacting cerebrovascular hemodynamics  (Mitchell GF 2008; Webb A.J. et al. 2012).  The current 
study found various measures of reduced CBF at rest and during walking to be significantly correlated 
with increased vascular stiffness (Figure 4-9 and Table 4-3). Increased EDV at rest was correlated to 
reduced carotid pulse pressure (r= -0.527, p=0.03), as well increased EDV while walking was correlated 
to increased carotid distensibility coefficient (r=0.511, p=0.036). Increased CVRi while walking was 
correlated to increased central diastolic blood pressure (r=0.582, p=0.037, Figure 4-9 and Table 4-3). 
These relationships suggest stiffer arteries are associated with reduced CBF (EDV) and altered 
cerebrovascular hemodynamics (CVRi) during over-ground walking. These findings are supported by 
Robertson et al. 2010 who reported increased vascular stiffness to be associated with lower resting 
CBF and higher resting CVRi  (Robertson A.D. et al. 2010a).  Increased vascular stiffness, marked by 
increased central pulse pressure by the Mobil-O-Graph, was associated with reduced gait speed during 
the supine-walk (r= -0.386, p=0.069) and the sit-walk (r= -0.446, p=0.033) conditions (Figure 4-10). 
Cumulatively, these results suggest increased vascular stiffness is associated with low CBF while 






Some limitations must be mentioned. This is an exploratory study whereby statistical power 
was low, meaning the probability of making a type II error (suggesting something is not there when it 
is) is high. Not only was there a low sample size but there were large inter-individual variations in 
response to walking. The sub-sample of participants in the current study had too small of a sample 
size which lacked a natural spread of data to allow for k-cluster analyses.  
The relationship between the two experiments lacked consistency between baselines, nadir 
and upright posture values of tSO2.  The baseline tSO2 values had similar ranges between experiments 
but were not significantly associated with one another. Effects of circadian rhythm on tSO2 in young 
adults have been shown to impact intra-individual variations of tSO2 as much as 4.32±1.76% (p<0.001 
between evening and morning  (Metz A.J. et al. 2013). It has also been found that tSO2 absolute values 
separated by 5-months have a cross correlation coefficient of 0.8 in older adults  (Hallacoglu B. et al. 
2012). The differences in time between the two experiments was on average 7.3 months and thus the 
differences observed in baseline tSO2 between experiments could be attributed to changes in 
medication (3 participants went off a BP lowering medication and 4 participants went on a BP 
lowering medication between experiments). The observed differences in tSO2 values at nadir and 
initial standing vs. early-walking would inherently differ because of the task at hand. The muscle pump 
with walking would likely impact both the nadir and early walking tSO2 values compared to a static 
stand.  
It was not possible to monitor arterial or end-tidal CO2 during the older adult studies. As CO2 
plays a major role in regulation of CBF, this is an important limitation, and it is not known how 
hyperventilation might have contributed to cerebral hypoperfusion. 
The estimated SV and subsequently Q derived from the Modelflow contour analysis 




has been recently reported that the Modelflow method does not accurately estimate SV during 
dynamic changes in SV, particularly during orthostatic stress  (Gibbons T. 2017).  
The prevalence of fallers reported (retrospectively 15%, prospectively 26%) are lower than 
population studies report (33.3%) (Tromp et al. 2001), therefore falls may be underestimated or the 
population selected may not be representative of a typical older adult population.  
 
Conclusions 
The novelty of this study lies in the simultaneous collection of cerebrovascular hemodynamics 
and gait variables during over-ground walking in older adults.  It can now be reported that a sub-
population of older adults are at increased risk of low tSO2 with walking and that individuals with 
reduced tSO2 have increased step-step variability, a predictor of future falls.  Complementary to these 
findings are the fact that older adults with stiffer arteries also have reduced CBF during walking, 
altered cerebrovascular hemodynamics while walking and slower gait speeds. These results describe a 
condition wherein some older adults are repeatedly exposed to cerebral hypoperfusion during 1-
minute of walking which is a constant act of daily living. Therefore, older adults with cerebral 




Tables and Figures 
 
Table 4-1: Subject Characteristics  






Age, years 87.5±5.0 84.7±5.6 N.S. 
Sex (women), % (n) 67 (12) 50 (4) N.S. 
BMI (kg/m2) 27.3±4.4 25.1±4.1 N.S. 
Height (cm) 161.4±8.4 165.4±8.4 N.S. 
Weight (kg) 71.4±12.9 69.0±14.3 N.S. 
BSA (m2) 1.75±0.19 1.76±0.21 N.S. 
Limb length (cm) 74.1±3.5 75.6±3.4 N.S. 
TBW (L), (n=13, n=6) 28.3±5.4 28.7±4.7 N.S. 
Brachial SBP (mmHg) 141±24 132±18 N.S. 
Brachial DBP (mmHg) 69±11 59±17 0.085 
Brachial MAP (mmHg) 93±13 83±11 0.071 
Current self-reported fear of falling (scale 0 to 10) (n=16, n=8) 3.06±3.04 2.13±2.17 N.S. 
Current self-reported balance confidence (scale 0-10) (n=16, 
n=8) 
5.13±2.94 4.88±2.95 N.S. 
Retrospective fallers within 6-months before data collection 
(past falls), % within group (n) 
6 (1) 13 (1) N.S. 
Prospective fallers within 6-months after data collection 
(future falls), % within group (n) 
11 (2) 25 (2) N.S. 
Combined gait speed slow: <0.6 m/s, % (n) 11 (2) 13 (1) N.S. 
Combined gait speed mildly abnormal: 0.6 – >1.0 m/s, % (n) 50 (9) 75 (6) N.S. 
Combined gait speed normal: 1.0 - > 1.3 m/s, % (n) 39 (7) 13 (1) N.S. 
Combined gait speed fast: ≥1.3 m/s, % (n) 0 (0) 0 (0) N.S. 
Mobil-O-Graph Data     
     Central SBP, mmHg (n=16, n=7) 129±20 110±16 0.039 
     Central DBP, mmHg (n=16, n=7) 85±13 72±14 0.042 
     Central PP, mmHg (n=16, n=7) 44±11 38±12 N.S. 
     Augmentation Index @75 [90%CI], %, (n=16, n=7) 36.0±13.9 28.1±17.4 N.S. 
     Augmentation Pressure, mmHg, (n=16, n=7) 20.1±10.7 16.3±6.4 N.S. 
     Reflection Magnitude, (n=16, n=7) 65.7±8.7 65.3±7.3 N.S. 
     ePWV, (n=16, n=7) 13.9±1.7 12.8±1.5 N.S. 
Vascular Stiffness    
     cfPWV, (n=18, n=7) 9.48±1.68 8.00±1.58 0.057 
     Carotid pulse pressure (mmHg), (n=16, n=7) 53.5±15.5 56.9±19.9 N.S. 
     Compliance Coeff (mm^2/Kpa), (n=16, n=7) 0.466±0.160 0.646±0.531 N.S. 
     Distensibility Coeff (10^-3/Kpa), (n=16, n=7) 18.3±6.3 24.6±19.7 N.S. 
     Intimal-medial thickness (cm), (n=17, n=8) 0.086±0.020 0.093±0.025 N.S. 
Physical Activity (Self-report questionnaire)    
          Sedentary, % (n) 33 (6) 63 (5) N.S. 
          Active, % (n) 50 (9) 38 (3) N.S. 




Past Health (Self-report questionnaire)    
     Heart attack, % (n) 17 (3) 13 (1) N.S. 
     Heart failure, % (n) 0 (0) 13 (1) N.S. 
     Open heart surgery, % (n) 6 (1) 0 (0) N.S. 
     Congenital heart disease, % (n) 0 (0) 0 (0) N.S. 
     Atrial Fibrillation, % (n) 22 (4) 25 (2) N.S. 
     Carotid stenosis, % (n) 6 (1) 0 (0) N.S. 
     COPD, % (n) 11 (2) 0 (0) N.S. 
     Hypertension, % (n) 39 (7) 25 (2) N.S. 
     High cholesterol, % (n) 33 (6) 13 (1) N.S. 
     Sleep Apnea, % (n) 6 (1) 0 (0) N.S. 
     Emphysema/pneumonia, % (n) 0 (0) 25 (2) 0.086 
     Asthma/bronchitis, % (n) 0 (0) 13 (1) N.S. 
     Kidney/liver disease, % (n) 6 (1) 38 (3) N.S. 
     Smoking (never), % (n) 67 (12) 50 (4) N.S. 
     Smoking (ex-smoker), % (n) 28 (5) 38 (3) N.S. 
Current Health (Self-report questionnaire)    
     Irregular heart beat, % (n) 17 (3) 13 (1) N.S. 
     Chest pain, % (n) 6 (1) 0 (0) N.S. 
     Persistent cough, % (n) 0 (0) 13 (1) N.S. 
     Wheezing/shortness of breath, % (n) 22 (4) 13 (1) N.S. 
     Memory complaints, % (n) 17 (3) 0 (0) N.S. 
     Fatigue (general) , % (n) 17 (3) 13 (1) N.S. 
     Headaches, % (n) 0 (0) 0 (0) N.S. 
     Dizziness/light-headedness, % (n) 28 (5) 13 (1) N.S. 
     Any pain (all recorded lower back pain other than one 
person in poor group reported leg pain), % (n) 
17 (3) 25 (2) N.S. 
Medications     
     Aldosterone antagonist % (n) 6 (1) 25 (2) N.S. 
     Alpha adrenoreceptor antagonist % (n) 6 (1) 25 (2) N.S. 
     Angiotensin receptor blocker % (n) 11 (2) 25 (2) N.S. 
     ACE inhibitor % (n)  17 (3) 13 (1) N.S. 
     Beta blocker % (n) 28 (5) 25 (2) N.S. 
     Calcium channel blocker % (n) 33 (6) 25 (2) N.S. 
     Proton pump inhibitor % (n) 44 (8) 38 (3) N.S. 
     Polypharmacy (≥ 3 different types of BP lowering meds) % 
(n) 
11 (2) 25 (2) N.S. 
BMI body mass index, BSA body surface area, TBW total body water, BP blood pressure, SBP systolic 
BP, DBP diastolic BP, MAP mean arterial pressure, combined gait speed equals the average of supine-
walk and sit-walk gait speeds, PWV pulse wave velocity, cfPWV carotid-femoral PWV, CPOD chronic 




Table 4-2: Pearson Product-moment correlations between gait speed and gait characteristics 








Mean gait cycle time early -0.553 0.003 -0.514 0.007 
Mean stance time early -0.597 0.001 -0.561 0.003 
Mean fractional stance time early -0.569 0.002 -0.595 0.001 
Mean gait cycle time late -0.522 0.006 -0.638 0.000 
Swing variability late 0.419 0.037  N.S. 
Mean stance time late -0.528 0.006 -0.688 0.000 
Mean fractional stance time late -0.522 0.006 -0.574 0.002 
SD fractional stance time late 0.437 0.029  N.S. 









Condition Time r-value p-value n 
carotidPP EDV Supine-walk Baseline -0.527 0.030 17 
cDC MFV Supine-walk Baseline 0.503 0.040 17 
cDC EDV Supine-walk Early walk 0.511 0.036 17 
cDBP CVRi Supine-walk Early walk 0.582 0.037 13 
cfPWV Deox Supine-walk Early walk -0.613 0.001 25 
cDC EDV Supine-walk Late walk 0.511 0.036 17 
cfPWV Deox Supine-walk Late walk -0.663 0.000 25 
EDV end diastolic velocity, MFV mean flow velocity, uration, DeoxHb deoxygenated hemoglobin, PP 





B.                 C. 
D. 
Figure 4-1: Gait analysis. 
 
A) Gait cycle time: represents 
the time from toe-off (blue x) 
to toe-off (blue x).  
 
B) Swing time: represents the 
time from toe-off (blue x) to 
heel strike (green x).  
 
C) Stance time represents the 
time from heel strike (green x) 
to toe off (blue x).  
 
D) Fractional mid-heel swing: 
represents the fraction of time 
from toe off (blue x) to mid 
swing (red x) divided by gait 
cycle time (A).  
 
E) Fractional stance time is the 
stance time (C) divided by gait 
cycle time (A).  
The mean and standard 
deviation of all the gait 
variables listed above were  
 
F) calculated during the 
approximate 25-second early 
and late walking intervals.  The 
standard deviation values 
represent variability of a gait 
variable.  
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Figure 4-2: Cerebrovascular hemodynamics and gait dynamics in a single high- and low-tSO2 
participant. Cerebrovascular response, accelerometer monitored walking response, and calculated 
gait cycle time variability, stance time variability, and gait speed in a single high-tSO2 participant and a 
single low-tSO2 participant.  Cerebral oxygenation (tSO2, A) and cerebral mean flow velocity (MFV, B) 
responses to a supine-walk transition in a typical regulator and impaired-regulator. Raw summation 
and filtered data from the 3-axis accelerometer are shown for individuals in the high-tSO2 group (C) 
and low-tSO2 group (D) during the late period walking for the supine-walk transition. Resulting values 




gait cycle time variability (E) and stance time variability (F) during the supine-walk condition for both 






       
 
 
Figure 4-3: Between experiment comparisons of cerebral oxygenation. Pearson Product-moment 
correlations were run between two experiments, the supine-stand for these same individuals 
measured during the previous study (Chapter 3) and the supine-walk. Baseline value represents a 30-
second supine resting average, nadir marks the lowest 3-beat (supine-stand) or 1-beat (supine-walk) 
value following the posture transitions, initial stand is a 20-second average from 2 to 22 seconds after 
upright posture (supine-stand), early walk is ~25-second average starting from the beginning of the 
fourth step (supine-walk).  One participant was removed from the between experiment correlation 













Figure 4-4: Cardiovascular responses to a supine-walk and sit-walk transition. Time at zero marks the 
first toe-off ankle movement, negative time represents rest and active transition. Black filled circles 
mark mean values of second-by-second data of high-tSO2  group (HR: n=18; SVi, Qi, TPRi: baseline 
n=13, nadir n=4, early and late walk n=13, BP: baseline n=14, nadir n=5, early and late walking n=14); 
white circles mark the postural response of the low-tSO2 group (HR: n=8; SVi, Qi, TPRi, BP: baseline 
n=7, nadir n=2, early and late walk n=5).  MAP mean arterial pressure, Qi cardiac output index, SVi 










Figure: 4-5: Cerebrovascular responses to a supine-walk and sit-walk transition. Time at zero marks 
the first toe-off ankle movement, negative time represents rest and active transition, positive time 
represents walking. Black filled circles mark mean values of second-by-second data of high-tSO2 group 
(NIRS data n=18, CBF data: baseline n=10, nadir n=5, early and late walking n= 11); white circles mark 
the postural response of the low-tSO2 group (NIRS data n=8, CBF data: baseline n=6, nadir n=2, early 




CVRi cerebrovascular resistance index, tSO2 cerebral tissue saturation, TotHb total hemoglobin, OxHb 






Figure 4-6: Cerebral blood flow and oxygenation. Pearson Product-moment correlations between TCD 
and cerebral oxygenation (tSO2) during supine-walk condition. PSV peak-systolic velocity, EDV end-








Figure 4-7: Gait variability between groups. Gait cycle variability (A) and stance time variability (B) 
during early and late walking of a supine-walk transition (p=0.037 and p=0.008 respectively). Black 
filled bars mark mean values and standard deviation data of the high-tSO2 group (n=17); grey bars 






Figure 4-8: Cerebral oxygenation and gait dynamics. Pearson Product-moment correlations between 
cerebrovascular hemodynamics and gait characteristics during the supine-walk condition. OxHb 









Figure 4-9: Cerebrovascular hemodynamics and vascular stiffness. Pearson Product-moment 






Figure 4-10: Vascular stiffness and gait speed. Pearson Product-moment correlations between gait 






 CHAPTER 5. GENERAL DISCUSSION 
It is estimated that a third of older adults fall each year (Tromp et al. 2001), having devastating 
impacts on a person’s quality of life  (Statistics Canada 2011b)  (Cumming R.G. et al. 2000).  Although 
the causes of falls are multifactorial, orthostatic hypotension is considered an independent risk factor 
for future falls, unexplained falls and injurious falls  (Finucane C. et al. 2017).  Posture related 
reductions in BP and CBF typically recover in a supine to stand maneuver within 30-s however in some 
older adults BP does not fully recover  (Romero-ortuno R. et al. 2011) and thus cerebral perfusion may 
not be maintained.  Yet the relationships between CBF and oxygenation (tSO2) to postural control, gait 
dynamics and fall history have not previously been investigated. This thesis examined i) the 
cerebrovascular response to various posture transitions while simultaneously recording measures of 
postural stability as well as ii) the relationships between cerebrovascular hemodynamics and gait 
strategies during different transitions into walking. Measures of vascular stiffness were a part of this 
thesis to identify if stiffer vessels, indicative of vascular aging  (Laurent S. 2012; Mitchell GF 2008; 
Webb A.J. et al. 2012), are related to cerebral hypoperfusion and compromised gait characteristics. 
Retrospective and prospective fall history reports were also collected for both studies to identify any 
relationships between cerebral hypoperfusion and falls in older adults. A supplementary component 
of this thesis was a proof of principle study in young adults whereby manipulating both arterial blood 
pressure and CBF velocity (CBFV) allowed the quantitative assessment of changes in postural stability 
as a function of tSO2.  
 
Primary Findings  
Posture related reduction of tSO2 during a supine-stand transition in older adults (69-100 
years old) resulted in varied responses (Chapter 3). A sub-population of older adults (impaired-




compared to older adults (regulators) with higher levels of tSO2 upon standing (Figure 3-4). It was also 
found that when going from supine to standing, a 10-s sitting pause time was enough time to improve 
tSO2 and postural stability in older adults from the sub-population with hypoperfusion (Figure 3-4). 
The prospective 6-month falls follow-up revealed that older adults with lower tSO2 upon standing had 
a trend for increased risk of a future fall (4 of 15 participants had a fall) compared to older adults with 
a higher tSO2 (6 out of 62 participants had a fall).  
When transitioning from a supine position into walking (Chapter 4) older adults (71-101 years 
old) demonstrated varied tSO2 recovery responses. A sub-population of older adults was identified to 
have lower tSO2 (Figures 4-2 and 4-5) during walking and these same individuals had increased step-
step variability (Figures 4-7), a predictor of falls in older adults  (Callisaya M.L. et al. 2011). 
Associations between increased arterial stiffness with reduced CBF and slower gait speeds were 
established.   
 
Rationale for intervention study in young adults 
The associations reported in Chapters 3 and 4 between cerebral oxygenation, postural 
stability and gait characteristics suggested that reduced delivery of oxygen to the brain was associated 
with poorer stability and gait patterns. It was not possible to manipulate cerebral oxygen delivery in 
these older adults, so a supplementary study (Supplement) was conducted to test this association.  
With the application of a double-thigh cuff occlusion and hyperventilation, CBFV was quantifiably 
reduced in young adults (20-33 years old) during a transition to standing posture. The magnitude of 
change of CBFV was assessed alongside changes in postural stability. Not all participants responded to 
the stimulus in the same way which allowed for a group comparison. Individuals who had significantly 
and progressively lower CBF (marked by increased CBFV deficit) across conditions, also had 




findings from the supplementary study in young adults can be extended to the results involving older 
adults (Chapters 3 and 4).  Quantifiable reductions in CBF follow the same time course and magnitude 
of reduced postural stability in young adults. Therefore, data obtained from the young adults can be 
used to interpret the associations made between cerebral hypoperfusion with reduced postural 
stability and compromised gait patterns in older adults.  
 
Significance   
The causes of falls are multifactorial however the associations of cerebral hypoperfusion to 
postural instability and increased step-step variability is a novel finding and the literature implicates 
poor balance control to an increased risk of having a future fall in older adults  (Muir S.W. et al. 2010; 
Berg K.O. et al. 1992; Callisaya M.L. et al. 2011). Falls in older adults can contribute up to 85% of all 
injury-related hospitalizations, 40% of nursing home admissions and approximately 20% of deaths due 
to injury  (Statistics Canada 2011b). Falls also impact balance confidence and fear of falling leading to 
reduced involvement in activities, further reducing strength and flexibility and increasing fall risk and 
lowering quality of life  (Cumming R.G. et al. 2000).   
A secondary consequence of cerebral hypoperfusion is its impact on cognition. Young adults 
(29±7 years old) with hypotension have demonstrated longer execution times during attentional tasks, 
reductions in accuracy during sustained attention tasks and working memory tasks compared to 
normotensives  (Duschek S. et al. 2005). Hypotensive older adults who additively experience 
orthostatic hypotension demonstrate increased odds of having a cognitive impairment  (Yap P.L. et al. 
2008). Mild cognitive impairment and dementia have been shown to predict reduced quality of life in 
older adults  (Kuo L.M. et al. 2017).  Thus, older adults with cerebral hypoperfusion, such as the 
participants in the sub-population of the current investigations, may be at risk of cognitive impairment 




It is noteworthy to point out that although not significant, when separating participants based 
on a cut off of tSO2 ≤ 60% while walking, the low-tSO2 group had a lower tSO2 at baseline, nadir and 
during initial standing and late walking (Figure 5-1). Similarly, there were trends for reduced cSBP and 
significantly reduced cDBP in the low-tSO2 group (Figure 5-2). This suggests that even though the 
criteria to split participants between experiments differed and regressions between experiments were 
not significant (Figure 4-3), both experiments yielded similar results of a reduced tSO2 in one of the 
groups.  
Finally, during the supine-walk experiment (Chapter 4) older adults with reduced tSO2 had 
increased step-step variability (Figure 4-7) and had increased OxHb (Figure 4-5). Older adults with 
increased OxHb also had increased mean stance time and mean gait cycle time (Figure 4-8).  Increased 
gait cycle time and mean stance time were significantly correlated to slower gait speed (Table 4-2). It 
was also found that older adults with stiffer arteries had lower CBF while walking and slower gait 
speeds. Increased vascular stiffness has been associated with reduced CBFV, increased vascular 
resistance  (Robertson A.D. et al. 2010a), cerebral small vessel disease  (Henskens L.H. et al. 2008) as 
well as cognitive impairment and cognitive decline  (Zeki Al Hazzouri A. et al. 2013). Although the 
relationship between reduced CBF and tSO2 were not directly linked to reduced gait speed, these 
findings suggests older adults with lower tSO2 are more likely to have compromised gait strategies 
which is associated with increased likelihood of having a future fall. Furthermore, older adults who 
have reduced tSO2 and higher OxHb with walking are more likely to have advanced vascular aging 
which is associated with reduced CBF, slower gait speed, and according to the literature an increased 







Some limitations to this thesis are:  
i) The studies involving older adults were under powered and this was in part due to the large 
variation in cerebrovascular and cardiovascular responses to a posture transition in older 
adults. Despite including n=77 and n=27 participants the low sample sizes increased the 
likelihood of making a type II error.  
ii) The nature of a cross-sectional study design prevents conclusions to be made on causal 
relationships. Therefore, it cannot be established that cerebral hypoperfusion is causing 
impaired stability or increased gait variability but rather associations are made.  
iii) The exclusion criteria rejected any participants who had a stroke, diabetes, neurological or 
neuromuscular disorder. These boundaries limit the generalizability of the results as the 
participant sample included no longer represents population norms.  
iv) The prevalence of fallers reported (Chapter 3: 10% retrospectively, 13% prospectively, Chapter 
4: retrospectively 15%, prospectively 26%) are lower than population studies report 
(33.3%) (Tromp et al. 2001), therefore falls may be underestimated or the population that 
volunteered to participate in this study was a generally healthier group of older adults 
than previously reported.  
v) The study protocols involved only a single performance of each condition all taken on a single 
day/time of day, where the orthostatic responses are known to be variable; this suggests a 
different response could be rendered on a different day/time  (Vara-Gonzalez L. et al. 
2006).  
vi) Cerebral blood flow velocity was not collected on the n=77 participants (Chapter 3); this 




is a qualitative indicator of cerebral blood flow that can be affected by variations in 
diameter of the middle cerebral artery.   
vii) It was not possible to monitor arterial or end-tidal CO2 during the older adult studies. As CO2 
plays a major role in regulation of CBF, this is an important limitation, and it is not known 
how hyperventilation might have contributed to cerebral hypoperfusion.  
viii) Potential neuromuscular contributions to gait speed and variability were not measured in the 
current study; it is possible that these factors contributed independently to between 
group differences. The low tSO2 observed in some participants in this study might have 
reflected a chronic cerebral hypoperfusion which could have independently affected 
neural gait control. 
ix) Other mechanisms, such as i) an insufficient muscle pump and thus reduced SV ii) impaired 
baroreflex regulation and iii) monitoring of CBF in areas of the brain not fed by the middle 
or anterior cerebral artery, were not evaluated and could influence cerebral 
hypoperfusion data. 
x) The estimated SV calculated by the Modelflow algorithm of the plethysmography devices 
integrates a three-element model of arterial impedance with the arterial pressure wave to 
reliably track beat-to-beat differences in stroke volume during rest  (Harms M et al. 1999).  
However, recent data suggests the Modelflow method does not accurately estimate SV 
during dynamic fluctuations in SV, such as during orthostatic stress  (Gibbons T. 2017).  
 
Future directions  
The supine-stand and supine-walk experiments (Chapters 3 and 4) could be extended to 
include a larger sample size, PETCO2 collection, as well as CBFV for the supine-stand experiment. By 




be better understood; For example, a larger sample size in Chapter 4 would allow further investigation 
of changes in BP and SV. Gathering additional information of SV to the current walking results (Figure 
4-4) would lend further insight about muscle pump activity and BP regulation. The gained knowledge 
by adding PETCO2 would help identify why some participants experienced hypoperfusion.  Providing a 
second measure of cerebral perfusion (CBFV) to the supine-stand experiment would allow for 
supplementary comparisons between experiments and assist in strengthening any current findings as 
CBFV is widely used and is a highly studied marker of CBF in the literature. New technologies such as 
three-dimensional ultrasound imaging could be added to assist in diagnosis of vascular abnormalities 
associated with aging (ex. Stenosis and turbulent flow patterns). These additions to the current thesis 
would confirm the tentative conclusions already established and expand on understanding the 
underlying mechanisms associated with cerebral hypoperfusion. 
The sit-stand and sit-walk conditions (Chapters 3 and 4) appear to be somewhat protective to 
tSO2 reductions in comparison to the supine to stand or walk tests (Figures 3-3 and 4-5). Tukey’s HSD 
test indicated that the sit-stand condition was the only condition which did not have group differences 
in delta tSO2 (Figure 3-4). Although not significant, the sit-walk condition demonstrate similar NIRS 
signal responses between groups and group differences in gait variability were only evident during the 
supine-walk condition. A future direction of work would be to i) investigate the mechanism for 
increased tSO2 during the sit conditions, ii) investigate if the lower tSO2 impacts cognition, and iii) 
investigate other modalities to increase tSO2 in a similar fashion (e.g. apply external leg compression 
or provide a hyperoxic environment). These latter experiments could extend into the study of younger 
adults in the Supplement to determine if acute changes in cerebral oxygenation could impact postural 
stability. 
The older adults with low tSO2 in Chapter 3 had a significantly higher prevalence of HF.  HF has 




reductions in CBF velocity while upright compared to age and sex matched controls  (Fraser K.S. et al. 
2015).  Therefore, this may be a sub-population of participants who are at increased risk of cerebral 
hypoperfusion with upright posture (both standing and walking) and at increased risk of postural 
instability and/or increased step-step variability. Therefore, future work should be directed towards 
investigating the relationships between cerebral hyoperfusion, gait strategies, falls and cognition in 
individuals with HF. 
Analysis on the supine-walk experiment could be extended to investigate delta responses 
between early and late walking (cerebrovascular hemodynamics and gait strategies) as well as using 
functional data analysis to compare i) CBFV and tSO2 and ii) cerebral perfusion and step-step 
variability on a continuum versus using discrete data points seen in the current thesis.  
Future studies could also be extended to testing stability once a participant has already 
invoked cerebral hypoperfusion; for example, during a double thigh cuff plus hyperventilation 
condition a perturbation could be exerted 2-s after upright posture has occur. This would test the 
ability of a participant to maintain postural stability in light of cerebral hypoperfuion.  Likewise, for an 
older adult following 1-minute of walking a stand test could be performed to evaluate postural 
stability following extended upright posture experience cerebral hypoperfusion.  
 
General Conclusions 
When transitioning to standing or walking, older adults demonstrated varied cerebrovascular 
responses. Older adults with significantly lower cerebral oxygenation had poorer postural stability, 
increased step-step variability and an increased likelihood of having a future fall.  A brief sitting-pause 
time before standing can improve cerebral oxygenation and postural stability. Older adults with stiffer 
arteries have lower CBF and altered cerebrovascular hemodynamics while walking as well as reduced 




provided evidence of a link between tSO2 and postural instability providing supportive evidence that 
postural instability in the older adults might have been caused by the lower tSO2 and CBFV.  In 
conclusion, this research found significant relationships between cerebral hypoperfusion, postural 
instability and compromised gait strategies. These changes might be placing some older adults at an 






















Tables and Figures 
 
 
Figure 5-1: Comparison between experiments for cerebral oxygenation (tSO2) values at baseline, nadir 
and upright standing/walking. Participants in the current graph are from the supine-walk experiment 
(Chapter 4). However, the tSO2 values are from baseline, nadir and initial-standing of the supine-stand 
condition (Chapter 3) and the baseline, nadir and early-walking tSO2 values form the supine-walk 
condition (Chapter 4). The classification of high- and low-tSO2 groups used in the supine-walk 
experiment (Chapter 4) was used again here for between experiment comparisons.  Black filled bars 
mark mean values and standard deviation data of high-tSO2 group (baseline and nadir: n=17, initial 
stand/early-walk n=18); grey bars mark mean values and standard deviation data of the low-tSO2 
group (n=8). Mixed model repeated measures ANOVA revealed a significant interaction for baseline, 
nadir and initial stand/early-walk (p=0.012, p=0.034 and p=0.009 respectively). Tukey’s HSD identified 
significant (p<0.05) differences are between the high- and low-tSO2 groups during the supine-walk 







Figure 5-2: Between experiment comparisons for central blood pressure. Central systolic and diastolic 
blood pressure (cSBP, cDBP) during supine rest of the supine-stand (Chapter 3) and supine-walk 
(Chapter 4) experiments. Participants in the current graph are from the supine-walk experiment 
(Chapter 4). However, the tSO2 values are from baseline, nadir and initial-standing of the supine-stand 
condition (Chapter 3) and the baseline, nadir and early-walking tSO2 values form the supine-walk 
condition (Chapter 4). The classification of high- and low-tSO2 groups used in the supine-walk 
experiment (Chapter 4) was used again here for between experiment comparisons. Black filled bars 
mark mean values and standard deviation data of high-tSO2 group (n=15); grey bars mark mean values 
and standard deviation data of the low-tSO2 group (n=7). Mixed model repeated measures ANOVA 
revealed a trend for cSBP to have group differences (p=0.067, marked as*) and cDBP to have a 





SUPPLEMENT. Acute reductions in cerebral blood flow affect postural stability 
in young adults  
 
Introduction 
The transition from supine to standing posture causes a transient, sometimes substantial, 
reduction in blood pressure (BP)  (Franke W.D. et al. 2006). In the Irish Longitudinal Study on Aging 
with 4475 adults over 50 years of age, initial orthostatic hypotension was found in 33% of the 
population, and orthostatic hypotension increased in prevalence from 7 – 18% as the population aged  
(Finucane C. et al. 2014) Importantly, impaired BP stabilization, requiring longer than 30s, also 
increased with age to over 40%  (Finucane C. et al. 2014). Although cerebrovascular autoregulation is 
largely effective in restoring cerebral blood flow (CBF) with transitions from supine to upright posture  
(Lipsitz L.A. et al. 2000), acute and prolonged reductions in BP on standing might be associated with 
cerebral hypoperfusion  (Edlow B.L. et al. 2010; Mehagnoul-Schipper D.J. et al. 2000b; Gutkin M. & 
Stewart J.M. 2016). A reduction in CBF large enough to cause postural instability is alluded to in the 
literature  (Shaw B.H. & Claydon V.E. 2014; van Wijnen V.K. et al. 2017; Lipsitz L.A. 1985; Hossain M. et 
al. 2001; Shaw B.H. et al. 2015) yet the direct link between changes in cerebral oxygenation and 
changes in postural control have not been investigated. 
Impaired postural control might be related to regulation of BP and CBF as suggested by the 
observation that both elevated and low levels of resting supine systolic BP are independent risk 
factors for postural instability during quiet standing  (Maciaszek J. et al. 2011).  A period of 
hyperventilation increased postural sway  (Sakellari V. & Bronstein A.M. 1997); this observation was 
probably related to reduced CBF, but no measurements were made of CBF or oxygenation (Sakellari V. 
& Bronstein A.M. 1997). 
To test a direct link between cerebral perfusion and postural stability, a repeated measures 




compared. The control condition had a rest to standing with no intervention. An additional challenge 
to BP regulation on standing was provided by 3-min bilateral thigh cuff deflation during the transition 
to standing. A third challenge added a period of hyperventilation during the supine period with thigh 
cuff occlusion, both of these interventions were stopped with standing. It was hypothesized that CBF 
would decrease on standing with greater reductions after the thigh cuff manipulation and the thigh 
cuff plus hyperventilation, and that a critical level of CBF deficit would be associated with increases in 
postural instability. 
 
Materials and methods 
Participant Description 
 Nineteen healthy young adults (10 females; age 26±4 years; height 172±6 cm; weight 71±13 
kg) gave written and informed consent to volunteer in the present study which was reviewed and 
approved by the Office of Research Ethics at the University of Waterloo. Participants were asked to 
refrain from exhaustive exercise and alcohol for 24 h before testing and caffeinated beverages for 12 h 
before testing. Participants arrived 2 h postprandial to testing where they completed a brief health 
questionnaire. The health questionnaire indicated that all participants were free of cardiovascular 
disease, 18 participants had never smoked (1 participant smoked 2 cigarettes/week) and 17 of the 
participants were active on a regular basis (minimum of 1-2 days/week). Total body water (TBW) was 
estimated using a body impedance analysis (MF-BIA QuadScan 4000: Bodystat LTD, Isle of Man, UK) 
with electrodes placed on the right wrist, middle finger, ankle and toe with the participant in a supine 







General Protocol  
All participants randomly completed three supine-stand transitions: i) control (CON), ii) thigh 
cuff deflation (TC), iii) thigh cuff deflation with hyperventilation (TC-Hyp). The three transitions were 
preceded by a practice transition (condition iii) to ensure tolerance of the test.  All transitions began 
with 10 min of supine rest, followed by a transition into the standing position with an assist to place 
the feet correctly for measurement of stability. Participants stood with feet together for 90 sec. Upon 
completion of the standing protocol participants were asked to rate their perceived pre-syncopal 
symptoms, if any, during the first 30 sec of standing. The pre-syncope symptoms were presented on a 
visual analog scale of 1 to 10 (1: no symptoms, 10: intolerable) for dizziness, visual or hearing 
disturbances, sweating, nausea, neck, back or precordial discomfort, palpitations, and fatigue  (Lewis 
N.C. et al. 2013; Thomas K.N. et al. 2009).  Cerebrovascular reactivity to carbon dioxide (CrCO2) was 
randomly conducted either before or after the completion of the posture transitions and the order of 
hypercapnic versus hypocapnic conditions was randomized.  
 
Double thigh cuff condition - The bladders of the thigh cuffs were placed over top of the femoral artery 
and inflated to 20mmHg above resting supine systolic BP for 3 min  (Kaya S. et al. 2011; Tiecks F.P. et 
al. 1995).  At the end of the 3 min inflation, during the transition from supine to standing, rapid 
deflation was achieved by a quick release valve.   
 
Double thigh cuff and hyperventilation condition - In addition to a double thigh cuff inflation/deflation 
protocol (above), participants were asked to hyperventilate for the final 90 sec of the supine thigh cuff 
inflation. Participants were asked to hyperventilate at 30 breaths/min and they were coached to alter 




et al. 2014). Participants were asked to breathe normally upon the commencement of the posture 
transition.  
   
Hemodynamics 
Continuous monitoring of heart rate (HR; electrocardiogram, Finapres Medical Systems, 
Amsterdam, The Netherlands), beat-beat arterial finger BP by plethysmography (Finometer Pro; 
Finapres Medical Systems, Arnheim, The Netherlands), and exhaled peak carbon dioxide (PETCO2; 
Roxon Medi-tech Ltd, St-Leonard QC, Canada) were recorded (1kHz) (PowerLab, ADInsturments, 
Colorado Springs, CO, USA) and processed (LabChart 7, ADInsturuments, Colorado Springs CO). 
Estimates of stroke volume, cardiac output, and total peripheral resistance (Finometer Pro; Finapres 
Medical Systems, Arnheim, The Netherlands) were normalized to body surface area  (DuBois D & 
DuBois EF 1916)(SVi, Qi and TPRi respectively).  
Cerebral blood flow was assessed by transcranial Doppler ultrasound (TCD) and near-infrared 
spectroscopy (NIRS). The TCD device with a 2-MHz transducer (TCD; Multigon Industries, Elmsford, NY, 
USA) continuously monitored CBF velocity (CBFV) in the middle cerebral artery. Offline analysis of 
CBFV included beat-to-beat averaging, gated to the ECG R-wave, where mean flow velocity (MFV), 
peak velocity (PSV), and minimum velocity (MV) for each beat were extracted for further analysis. 
Mean arterial pressure at the level of the middle cerebral artery (MAPmca=MAP – (distance above 
heart*0.78)) and the TCD velocity signal were utilized in the following calculations; cerebrovascular 
resistance index (CVRi=MAPmca/MFV)), resistance index (RI=[PSV-MV]/PSV), pulsatility index 
(PI=[PSV-MV]/MFV), and dynamic cerebral autoregulation (dCA= [(MFV(t2) – MFV(t1)) / MFV(t1)] / 
[(MAP(t2) – MAP(t1)) / MAP(t1)]), where t1 = nadir value and t2 = resting supine baseline. 
A NIRS device (NIRS; PortaLite, Artinis Medical Systems BV, Netherlands) was used to collect 




TotHb respectively) as well as cerebral oxygenation (tSO2=OxHb/TotHb). The NIRS device was placed 
over the prefrontal lobe in accordance with the international 10-20 EEG land marking system (right: 
Fp2, F4, F8.  left: Fp1, F7, F3) (Perrey S. 2008).  A source detector distance of 4 cm was used for the 
OxHb, DeoxHb and TotHb signals to reduce signal contamination from surrounding tissues  (Kohri S. et 
al. 2002). The NIRS signal was later processed into beat-by-beat data points where the mean, 
maximum, and minimum hemoglobin values were extracted from each beat.  
 
Time scale and averaging  
Resting baseline values were averaged over 30 sec of supine rest (from -45 sec to -15 sec prior 
to a transition or any cuff inflation). Time at zero seconds indicates upright posture. Nadir signifies the 
single lowest MV beat following upright posture.  Initial standing is characterized by a 10 sec average 
starting at nadir. Prolonged standing represents a 10 sec average from 50 sec to 60 sec after nadir (Fig. 
S-1).  
 
Cerebral blood flow deficit  
A cerebral blood flow deficit (Eq. 1) represents the amount of CBF which falls short of resting 
supine levels during a posture change. The CBF deficit is defined as the area above the curve from 
nadir (single lowest CBF MV beat following upright posture) to resting baseline values (along the y-
axis) and from nadir to recovery (first MV beat which exceeded resting baseline values or was no 
longer increasing) (along the x-axis). A larger area above the curve suggests a larger CBF deficit.  A 
delta CBF MV was also used to characterize the change in CBF from supine resting conditions (30 sec 






Eq. S-1 – Area above the curve:  
where  corresponds to the time point at nadir,  corresponds to the time point where the curve 
reached the resting baseline (i.e. recovery), and  corresponds to the spacing between 
consecutive time points. 
 
Cerebrovascular reactivity to carbon dioxide  
Cerebrovascular reactivity to carbon dioxide was assessed in the seated position during 
steady-state hypocapnia (hyperventilation) and hypercapnia (inhalation of a gas mixture: 5% CO2, 21% 
O2 and balanced nitrogen). Hyperventilation was achieved by increasing breathing rate (20 
breaths/min) and coaching participants to reduce exhaled CO2 (-10mmHg). Participants were asked to 
breathe normally for 3 min prior to and following hypo- and hypercapnic conditions. A three-way 
valve (Three-way T-shape Stopcock Type, Hans Rudolph) was secured to a 5-liter non-diffusing 
reservoir bag (Series 6000, Hans Rudolph, Shawnee, KS, USA) to allow for manual switching between 
the delivery of the gas mixture and room air. The gas sampling line from the CO2 analyzing device was 
secured to a disposable facemask covering the participant’s nose and mouth. Total CRCO2 
(hypercapnia – hypocapnia) was calculated by dividing the percentage change in CBF by the absolute 
change in PETCO2 [CRCO2 = [ (MFV(t2) – MFV(t1)) / MFV(t1) ∙ 100%] / (PETCO2(t2) – PETCO2(t1))] 
 
Postural Stability 
A single Nintendo Wii Balance Board (Nintendo, Koyoto, Japan) was used to collect (100Hz) 
center of pressure (COP) displacement. Bluetooth technology was used to wirelessly transmit the data 
from the Nintendo Wii Balance Board to a customized nearby software program (LabView, National 
Instruments, Austin TX USA). Postural stability measures were later analyzed alongside cardio- and 




Inc, Natick, MA, USA).  Stability data were analyzed in the anterior-posterior (AP), medial-lateral (ML) 
and combined AP + ML directions. Measures of postural stability were calculated as the root mean 
square (RMS; Eq. 2), total path length (TPL; Eq. 3c), TPL AP and ML (Eq. 3a and 3b), sway vector 
average (SV avg; Eq. 4), and SV standard deviation (SV SD; Eq. 5). Postural stability was calculated over 
a 10 sec average during initial standing (from nadir to 10 sec after nadir) and prolonged standing (from 
50 sec to 60 sec). The initial standing was chosen to start at nadir as this aligns with the CBF deficit and 
eliminates any initial overshoot responses in postural stability.  
 
Eq 2:  
where the resultant distance (RD) is the vector distance from mean COP to each point in either the ML 
or AP plane  (Prieto T.E. et al. 1996) 
Eq 3a:  
Eq 3b:  
Eq 3c:  
Eq 4:  
 
Statistical analysis 
Regressions were run in Sigmaplot version 12.5 (Systat Software Inc., San Jose, CA, USA), all 
other statistical analyses were completed using IBM SPSS version 20 (IBM SPSS Statistics 20; IBM Corp, 





 Participant Grouping- Not all participants responded to the manipulations by having a marked 
reduction of CBF. Therefore, participants were split into two groups (non-responders and responders). 
The non-responders group had a constant CBF deficit across conditions. Comparatively the responders 
group progressively increased their CBF deficit across CON, TC, and TC-Hyp conditions. A TwoStep 
cluster analysis (k-cluster) was used to automatically create the number of clusters (participant 
groups) and only a good cluster quality (silhouette measure of cohesion and separation of 0.5 to 1.0) 
was considered acceptable. The change in CBF deficit observed from the CON to the TC-Hyp condition 
was used as the continuous k-clustering variable (Romero et al 2011) to separate participants into the 
two groups: those who did not demonstrate a greater decrease in CBF, whereby rendering the TC-Hyp 
manipulation to be unsuccessful in lowering CBF (non-responders’ deficit group, n=12) and those who 
demonstrated a marked decrease in CBF, suggesting the TC-Hyp manipulation significantly lowered 
CBF and increased the CBF deficit (responders’ group, n=7).  
 
 Transition by grouping main effects – A two-way mixed ANOVA (general linear model in SPSS) 
was used to evaluate the main effects of transition type and group. Three levels of repeated measures 
were used for within-subject evaluation for the type of transition (transition: CON, TC, and TC-Hyp) 
and two levels of between-subject factors were used to evaluate group effects (group: non-
responders vs. responders).  If Mauchly’s test of Sphericity was significant the Greenhouse-Geisser 
correction was used.  In cases where a main effect for transition was found, pairwise comparisons 
(adjusted for multiple comparisons) were conducted. The two-way mixed ANOVA was performed to 
investigate the impact of transitions and CBF deficit grouping on measures of CBF (CBF deficit, MF, 
OxHb, DeoxHb, TotHb, and tSO2), cardiovascular hemodynamics (HR, SVi, Qi, MAPmca, and TPRi), and 
postural stability (RMS AP, RMS ML, TPL, TPL AP, TPL ML, SV). Interaction effects were tested by 




Cerebral blood flow deficit and postural stability - Pearson product correlations and regression analysis 
were used to examine relationships between measures of cerebrovascular hemodynamics (CBF deficit 
and ΔMV from baseline to prolonged standing) and postural stability (RMS ML, RMS AP, and SV SD).  
Symptoms analysis – A proportional odds regression was used to assess differences between groups 
and conditions.  
 
Results 
General orthostatic response (Control condition) 
There were no significant differences between groups for age, BMI, BSA, TBW or CrCO2 (Table 
S-1). Approximately half of all participants in the CON condition demonstrated initial orthostatic 
hypotension for diastolic BP (DBP drop ≥20 mmHg). Only a small proportion (11%) of participants 
demonstrated initial orthostatic hypotension for systolic BP (SBP drop ≥ 40 mmHg) but all participants 
with an SBP drop ≥ 40mmHg also had a DBP drop ≥ 20 mmHg (Table S-2).  
 
Cardio- and cerebrovascular hemodynamics – at nadir of MFV 
Compared to the control condition, the two conditions with a thigh cuff deflation (TC and TC-
Hyp) had higher HR and SVi and lower MAPmca at nadir (Figure S-2, main effect: condition all 
p=<0.05). Cardiac output was not different between conditions as the reduction in SVi was countered 
by the increase in HR. There were no interactions or group effects observed for cardiovascular 
hemodynamics at nadir.    
Cerebral blood flow MV was reduced (p<0.05) across transitions (CON to TC to TC-Hyp) and a 
trend (p=0.089) for group differences indicates that responders had a lower CBF at nadir (Fig S-3). 
Expectedly, PETCO2 at nadir was lower during the TC-Hyp condition compared to the CON or TC 




was effective in lowering MAPmca for both the TC and TC-Hyp condition and the hyperventilation task 
was effective in further lowering CBF MV as it was significantly lower than the CON and TC conditions.   
The trend to group differences in CBF MV at nadir (p=0.085) suggests the responders group are driving 
the lower nadir values in the TC and TC-Hyp conditions (table S-2).  
 
CBF deficit 
The CBF deficit progressively grew from CON to TC because the thigh cuff deflation caused a 
greater reduction in both BP and MV during the TC and TC-Hyp conditions. Subsequently, the CBF 
deficit increased further from TC to TC-Hyp because the addition of hyperventilating reduced MV even 
further. Group differences in MV at nadir (Fig. S-3 p=0.089) suggest significant differences between 
conditions were driven primarily by the responders group. The lower MV nadir values in the 
responders group combined with the significant interaction for the duration of CBF deficit (time from 
nadir to recovery) suggests responders had a lower MV for a longer duration during the TC and TC-hyp 
conditions lending to a larger CBF deficit value (table S-2). 
 
Cardio- and cerebrovascular hemodynamics – Prolonged standing  
Heart rate and SVi had an interaction effect (transition*group, p<0.01) whereby HR was 
significantly higher during the TC-Hyp condition at 1-min compared to the Con and TC conditions; 
furthermore, the responders had a significantly higher HR compared to non-responders during the TC-
Hyp condition (Fig. S-2).  Comparatively, SVI was significantly lower in the responders group compared 
to the non-responders group during the TC-Hyp condition (Fig. S-2). 
During prolonged standing CBF MV was reduced (p=0.061) between the CON and TC-Hyp conditions 
(Fig. S-3). The reduction in CBF MV can be attributed to the reduction (P<0.001) in PETCO2 between the 




Effects on postural instability – Initial standing 
When examining the relationship between CBF deficit and postural stability between groups 
(group*condition p<0.001, Fig. S-5 left panel), it is clear that the non-responders group had a relatively 
constant CBF deficit across conditions and comparatively the responders group progressively and 
significantly increased their CBF deficit across CON, TC and TC-Hyp conditions (Tukey’s HSD identified 
significant differences between all conditions for the responders group only, p≤0.05, Fig. S-5). Identical 
trends between groups and conditions were observed during the initial standing phase for COPV-avg, 
RMS AP, and RMS ML measures of postural stability (group*condition, p=0.005, p=0.007, p=0.09 
respectively, Fig S-5 left panel).  Specifically, Tukeys HSD analysis revealed that for COPV-avg 
significant differences exist between the CON condition and both TC and TC-Hyp for only the 
responders group. Furthermore, there was a group effect in the TC-Hyp condition for COPV-avg. For 
RMS AP significant differences were present between the CON condition and TC-Hyp as well as 
between groups during the TC-Hyp condition. For RMS ML there were differences between groups 
during the TC-Hyp condition. Thus, when the CBF deficit was unchanged (non-responders group) 
postural stability upon standing was also unchanged, however when the CBF deficit became 
progressively larger (responders group) postural stability also became progressively poorer (Fig. S-5 
left panel).  
Postural stability showed considerable variability between participants as evident by examples 
of the first 10-sec of standing after nadir for a non-responder and a responder in figure S-4. Due to the 
angular momentum generated from a supine-stand transition, greater RMS AP movement was 
observed compared to RMS ML movement during initial standing (Fig. S-4 and S-5), for this reason the 






Effects of CBF during prolonged standing and postural instability – Prolonged standing  
During prolonged standing (50-60s after transition), there were no differences in CBF MV 
between the responder and non-responder groups, but there was a trend to a lower value in the TC-
Hyp condition (p=0.061, Fig S-5, right panel).  Condition by group interactions reveal similar patterns 
for COPV-avg (p=0.07) and RMS ML (p=0.013); whereby, Tukey’s HSD analysis identified significant 
differences in COPV-avg between the CON and TC-Hyp conditions for responders only, and group 
differences for RMS ML during the TC-Hyp condition.  These data demonstrate that the non-
responders had relatively unchanging measures of stability and the responders group had 
progressively poorer COPV-avg and RMS ML from the CON to the TC-Hyp condition (Fig. S-5 right 
panel). These results suggest that reductions in CBF even 1-min post-transition are linked with 
postural instability.  
 
 Perceived Symptoms 
 Across conditions the percent of participants with symptoms increased as well as the severity 
of the symptom (Fig. S-6). The only symptoms evident during the CON condition were dizziness/light-
headedness and unsteadiness. The proportional odds regression identified that relative to the 
reference group (TC-Hyp Responders) all other conditions and the non-responders group had a 
substantially lower response to dizziness/light-headedness. The order in which the severity of 
dizziness/light-headedness regressed is as follows: TC-Hyp non-responders, TC responders, TC non-
responders, CON responders, CON non-responders. Although, TC-Hyp non-responders had a lower 
severity of dizziness/light-headedness compared to the reference group it was the only condition 
which was not significantly lower.  Likewise, the symptom of unsteadiness was markedly lower during 
all other conditions as well as in the non-responders groups. The order in which the severity of 




non-responders, CON responders. Only the TC responders group had a trend to be lower than the 
reference group (TC-Hyp responders), all other comparisons were significantly lower.  
 
Discussion 
In this study, we progressively reduced CBF and measured postural instability following a 
unique combination of standing plus thigh cuff release, and standing plus thigh cuff release with 
hyperventilation in young healthy adults. Consistent with the hypothesis, accumulation of a larger CBF 
deficit was associated with greater postural instability (a well-known risk factor for future falls) (Muir 
S.W. et al. 2010) observed in the early phase after standing, and persisting for up to 1-min. These data 
provide an experimental basis for the proposed links between cerebral hypoperfusion, dizziness and 
falls  (Edlow B.L. et al. 2010; Mehagnoul-Schipper D.J. et al. 2000b; Gutkin M. & Stewart J.M. 2016).  
Previous research has employed supine or sitting to standing transitions to challenge arterial 
BP and CBF regulation  (Lipsitz L.A. et al. 2000; Demura et al. 2008; Demura et al. 2010). Likewise, 
rapid release of double thigh cuff occlusion has been used in supine  (Aaslid R. et al. 1989) and seated  
(Lind-Holst M. et al. 2011) postures. To the best of our knowledge, this is the first time that standing 
and leg cuff deflation have been combined. An unexpected finding was the observation of participants 
whom we called responders and non-responders according to their CBF deficit responses to these 
additive stimuli during posture transition. In the CON condition, there were no differences in CBF 
deficit between the groups. However, a highly significant interaction effect showed that responders 
progressively increased the CBF deficit from CON to the TC and further to the TC-Hyp conditions. The 
non-responder group increased CBF deficit from CON to TC, but there was no further change in TC-
Hyp.   
Potential explanations for the differences in CBF deficit between include the tendencies for 




participants were encouraged to reduce PETCO2 and were given visual and verbal encouragement to 
accomplish the reduction. The absence of statistically significant interaction effects between condition 
and group for PETCO2 suggested that each group hyperventilated to the same extent. There were, 
however, some differences as the non-responder group had a slightly smaller reduction in PETCO2 from 
the TC to the TC-Hyp condition (35.3 to 30.3 mmHg at nadir compared to 34.1 to 26.8 mmHg). With 
the lower PETCO2, the non-responders did have lower MFV at nadir in TC-Hyp than TC, but CBF deficit 
was not different between conditions. The small differences in PETCO2 in the TC-Hyp between groups 
might have contributed to the relatively greater indicator of cerebrovascular resistance, RI, which 
could have been reflected in the greater CBF deficit in the responder group. The two groups had 
similar cerebrovascular response to CO2 so this was unlikely to be related to the difference. A longer 
duration from nadir to CBF deficit recovery in the responder group might reflect differences in 
cerebrovascular autoregulation, but autoregulation is expected to be enhanced with lower PETCO2  
(Aaslid R. et al. 1989; Edwards M.R. et al. 2004). The larger CBF deficit from CON to TC-Hyp in the 
responders group (199±62(cm/s)*s) versus non-responders (18±32(cm/s)*s) was a combination of 
differences in PETCO2, a lower MV value at nadir combined with a longer time to reach recovery values 
(baseline average) lending to the larger CBF deficit during the TC-Hyp condition of non-responders. 
The combination of manipulations were successful in driving a greater reduction of arterial BP 
(p=0.017) at nadir. The reductions in artieral BP can be attributed to reduced SVi (p<0.001) and TPRi 
(not significant) during the TC and TC-Hyp conditions.  The reduction in BP likely triggered the 
baroreflex thus increasing HR and resulting in an unchanged Qi between conditions. The combination 
of standing with a thigh cuff occlusion method did not demonstrate any group differences in BP (Fig. 
S-2). The addition of hyperventilation (commonly used to reduce CBF  (Coverdale N.S. et al. 2014)) to 




conditions and among groups the average supine MFV was 66 cm/s and PETCO2 was 39 mmHg (Table. 
S-2).   
 
Cerebral blood flow and postural instability 
 This is the first study to demonstrate measured reductions in CBF alongside increases of 
postural instability (responders, left panel Fig. S-5). Elevated and low resting seated SBP values have 
been indicated to negatively affect postural stability (COP 95% area) during quiet standing in older 
adult males (Maciaszek J. et al. 2011). However, the current study ascertains that CBF and more 
specifically CBF deficit are more closely linked to postural instabilities than indices of BP.  In 
consideration of the Romero-Ortuno et al. 2011 study which has reported a wide-range of postural BP 
responses in older adults  (Romero-ortuno R. et al. 2011), the current study findings would suggest a 
wide-range of CBF deficits in young adults are possible (attributed to both changes in BP and CBF) and 
that the impact of varied responses are reflected in different degrees of postural instability.  
The current study also found similar transition trends and group differences in TotHb (Fig. S-3) 
to MV. Demura et al. 2008 and 2010 reported measures of TotHb within the cerebral tissue alongside 
body sway parameters during a supine-stand and sit-stand transition at varied room temperatures  
(Demura et al. 2008; Demura et al. 2010). The authors suggest that in young healthy adults a 
relationship exists between TotHb recovery time and postural sway patterns following a posture 
transition. They also state that the starting position (sitting vs. supine) influences the delay of BP 
regulation which may impact TotHb recovery time and thus COP (Demura et al. 2008). The current 
study findings agree that a relationship clearly exists between sway parameters and measures of 
cerebral flow but we have taken this one step further by maintaining a consistent transition 
movement pattern (supine-stand) yet manipulating CBF and measuring its relationship to COP sway; 




manipulations of CBF and we found that as the CBF deficit either remains unchanged (non-
responders) or as it increases (responders) postural stability also remains unchanged (non-responders) 
or increases (responders). 
Hyperventilation during standing has also been shown to impact postural sway because of 
both the mechanical movement of hyperventilating (rib cage and thoracic movement) and changes in 
respiratory centers in the brain which may modulate postural control  (David P. et al. 2012). David et 
al. 2012 suggest postural control while hyperventilating may be compromised as the voluntary effort 
of hyperventilating bypasses automatic centers of the forebrain and compromises postural control. 
The current investigation evaluated postural control following hyperventilation in an effort to 
minimize the effects of voluntary hyperventilation on postural stability. Similar to the current study, 
Sakillari and Bronstein 1997 evaluated postural stability following bouts of hyperventilation. The 
authors assessed unsteadiness following varied degrees of hyperventilation (0 sec, 30 sec, 60 sec and 
90 sec when breathing as deeply and quickly as possible) preceding an eyes closed quiet stand task 
(Sakellari V. & Bronstein A.M. 1997); whereby hyperventilating for 30 sec significantly increased 
postural sway (RMS AP and ML). However, as the percent of transcutaneous partial carbon dioxide 
pressure decreased from 30 sec to 90 sec of hyperventilation, a progressive increase in body sway was 
not observed. Sakillari and Bronstein 1997 suggest unsteadiness associated with hyperventilating may 
be due to a disruption in proprioception although they did not consider effects of PETCO2 on CBF and 
cerebral hypoperfusion.  
 
Standing CBF MV and postural instability at 1-min standing 
The relationships between CBF and postural stability were maintained 1-min post-transition. 
Cerebral blood flow MV was lower in the TC-Hyp versus CON condition (p=0.061), and although not 




(Fig. S-5). The responders group also had significantly lower SVi during the TC-Hyp condition versus the 
TC condition (Fig. S-1) and they had significantly higher HR during the TC-Hyp condition (Fig. S-2).  
During prolonged standing both COPV-avg and RMS ML demonstrate interactions (p=0.07 and 
p=0.013) where COPV-avg is significantly greater in the responders group during the TC-Hyp condition 
compared to the CON condition and RMS ML is significantly greater in the responders compared to 
the non-responders during the TC-Hyp condition. These findings identify that between the CON and 
TC-Hyp conditions MV is lower and for responders they also have increased HR and COPV-avg. The 
aforementioned results are the first to demonstrate a maintained relationship between BP and CBF 
regulation (SVi and MV) to postural instability (COPV-avg and RMS ML) 1-min post-transition.   
 
Conclusions  
Orthostatic hypotension and blood pressure disturbances have been proposed as a cause or 
primary contributor for falls in older adults because of its theoretical link to cerebral hypoperfusion  
(Shaw B.H. & Claydon V.E. 2014; van Wijnen V.K. et al. 2017) yet this is the first study to report 
concurrent reductions in CBF with increasing measures of postural unsteadiness. Although not all 
participants responded to the stimulus (thigh cuff deflation or hyperventilation) in the same fashion 
the individual responses allowed us to group participants and evaluate the effects of CBF (unchanged 
or reduced) relative to differed responses in postural stability (unchanged or increased). We found 
that individuals who had significantly lower CBF (marked by increased CBF deficit) had significantly 
poorer postural stability upon standing and during prolonged standing. The CBF decrease appears to 
impact measures of quiet standing in a young healthy adult population even up to 1-min post 
transition.  These findings provide support to proposed mechanisms suggesting that older adults who 









 Tables and Figures 
 
Table S-1. Participant characteristics separated by cerebral blood flow deficit group 






Age, years 25.8±3.5 26.7±2.5 24.1±4.5 N.S. 
Sex (women), % (n) 52.6 (10) 58.3 (7) 42.9 (3) - 
BMI (kg/m2) 24±3.5 24.7±3.7 22.8±2.9 N.S. 
Height (cm) 171.7±6.3 172±7.3 171.2±4.7 N.S. 
Weight (kg) 71.1±13.4 73.4±14.4 67.1±11.5 N.S. 
BSA (m2) 1.83±0.18 1.86±0.19 1.78±0.16 N.S. 
TBW (L) 38.7±11.3 36.6±10.3 42.5±13.4 N.S. 
CrCO2 (%/mmHg) 2.159±0.363 2.178±0.448 2.126±0.159 N.S. 
Smoking (never), % (n) 94.7 (18) 91.7 (11) 100 (7) - 
Smoking (current), % (n) 5.3 (1) 83.3 (1) - - 
Physical Activity (Self-report 
questionnaire) 
    
     Activity level, % (n)     
          Regular Exercise (3d/wk 50% mod) 89.5 (17) 83.3 (10) 100 (7) - 
          Sedentary, % (n) 15.8 (3) 25.0 (3) - - 
          Active, % (n) 52.6 (10) 66.7 (8) 28.6 (2) - 
          Highly Active, % (n) 31.6 (6) 8.3 (1) 71.4 (5) - 
     Frequency of activity, % (n)     
          0 days/week, % (n)     
          1-2 days/week, % (n) 10.5 (2) 16.7 (2) - - 
          3-4 days/week, % (n) 57.9(11) 66.7 (8) 42.9 (3) - 
          5 or more days/week, % (n) 26.3 (5) - 71.4 (5) - 
     Intensity (%) of total activity     
          Light, mean±SD (median) 18.9±22.3 (10) 21.3±26.1 (15) 15.0±14.4 (10) - 
          Moderate , mean±SD (median) 46.3±29.9 (50) 42.1±35.3 (35) 53.6±17.5 (60) - 
          Hard , mean±SD (median) 24.2±25.4 (20) 20.0±28.8 (2.5) 31.4±17.7 (30) - 
BMI body mass index, BSA body surface area, TBW total body water, CrCO2 Cerebrovascular reactivity 





Table S-2. Cardio- and cerebrovascular hemodynamics separated by condition and cerebral blood flow deficit group 
Characteristic Control Condition (CON) Thigh Cuff Deflation Condition (TC) 




























119.3±52.7 125.4±56.7 108.8±47.3 168.6±90.3 151.6±74.2 197.7±113.2 204.1±112.2 143.4±66.4 308.2±98.3 ** 
p<0.001 




















Time at nadir (s) 3.22±0.96 3.26±0.76 3.15±1.31 3.85±1.65 3.85±1.77 3.83±1.56 3.45±1.98 4.37±1.63 1.87±1.53 ** 
Duration of CBF 
deficit - nadir to 
recovery (s) 
6.65±1.64 6.82±1.54 6.35±1.89 8.03±2.34 7.67±1.90 8.66±3.01 8.24±2.21 7.32±1.89 9.81±1.89 ** 
Initial OH: DBP, n 
(%) 
10 (53) 7 (58) 3 (43) 13 (68) 9 (75) 4 (57) 13 (68) 8 (67) 5 (71) - 
Initial OH: SBP & 
DBP, n (%) 
2 (11) 1 (8) 1 (14) 4 (21) 2 (17) 2 (29) 7 (37) 4 (33) 3 (43) - 
Supine           
     HR, bpm 59.3±6.3 58.0±6.3 61.4±6.1 59.9±7.9 58.8±7.6 61.8±8.5 60.1±9.8 58.3±9.3 63.2±10.6 N.S. 
     SBP, mmHg 116.6±8.3 116.4±9.7 117.0±6.0 116.8±8.2 115.2±9.0 119.5±6.2 116.3±8.6 114.0±9.5 120.3±5.4 N.S. 
     DBP, mmHg 69.0±5.6 71.0±5.5 65.7±4.1 69.0±4.9 70.4±4.6 66.5±4.7 68.8±4.8 69.2±5.8 68.0±2.8 N.S. 
     MAP, mmHg 84.9±5.5 86.1±6.0 82.8±4.0 84.9±4.8 85.3±5.1 84.2±4.7 84.6±5.3 84.1±6.5 85.5±6.5 N.S. 
     PP,mmHg 47.6±7.9 45.4±8.4 51.3±5.9 47.8±8.2 44.8±8.3 52.9±5.1 47.6±7.3 44.8±6.5 52.3±6.4 †† 
P=0.042 
     Qi, L/min/m2 2.87±0.44 2.82±0.42 2.96±0.49 2.88±0.53 2.77±0.37 3.08±0.72 2.86±0.56 2.79±0.42 2.96±0.77 N.S. 
     SVi, mL/m2 48.6±5.8 48.9±6.3 48.3±5.2 48.8±6.2 48.2±6.6 49.7±5.6 47.8±6.5 48.5±7.3 46.6±5.3 * p=0.062, 
c 
     TPRi, 
mHg/L/min/m2 
9.28±2.36 9.37±2.66 9.13±1.94 9.26±2.23 9.43±2.57 8.98±1.64 9.37±2.40 9.26±2.69 9.56±2.01 N.S. 
     PSV, cm/s 100.9±19.5 98.8±19.3 104.5±20.8 102.3±19.2 101.7±19.3 103.3±20.6 101.1±18.7 99.2±19.9 104.4±17.2 N.S. 
     MV, cm/s 44.6±9.3 45.1±9.8 43.8±9.1 44.2±9.0 44.8±10.0 43.1±7.5 43.2±8.5 42.1±9.6 45.1±6.5 N.S. 
     MFV, cm/s 66.0±14.2 65.8±14.8 66.4±14.3 65.9±14.0 66.3±15.0 65.1±13.2 64.7±13.2 63.3±15.0 66.9±10.0 N.S. 




     CVRi, 
mmHg/cm/s 
0.898±0.212 0.940±0.225 0.828±0.183 0.897±0.187 0.914±0.192 0.868±0.190 0.915±0.235 0.954±0.273 0.848±0.145 N.S. 
     RI, 0.56±0.04 0.54±0.04 0.58±0.033 0.57±0.04 0.56±0.04 0.58±0.03 0.57±0.04 0.58±0.03 0.56±0.06 ** 
p=0.021 
     PI, 0.86±0.01 0.83±0.10 0.92±0.10 0.89±.011 0.87±0.1 0.93±0.09 0.90±0.12 0.91±0.08 0.89±0.18 * p=0.06 
     PETCO2, mmHg 39.1±4.2 39.2±3.9 38.9±5.0 39.0±4.3 39.3±4.3 38.5±4.6 38.7±3.9 38.6±3.9 38.9±4.1 N.S. 
     tSO2, percent 65.4±5.2 66.3±6.3 63.7±2.2 63.3±3.8 63.2±3.6 63.6±4.4 64.7±5.0 65.6±5.8 63.0±2.8 N.S. 
     TotHb, µMol 0±0 0±0 0±0 0±0 0±0 0±0 0±0 0±0 0±0 - 
     PPTotHb, µMol 0.581±0.125 0.614±0.128 0.529±0.110 0.583±0.098 0.631±0.089 0.507±0.055 0.573±0.146 0.628±0.118 0.488±0.153 †† p=0.02 
     OxHb,µMol 0±0 0±0 0±0 0±0 0±0 0±0 0±0 0±0 0±0 - 
     PP OxHb, µMol 0.490±0.100 0.515±0.098 0.450±0.095 0.494±0.084 0.535±0.080 0.429±0.038 0.488±0.118 0.534±0.098 0.416±0.116 †† 
p=0.017 
     DeoxHb, µMol 0±0 0±0 0±0 0±0 0±0 0±0 0±0 0±0 0±0 - 
     PP DeoxHb, 
µMol 
0.100±0.031 0.105±0.031 0.092±0.031 0.097±0.019 0.103±0.011 0.088±0.026 0.094±0.032 0.099±0.021 0.086±0.046 N.S. 
Nadir           
     HR, bpm 84.2±12.6 83.3±13.1 85.8±12.6 90.9±1.2 90.0±10.9 92.5±21.6 93.6±17.4 93.5±14.2 93.7±23.2 ‡‡ 
p<0.001, 
a,b 
     SBPmca, 
mmHg 
96.5±18.1 95.1±20.4 99.0±14.4 87.8±18.7 86.5±21.7 89.9±13.6 85.5±18.6 81.5±17.9 92.3±19.0 ‡‡ 
p=0.004, 
a,b 
     DBPmca, 
mmHg 
51.7±14.1 52.2±14.8 51.0±14.1 46.7±12.9 47.9±13.2 44.8±13.0 47.3±16.3 46.6±13.4 48.6±21.6 ‡‡ 
p=0.046, a 
     MAPmca, 
mmHg 
66.7±14.8 66.5±16.3 67.0±13.1 60.4±13.9 60.8±15.6 59.8±11.6 60.1±16.3 58.2±14.5 63.1±19.9 ‡‡ 
p=0.017, 
a, b 
     PPmca,mmHg 44.8±10.0 43.0±8.9 48.0±11.5 41.0±12.2 38.6±11.2 45.2±13.6 38.1±10.8 34.8±8.4 43.8±12.7 ‡‡ 
p=0.001, 
a, b 
     Qi, L/min/m2 3.85±0.80 3.71±0.91 4.09±0.55 3.80±0.93 3.60±1.07 4.14±0.55 3.56±0.92 3.33±0.95 3.95±0.79 N.S. 
     SVi, mL/m2 46.0±8.7 44.5±7.9 48.6±9.9 42.4±11.2 39.9±10.6 46.7±11.6 38.8±11.0 35.6±8.6 44.2±13.1 ‡‡ 
p<0.001, 
a,b 
     TPRi, 
mmHg/L/min/m2 




     PSV, cm/s 104.9±20.5 104.9±24.2 104.9±13.9 101.0±22.3 101.3±22.6 100.5±23.7 98.7±17.1 98.2±18.9 99.4±14.8 N.S. 




     MFV, cm/s 44.4±11.6 45.1±13.8 43.4±7.3 39.0±8.4 40.0±9.6 37.3±6.1 33.7±6.5 35.1±6.4 31.2±6.3 ‡‡ 
p<0.001, 
a, b, c 
     PPcbfv,cm/s 90.3±17.3 89.1±19.5 92.3±13.9 91.0±22.7 88.7±21.2 94.9±26.3 92.9±18.1 90.8±20.1 96.4±14.8 N.S. 
     CVRi, 
mmHg/cm/s 
0.931±0.497 0.950±0.537 0.899±0.458 0.868±0.447 0.881±0.484 0.846±0.410 1.009±0.644 0.901±0.419 1.195±0.927 N.S. 




     PI, 2.09±0.39 2.05±0.42 2.16±0.33 2.36±0.48 2.26±0.42 2.53±0.56 2.81±0.58 2.61±0.53 3.16±0.55 ‡‡ 
p<0.001, 
a, b, c 
    PETCO2, mmHg 35.6±4.5 35.9±4.7 35.3±4.3 34.9±4.7 35.3±5.0 34.1±4.5 29.0±4.3 30.3±4.8 26.8±2.2 ‡‡ 
p<0.001, 
b, c 
     tSO2, percent 62.5±5.5 63.5±6.7 60.8±2.1 59.6±4.0 59.1±3.7 60.3±5.0 59.4±5.7 60.6±6.5 57.3±3.3 ‡ p=0.062, 
b 

















     PPTotHb, µMol 0.635±0.154 0.637±0.159 0.631±0.158 0.707±0.258 0.736±0.285 0.662±0.221 0.613±0.192 0.521±0.153 0.759±0.158 ** 
p=0.028 

















     PP OxHb, µMol 0.598±0.141 0.598±0.156 0.598±0.126 0.649±0.229 0.675±0.268 0.606±0.162 0.559±0.170 0.476±0.137 0.690±0.133 ** 
p=0.023 













     PP DeoxHb, 
µMol 
0.100±0.046 0.099±0.053 0.100±0.036 0.104±0.044 0.105±0.048 0.101±0.041 0.075±0.038 0.059±0.036 0.100±0.029 ‡ p=0.055 
c, * 
p=0.075 
Delta (supine to 
nadir) 




     HR, bpm 25.0±8.8 25.3±9.0 24.4±9.1 31.0±11.6 31.2±8.9 30.8±16.0 33.4±13.1 35.2±11.0 30.4±16.7 ‡‡ 
p=0.001, 
a, b 
     SBPmca, 
mmHg 
-20.1±16.8 -21.2±16.5 -18.1±18.5 -29.0±17.2 -28.7±18.8 -29.5±15.4 -30.8±15.2 -32.5±12.5 -28.0±19.9 ‡‡ 
p=0.003, 
a, b 
     DBPmca, 
mmHg 
-17.3±14.8 -18.8±15.8 -14.8±13.6 -22.2±12.8 -22.5±13.7 -21.8±12.1 -21.4±14.4 -22.6±11.6 -19.5±19.2 ‡ p=0.058 
a, b 
     MAPmca, 
mmHg 
-18.2±15.0 -19.6±15.7 -15.9±14.6 -24.5±13.8 -24.6±15.1 -24.4±12.5 -24.6±14.2 -25.9±11.5 -22.3±18.8 ‡‡ 
p=0.015, 
a, b 
     PPmca,mmHg -2.8±7.9 -2.4±6.5 -3.3±10.4 -6.8±8.9 -6.2±8.6 -7.8±9.9 -9.4±7.6 -10.0±6.3 -8.6±9.9 ‡‡ 
p=0.003, 
a, b 
     Qi, L/min/m2 0.976±0.682 0.890±0.607 1.124±0.823 0.918±0.765 0.833±0.793 1.063±0.751 0.703±0.796 0.537±0.810 0.988±0.740 ‡‡ 
p=0.004, 
a, b 
     SVi, mL/m2 -2.62±8.37 -4.35±6.44 0.35±10.86 -6.34±10.29 -8.29±8.92 -3.00±12.30 -9.01±11.74 -12.85±9.74 -2.42±12.63 N.S. 
     TPRi,   
     
mmHg/L/min/m2 
-3.83±1.66 -3.87±1.69 -3.74±1.73 -4.24±1.40 -4.23±1.63 -4.27±1.00 -3.92±1.71 -3.76±1.42 -4.19±2.22 N.S. 
     PSV, cm/s 4.0±10.2 6.0±8.7 0.4±12.3 -1.3±18.5 -0.5±15.0 -2.8±24.7 -2.5±7.6 -0.9±8.9 -5.1±3.8 N.S. 
     MV, cm/s -30.0±7.2 -29.3±8.0 -31.3±5.9 -34.2±9.0 -32.2±9.8 -37.5±6.7 -37.4±9.3 -34.7±10.1 -42.1±5.7 ‡‡ 
p<0.001, 
a, b, c 
     MFV, cm/s -21.6±8.2 -20.8±8.2 -23.0±8.8 -26.9±11.1 -26.3±12.0 -27.8±10.2 -31.0±10.2 -28.2±11.0 -35.7±6.8 ‡‡ 
p<0.001, 
a, b, c 
     PPcbfv,cm/s 34.0±12.1 35.3±12.8 31.7±11.5 32.8±18.8 31.8±14.4 34.7±26.0 34.9±10.7 33.7±13.1 37.0±4.2 N.S. 
     CVRi, 
mmHg/cm/s 













     PI, 1.23±0.37 1.22±0.42 1.24±0.29 1.47±0.44 1.39±0.37 1.60±0.55 1.91±0.57 1.70±0.50 2.27±0.51 **p=0.043 







     tSO2, percent -2.89±1.42 -2.87±1.22 -2.91±1.82 -3.78±1.67 -4.05±1.79 -3.32±1.46 -5.28±1.99 -5.04±2.32 -5.69±1.31 ‡‡ 
p<0.001,  
a, c 

















     PPTotHb, µMol 0.054±0.194 0.024±0.224 0.102±0.135 0.124±0.259 0.105±0.275 0.155±0.249 0.040±0.265 -
0.107±0.175 
0.272±0.215 ** p=0.01 













































         N.S. 
     HR, bpm 75.6±11.1 75.8±13.1 75.2±7.6 78.1±12.9 79.7±14.0 75.4±11.1 77.8±12.9 74.3±12.5 83.9±12.0 ** 
p=0.001 
     SBPmca, 
mmHg 
124.1±14.7 121.6±16.4 128.3±11.2 126.7±15.9 124.1±18.3 131.0±10.3 127.7±14.9 126.7±16.3 129.5±13.0 N.S. 
     DBPmca, 
mmHg 
79.3±10.1 79.4±10.1 79.2±10.8 80.1±9.7 80.5±10.0 79.4±9.9 81.7±10.2 81.8±10.0 81.5±11.4 N.S. 
     MAPmca, 
mmHg 
94.2±10.9 93.4±11.5 95.6±10.6 95.6±11.1 95.0±12.3 96.6±9.5 97.0±11.1 96.8±11.3 97.5±11.6 N.S. 
     PPmca,mmHg 44.8±9.6 42.2±10.7 49.1±5.8 46.6±10.5 43.6±11.4 51.6±6.6 46.0±9.5 44.9±11.1 48.0±6.2 N.S. 
     Qi, L/min/m2 2.59±0.53 2.59±0.54 2.58±0.55 2.67±0.57 2.62±0.40 2.74±0.82 2.55±0.48 2.51±0.34 2.62±0.62 N.S. 
     SVi, mL/m2 34.7±7.2 34.9±7.7 34.5±6.9 34.6±7.0 33.7±6.9 36.2±7.4 33.5±7.5 34.7±8.4 31.4±5.7 ** 
p=0.006 
     TPRi, 
mmHg/L/min/m2 
11.9±4.6 11.3±3.8 12.9±6.0 11.6±3.9 11.2±3.3 12.3±5.0 12.2±4.0 11.9±3.70 12.7±4.7 N.S. 
     PSV, cm/s 95.3±20.4 95.9±23.6 94.2±14.9 96.2±20.2 96.7±20.9 95.4±20.6 91.3±19.6 93.1±21.7 88.0±16.2 N.S. 
     MV, cm/s 42.3±9.5 43.1±11.2 40.9±6.2 42.7±8.62 43.8±9.5 40.9±7.3 39.3±11.0 41.1±11.4 36.4±10.6 ‡ p=0.061, 
b 





     PPcbfv,cm/s 53.0±12.5 52.9±14.1 53.2±10.2 53.5±13.5 52.9±12.8 54.6±15.6 51.9±11.5 52.1±12.6 51.6±10.3 N.S. 
     CVRi, 
mmHg/cm/s 
1.17±0.38 1.18±0.41 1.16±0.35 1.18±0.34 1.17±0.35 1.19±0.36 1.35±0.61 1.30±0.49 1.44±0.81 ‡‡ 
p=0.032, b 
     RI, 0.56±0.05 0.55±0.05 0.56±0.04 0.55±0.05 0.55±0.43 0.57±0.68 0.57±0.07 0.56±0.06 0.59±0.09 ‡ p=0.056, 
c 
     PI, 0.89±0.12 0.88±0.14 0.91±0.11 0.90±0.15 0.87±0.11 0.94±0.20 0.97±0.24 0.92±0.17 1.04±0.32 ‡‡ 
p=0.031, c 
     PETCO2, mmHg 37.0±4.7 37.2±4.7 36.8±5.0 37.3±4.6 37.7±4.5 36.7±5.0 33.2±5.0 34.3±4.0 31.3±6.2 ‡‡ 
p<0.001, 
a, c 
     tSO2, percent 63.3±5.6 64.4±6.4 61.2±3.1 61.3±4.5 60.6±4.8 62.5±4.0 62.6±4.9 63.8±5.7 60.6±2.1 N.S. 

















     PPTotHb, µMol 0.397±0.121 0.408±0.120 0.379±0.130 0.398±0.127 0.411±0.141 0.377±0.107 0.377±0.122 0.419±0.129 0.311±0.078 N.S. 

















     PP OxHb, µMol 0.344±0.098 0.350±0.097 0.335±0.107 0.352±0.128 0.367±0.150 0.328±0.089 0.327±0.104 0.359±0.119 0.276±0.066 N.S. 
     DeoxHb, µMol 0.895±0.721 0.943±0.666 0.820±0.849 0.816±0.953 1.085±1.012 0.392±0.722 0.744±0.735 0.732±0.612 0.763±0.951 N.S. 
     PP DeoxHb, 
µMol 
0.067±0.023 0.072±0.022 0.060±0.025 0.081±0.059 0.092±0.073 0.063±0.021 0.063±0.017 0.068±0.016 0.054±0.017 N.S. 
Supine -45 to -15sec average, Nadir single lowest MV beat, Delta nadir value minus supine average, Prolonged Standing 50 to 60sec, CBF cerebral blood flow, 
dCA dynamic cerebral autoregulation, OH orthostatic hypotension, SBP systolic blood pressure, DBP diastolic blood pressure, MAP mean arterial pressure, PP 
pulse pressure, Qi cardiac output, SVi stroke volume, TPRi total peripheral resistance, PSV peak systolic velocity, MV minimum velocity, MFV mean flow 
velocity, PPcbfv pulse pressure cerebral blood flow velocity, CVRi cerebrovascular resistance index, RI resistance index, PI pulsatility index, PETCO2 end-tidal 
carbon dioxide,  tSO2 cerebral tissue saturation, TotHb total hemoglobin, PPTotHb pulse pressure total hemoglobin, OxHb oxygenated hemoglobin, PPOxHb 
pulse pressure oxygenated hemoglobin, DexHb deoxygenated hemoglobin, PPDeoxHb pulse pressure deoxygenated hemoglobin. **interaction (group by 
condition) p≤ 0.05, *interaction (group by condition) p≤ 0.1 >0.05, †† group effect p≤ 0.05, † group effect p≤ 0.1 >0.05, ‡‡ condition effect p≤ 0.05, ‡ condition 
effect p≤ 0.1 >0.05, N.S. not significant, ‘a’ pairwise comparison between CON and TC conditions, ‘b’ pairwise comparison between CON and TC-Hyp conditions, 





Table S-3. Measures of postural stability separated by condition and cerebral blood flow deficit group 
Characteristiccccccccccccc Control Condition (CON) Thigh Cuff Deflation Condition (TC) 


























Initial (nadir to 10s) 
     RMS AP, cm 0.448±0.181 0.485±0.209 0.384±0.103 0.555±0.230 0.537±0.228 0.586±0.250 0.575±0.205 0.475±0.143 0.746±0.187 **p=0.007 





     TPL ML+AP, cm 12.17±2.58 12.15±2.75 12.20±2.48 14.91±6.45 14.96±6.58 14.84±6.74 14.40±5.43 13.06±4.70 16.70±6.18 ‡‡ 
p=0.047, 
b 
     TPL ML, cm 7.13±2.26 7.10±2.59 7.16±1.74 9.17±4.93 8.84±4.22 9.75±6.31 8.39±4.20 7.58±4.34 9.77±3.85 ‡ p=0.077, 
a, b 
     TPL AP, cm 8.29±1.49 8.26±1.61 8.34±1.39 9.71±43.97 10.07±4.71 9.08±2.42 9.82±3.26 8.90±2.01 11.40±4.46 ‡ p=0.105, 
b 
     COPV-avg, cm 0.468±0.157 0.505±0.177 0.405±0.096 0.614±0.218 0.578±0.215 0.676±0.224 0.560±0.195 0.494±0.127 0.754±0.187 ** 
p=0.005 
     COPV-sd, cm 0.276±0.072 0.289±0.063 0.253±0.085 0.354±0.154 0.347±0.164 0.366±0.148 0.338±0.149 0.258±0.065 0.474±0.156 ** 
p=0.006 
Prolonged Standing (50 to 60s) 
     RMS AP, cm 0.293±0.131 0.316±0.156 0.255±0.062 0.363±0.224 0.354±0.271 0.378±0.125 0.373±0.165 0.324±0.138 0.456±0.183 N.S. 
     RMS ML, cm 0.215±0.091 0.215±0.112 0.216±0.044 0.225±0.099 0.214±0.096 0.245±0.109 0.217±0.104 0.164±0.067 0.309±0.093 ** 
p=0.013 
     TPL ML+AP, cm 7.78±1.74 8.12±2.03 7.19±0.93 8.55±2.22 8.45±2.66 8.71±1.33 8.26±2.05 7.87±1.49 8.94±2.78 N.S. 




     TPL AP, cm 5.65±1.48 5.98±1.7 5.07±0.73 6.12±1.53 5.99±1.80 6.33±1.03 6.28±1.60 6.04±1.18 6.70±2.20 N.S. 
     COPV-avg, cm 0.328±0.132 0.342±0.163 0.304±0.051 0.384±0.190 0.369±0.234 0.410±0.086 0.384±0.176 0.317±0.131 0.499±0.193 * p=0.07 
     COPV-sd, cm 0.165±0.074 0.179±0.086 0.141±0.042 0.215±0.110 0.209±0.137 0.226±0.039 0.200±0.072 0.177±0.079 0.240±0.033 ‡‡ p=0.05, 
a, b 
Initial nadir to 10 s, Prolonged Standing 50 to 60sec, ML medial-lateral plane, AP anterior-posterior plane, RMS root mean square, TPL total path length, COPV 
center of pressure vector, Avg average, SD standard deviation.  ** and * interaction (group by condition), †† group effect and † group effect, ‡‡ and ‡ 
condition, N.S. not significant, post-hoc ‘a’ pairwise comparison is between CON and TC conditions, post-hoc ‘b’ pairwise comparison is between CON and TC-





Figure S-1 Time scale: Negative time represents supine rest and active transition where time at zero 
marks up-right posture and positive time represents standing. A 30 sec baseline average was 
calculated from -45 sec to -15 sec during the control condition and from -210 sec to -240 sec for the 
thigh cuff inflation (TC) and thigh cuff inflation with hyperventilation (TC-Hyp) conditions. The nadir 
value signifies the lowest single CBFVmin beat, recovery marks the time at which CBFVmin reaches 
baseline average values and peak flow identifies the CBFVmin beat which no longer increases past 
upright posture. The cerebral blood flow (CBF) deficit is the area above the curve between nadir and 
recovery. Initial standing begins at the time of in which nadir occurs and continues for 10 sec and 
prolonged standing is from 50 sec to 60 sec of standing. During the TC and TC-Hyp conditions there 
was a 3 min double thigh cuff inflation which preceding upright posture. Additionally, during the TC-
Hyp condition there were 90 sec of hyperventilation which began 90 sec into the double thigh cuff 





Figure S-2 Cardiovascular hemodynamics: A two way mixed ANOVA (condition by participant group) 
revealed significant main effects of condition at nadir for heart rate (HR), stroke volume (SVi) and 
mean arterial pressure at the level of the middle cerebral artery (MAPmca); whereby HR was 
significantly higher and SVi and MAPmca were significantly lower in the thigh cuff deflation and thigh 
cuff deflation and hyperventilation conditions. A significant interaction was observed during 
prolonged standing for HR and SVi where HR is elevated and SVi is lower in the responders group 
compared to the non-responders group during the thigh cuff deflation and hyperventilation condition. 





Figure S-3 Cerebrovascular hemodynamics: A two way mixed ANOVA (condition by participant group) 
revealed significant main effects of condition at nadir for cerebral blood flow velocity minimum (MV), 
end tidal carbon dioxide (PETCO2) and cerebral tissue saturation (tSO2); whereby   MV was significantly 
different between all conditions and it progressively lowered from control to thigh cuff deflation to 
thigh cuff deflation and hyperventilation.  There was also a trend for a main effect of grouping where 
the responders tended to have a lower MV versus non-responders. PETCO2 was significantly lower in 
the thigh cuff deflation and hyperventilation condition compared to any other condition. A main effect 




deflation and hyperventilation condition had lower PETCO2 compared to the other two condition and 





Figure S-4: Responders and non-responders cerebral blood flow velocity (CBFV) and stability. Top row 
of figures present the group mean (SD) during the control condition for CBFV minimum (supine to 60 s 
standing) and center of pressure (COP) postural stability tracing (nadir to 10 s) for a representative 
non-responder and non-responder. The lower row of figures show CBF velocity minimum during the 
thigh cuff and hyperventilation condition for the same non-responder and non-responder. CBF deficit 
and root mean square (RMS) medial-lateral (ML) and anterior-posterior (AP) shown on the panels are 
group by condition averages ± standard deviation. Responders had significantly larger CBF deficit 







Figure S-5. Initial and prolonged standing cerebral blood flow (CBF) and stability. Initial and prolonged 
standing cerebral blood flow (CBF) deficit and postural stability (COPV-avg center of pressure vector 
average, RMS root mean square, AP anterior-posterior, and ML medial-lateral) are shown for the 
three conditions for the non-responder and responder groups. During initial standing significant 
interactions for CBF deficit, COPV-avg and a trend for an interaction for RMS ML reveals that as the 
CBF deficit increased across conditions for the responders group, postural instability also increased. 
Comparatively, the CBF deficit for the non-responders group remained relatively constant and so did 




demonstrate interactions (p=0.07 and p=0.013 respectively) depicting a relationship where 
responders have a lower MV during the thigh cuff and hyperventilation condition as well as a higher 
RMS ML compared to the relatively unchanging values of the non-responders group. Tukey’s HSD 
analysis identified significant differences between: * TC-Hyp condition non-responders vs. responders, 
‘a’ responders between CON and TC conditions, ‘b’ responders between CON and TC-Hyp conditions, 





Figure S-6. Self-report symptoms of initially standing (scale 0-10). As the conditions progressively reduced the cerebral blood flow (Fig. S-5) the 
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APPENDIX A – HEALTH STATUS QUESTIONNAIRES  
HEALTH STATUS QUESTIONNAIRE – A – Chapter 4 
 
Study Title: Brain blood flow and stability during standing after a change in posture 
Researchers and Contact Information: 
Laura Fitzgibbon, MSc     phone: 226-808-4530                    e-mail: lfitzgib@uwaterloo.ca  
Deborah O’Leary, PhD     phone: 905-688-5550 ext 4339     e-mail: doleary@brocku.ca  
Richard Hughson, PhD     phone: 519-888-4567 ext 32516   e-mail: hughson@uwaterloo.ca  
Department of Kinesiology, Applied Health Sciences, University of Waterloo, Waterloo ON N2L 3G1 
 
Study ID: _______________  
  
 
Are you near sighted?   
Do you wear corrective glasses or contacts? 
 
Past Health  
Check all that apply and identify approximate date of diagnosis/event 
(   ) Heart Attack  (   ) Hypertension 
(   ) Heart Failure  (   ) High Cholesterol 
(   ) Open Heart Surgery  (   ) Diabetes (diet or insulin) 
(   ) Congenital Heart Disease  (   ) Sleep Apnea 
(   ) Atrial Fibrillation  (   ) Emphysema or Pneumonia 
(   ) Stroke  (   ) Asthma or Bronchitis 
(   ) Transient Ischemic Attack  (   ) Kidney or Liver Disease 
(   ) Carotid Stenosis  (   ) Ulcers 
(   ) Peripheral Vascular Disease  (   ) Chronic Inflammation: ___________ 
(   ) Blood Clots  (   ) Other: _________________ 
(   ) Chronic Obstructive Pulmonary Disease 
 
Current Health  
Do you have a pacemaker?  ______ If yes, when did you have it 
implanted?_______________ 
Do you have arthritis? __________ If yes, what joints are affected? 
_____________________   






List any current (within the past 3 months) health issues (examples are listed under past 
health) and medications 
Current health issues: Current medications: 
1. 1.  7. 
2. 2.  8. 
3. 3.  9. 
4. 4.  10. 
5. 5.  11.  
6. 6.  12. 
Current Symptoms (within the past 3 months) 
(   ) Irregular Heart Beat (   ) Fatigue 
(   ) Chest Pain (   ) Headaches 
(   ) Persistent Cough (   ) Dizziness/Light-Headedness 
(   ) Wheezing/Shortness of Breath (   ) Pain; If yes, where? 
________________ 




Never(   )     Ex-smoker: quit year(          )    Regular: # cigarettes/day(      )     Years smoking(     
) 
 
Current Activity Level 
Please list the types of activities/exercises you have done in the past 3 months.  Also, indicate 
how often (frequency) and how long (duration) you do these activities for. 
 
Type of Activity Frequency 
(how often) 
Duration 











Balance Screening  
Please select which number best represents your fear of falling and balance confidence. 
 
 Not Afraid Somewhat Afraid Extremely Afraid 
Fear of 
Falling 
0 1 2 3 4 5 6 7 8 9 10 
    
 Not Confident Somewhat Confident Extremely Confident 
Balance 
Confidence 
0 1 2 3 4 5 6 7 8 9 10 
 
 
Identify if you have any known, 
(  ) Neurological Disorders (such as, Parkinson’s Disease or Multiple Sclerosis) 
(  ) Neuromuscular Disorders (such as, Muscular Dystrophy, Adults Spinal Muscular Atrophy) 
 
If so, please specify _____________________________________ 
Recent Nutritional Intake 
Please list the time of your last meal, along with the type and quantity of food/beverages 
consumed during that last meal. 












HEALTH STATUS QUESTIONNAIRE – B – Chapter 5 
 
Study Title: Brain blood flow and balance during a transition to walking 
 
Researchers and Contact Information: 
Laura Fitzgibbon, MSc          phone: 226-808-4530                      e-mail: lfitzgib@uwaterloo.ca  
Richard Hughson, PhD         phone: 519-888-4567 ext 32516   e-mail: hughson@uwaterloo.ca  
Department of Kinesiology, Applied Health Sciences, University of Waterloo, Waterloo ON N2L 3G1 
 
Study ID: _______________  
  
Exclusion Criteria: If any of the following apply, you should not participate in this study 
- Diagnosis of dementia  
-  A history of cerebrovascular disease (ex. stroke or transient ischemic attack)       
- An uncontrolled medical condition (ex. uncontrolled Diabetes)               
- A cardiac event within the past 3 months (heart attack within the past 3 months) 
- A neuromuscular disease affecting your balance or stability (ex. Muscular Dystrophy) 
- A neurological disease affecting your balance or stability (ex. Parkinson’s Disease) 
 
SELF-REPORT CHECK LIST (check all that apply) 
(   ) Have you ever been diagnosed with dementia by a physician?  
(   ) Do you have a pacemaker?   If yes, when did you have it implanted?    .  
(   ) Do you have any known neurological disorders (e.g. Parkinson’s Disease)?  
(   ) Do you have any known neuromuscular Disorders (ex. Muscular Dystrophy)? 
(   ) Do you have any allergies or sensitivities to water based gels or adhesives? 
(   ) Do you have arthritis? If yes, what joints are affected?    .   
(   ) Do you experience moderate to severe pain while standing or walking?  
(   ) Are you near sighted?   
(   ) Do you wear corrective glasses or contacts? 
 
Past Health (identify approximate year of diagnosis/event) 
(   ) Heart Attack (   ) Hypertension 
(   ) Heart Failure (   ) High Cholesterol 
(   ) Open Heart Surgery (   ) Diabetes (diet or insulin) 
(   ) Congenital Heart Disease (   ) Sleep Apnea 
(   ) Atrial Fibrillation (   ) Emphysema or Pneumonia 
(   ) Stroke (   ) Asthma or Bronchitis 
(   ) Transient Ischemic Attack (   ) Kidney or Liver Disease 
(   ) Carotid Stenosis (   ) Ulcers 
(   ) Peripheral Vascular Disease (   ) Chronic Inflammation:   . 




(   ) Chronic Obstructive Pulmonary Disease 
Current Health (within the past 3 months) 









List current medications: 
1.       2. 
3.       4. 
5.       6.  
7.       8. 
9.       10. 
11.       12.  
        
Current Symptoms (within the past 3 months) 
(   ) Irregular Heart Beat (   ) Fatigue 
(   ) Chest Pain (   ) Headaches 
(   ) Persistent Cough (   ) Dizziness/Light-Headedness 
(   ) Wheezing/Shortness of Breath (   ) Pain; If yes, where? ___________ 
(   ) Memory Complaints (   ) Other: ________________ 
 
Habits  
Smoking: Never (   ) Ex-smoker: year (        ) Regular: # cigarettes/day (    ) 
Exercise: Never (   ) 1-3 times per week (   ) 3+ times per week (   )  
 
Balance Screening  
Please select which number best represents your fear of falling and balance confidence. 
 










0 1 2 3 4 5 6 7 8 9 10 






0 1 2 3 4 5 6 7 8 9 10 
 
Current Activity Level 
 
Please list the types of activities/exercises you have done in the past 3 months.  Also, indicate 
how often (frequency) and how long (duration) you do these activities for. 
 
Type of Activity Frequency 
(how often) 
Duration 





What percentage of your total time spent performing physical activity is light, moderate and 
hard? 
 
LIGHT: 2-4 on a scale from 0-10.  
No sweating, but faster breathing, e.g. walking. 
 
MODERATE: 5-6 on a scale from 0-10.  
Some sweating and deeper breathing, but still able to talk comfortably, e.g. 
brisk walking or biking. 
 
HARD: 7-8 on a scale from 0-10.  







Recent Nutritional Intake 
Please list the time of your last meal, along with the type and quantity of food/beverages 
consumed during that last meal. 










HEALTH STATUS QUESTIONNAIRE – C – Supplementary Study 
 
Study Title: The influence of low cerebral blood flow on postural stability 
 
Researchers and Contact Information: 
Laura Fitzgibbon, MSc        phone: 226-808-4530                     e-mail: lfitzgib@uwaterloo.ca  
Richard Hughson, PhD        phone: 519-888-4567 ext 32516    e-mail: 
hughson@uwaterloo.ca  
Department of Kinesiology, Applied Health Sciences, University of Waterloo, Waterloo ON N2L 3G1 
 
Study ID: _______________  
  
 
Exclusion Criteria: If any of the following apply, you should not participate in this study 
- Psychiatric illness or use of psychoactive drugs       - Diabetes 
- History of drug/alcohol abuse               - Resting heart rate > 110bpm 
- High blood pressure (≥ 140/90 mmHg)   - Respiratory illness (ex. asthma) 
- Medications which influence heart rate or blood pressure - Peripheral vascular disease 
- If you are or you think you may be pregnant 
 
Do one or more of these apply to you?:    Yes    or    No 
 
Do you have any allergies or sensitivities to water based gels or adhesives?     Yes    or    No 
 
 
Current Health (within the past 3 months) 
List current health issues: List current medications: 
1. 1. 5. 
2. 2. 6. 
3. 3. 7. 
4. 4. 8. 
 
 







How many days per week do you participate in at least 30 minutes of continuous physical 
activity? Circle one. 
 
None  1-2 days                3-4 days              5+days 
 







What percentage of your total time spent performing physical activity is light, moderate and 
hard? 
 
LIGHT:  2-4 on a scale from 0-10.  
No sweating, but faster breathing, e.g. walking. 
 
MODERATE: 5-6 on a scale from 0-10.  
Some sweating and deeper breathing, but still able to talk 
comfortably, e.g. brisk walking or biking. 
 
HARD:  7-8 on a scale from 0-10.  
Heavy sweating and heavy breathing with difficulty talking, e.g. 







Recent Nutritional Intake 
 
Please list the time of your last meal, along with the type and quantity of food/beverages 
consumed during that last meal. 
 




Researcher Confirmation: ____________________ Date: _____________ 
 
